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Abstract
Systems Biology encompasses different research areas, sharing graph theory as a
common conceptual framework. Its main focus is the modelling and investigation
of molecular interactions as complex networks. Notably, although experimental
datasets allow the construction of context-specific molecular networks, the effect
of quantitative variations of molecular states, i.e. the biochemical status, is not in-
corporated into the current network topologies. This fact poses great limitations
in terms of predictive power. To overcome these limitations we have developed a
novel methodology that allows incorporating experimental quantitative data into
the graph topology, thus leading to a potentiated network representation. It is
now possible to model, at graph level, the outcome of a specific experimental
analysis. The mathematical approach, based on a demonstrated theorem, was
validated in four different pathological contexts, including B-Cell Lymphocytic
Leukaemia, Amyloidosis, Pancreatic Endocrine Tumours and Myocardial Infarc-
tion. Reconstructing disease-specific, potentiated networks coupled to topolog-
ical analysis and machine learning techniques allowed the automatic discrimina-
tion of healthy versus unhealthy subjects in every context. Our methodology
takes advantage of the topological information extracted from protein-protein in-
teractions networks integrating experimental data into their topology. Incorpo-
rating quantitative data of molecular state into graphs permits to obtain enriched
representations that are tailored to a specific experimental condition, or to a sub-
ject, leading to an effective personalised approach. Moreover, in order to validate
the biological results, we have developed an app, for the Cytoscape platform,
that allows the creation of randomised networks and the randomisation of exist-
ing, real networks. Since there is a lack of tools for generating and randomising
networks, our app helps researchers to exploit different, well known random net-
work models that could be used as a benchmark for validating the outcomes from
real datasets. We also proposed three possibile approaches for creating randomly
weighted networks starting from the experimental, quantitative data. Finally,
some of the functionalities of our app, plus some other functions, were devel-
oped, in R, to allow exploiting the potential of this language and to perform
network analysis using our multiplication model. In summary, we developed
a workflow that starts from the creation of a set of personalised networks that
are able to integrate numerical information. We gave some directions that guide
the researchers in performing the network analysis. Finally, we developed a Java
App and some R functions that permit to validate all the findings using a random
network based approach.
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Introduction
1.1 Systems Biology
Systems Biology is a relatively new and inter-disciplinary field that involves differ-
ent subjects. It takes great advantage of network-based approaches to model and
study complex biological processes [1]. Classic biology is, and historically was,
focusing on single biological entities like, for instance, a protein. The innovative
perspective that the Systems Biology’s approach proposes aim at studying what
happens when different actors play their role together, giving rise to complex sys-
tems. This goal is achieved by considering the set of all the interactions that take
place between these objects in order to build, and model, a system. The system
can finally be exploited by investigating i) the role of each single actor and also,
more interestingly, ii) the emergent properties that arise because of their interac-
tions. This is a new, and very promising, approach that gives us the possibility to
obtain a comprehensive view of complex biological systems like, for instance, a
cell [2].
Denis Noble, one of the pioneers in this field, said that ”Systems Biology. . . is
about putting together rather than taking apart, integration rather than reduction. It
requires that we develop ways of thinking about integration that are as rigorous as our
reductionist programs, but different. . . . It means changing our philosophy, in the full
sense of the term” [3]. This quote is a very good summary of what is waiting in the
future of biology. A very big effort is currently carried out and aims at obtaining a
complete description of living organisms by understanding how cells, tissues and
all the biological bricks interact with each other in order to carry out what we call
life. Systems Biology is not only devoted to investigate what happens in human
or other organisms but it is also a way of thinking that permits to describe any
complex systems like, for instance, the interactions that take place in the Great
Barrier Reef or between each single component of a complex organic molecule.
In this scenario it is easy to understand how many different subjects are in-
volved. Systems Biology is a mixture of very different techniques, skills and tech-
nologies and requires knowledge from very different fields. Genetics, genomics,
proteomics, metabolomics and transcriptomics are current high-throughput tech-
nologies that generate a very large amount of data. Mathematical skills are re-
quired to define and build the systems of interacting actors [4, 5]. Statistical
3
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techniques are used to investigate the data and are used to test the hypothesis and
results. Finally information technologies play a very important role since they
allow managing the big amount of data, to extract useful information through al-
gorithms and to visualise models and results in a meaningful way and, especially,
in a human-readable format.
Bioinformatics and computational biology are the natural conjugations of the
skills that are considered necessary to investigate all the complexity that comes
from this amount of information. There are many different methodologies to
exploit all the data produced by the modern -omics techniques and it is possible to
find many softwares, webservices and programming languages. We could use soft-
ware for the visualisation of molecular structures, e.g. PyMol [6] or SwissPDB-
Viewer [7], suites that permit to perform all kinds of statistical analysis and tests,
e.g. R [8], programming language like BioPython [9] and BioJava [10] that are de-
signed to deal with biological data and manage biological problems. Webservices,
like Blast [11] or ClustalW [12], that permit to investigate proteins structures,
homologies between a great number of protein sequences at the same time and,
also, provide a lot of other features. There are also many biological databases that
we can easily access to download protein structures, sequenced genomes, biologi-
cal and disease networks, ontologies, standardised names and so on: UniProt [13],
GeneOntology [14] and Kegg [15, 16] are just very few examples. But, because
of this huge amount of information, we also have to face some drawbacks. Differ-
ent data format used to describe the same process and data type, softwares with
an interesting feature but without another one, different platforms and operative
systems, huge datasets that are increasing their dimension every day. Another
issue comes from the interface between biologists and computer scientists and
mathematicians because of the different spoken languages. A biologist may find
a lot of difficulties in managing a programming language and a programmer must
understand what the physician really wants to investigate and what is the most
informative, and useful, output. One of the purposes of our work, and of all
the other works that consider biological and computational aspects two faces of
the same coin, refers to the nature of these kinds of works. They can be consid-
ered as bridges between the two mentioned worlds, i.e. biology and computer
science. Developing novel tools and providing working examples, showing the
algorithms behind the softwares, contextualising these mathematical formalisms
using real, biological examples, showing numerical results and interpreting them
are practices that create links between different worlds. These works allow to
understand and to obtain a different point of view, wether more mathematical or
more biological, that, ideally, works as a bridge. We aim at creating new bridges.
This is the general context for the modern transition from a reductionist to
a holistic view of biology. Reductionism is, and was, the main method used
to address biological problems but things seem to be changing. Some scientists
in the past, i.e. in the sixties, seventies and nineties, and an increasing number
of researchers today, are considering biology as a set of interacting objects that
should be considered toghether. In this sense, the holistic approach is (re)gaining
more and more interest and an interdisciplinary knowledge that crosses different
fields like, for instance, mathematics and biology, is becoming more and more
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important.
A very interesting, current, model that allows investigating biological systems
properties takes advantage of graph theory. Networks, or graphs, are mathemati-
cal abstractions that could be used to model complex biological systems. Biolog-
ical networks are composed by different kinds of actors that may be metabolites,
genes, RNAs, and proteins [17]. From a mathematical perspective, networks, ab-
stracted as graphs, are sets of objects that are used to describe interactions, called
edges, between actors, called nodes. Formally a graph is defined as G = (E, V )
where E is a set of edges and V the set of vertexes, i.e. the nodes. This simple no-
tation is very useful to model complex, static biological processes where hundreds
of genes, RNAs, proteins and metabolites interact together generating thousands
of connections [18]. This static representation gives us a frame of the cell. It is
not able to take into account the time, which means that the interactions do not
change over time. But graphs can be used to represent dynamic processes. These
dynamic models permit to describe a changing system and the kinetics that take
place, for instance, inside a cell. Some of these models are i) Lotka-Volterra based
on differential equations systems, ii) Petri-nets [19], iii) P-systems [20] and iv)
pi-calculus models [21] just to cite few interesting methodologies in the field.
1.2 Personalised Medicine
A branch of Systems biology, called Network Medicine [22], takes advantage of
all the technologies and methodologies we mentioned to study biological systems.
It has specific applications in the field of life science. Some of the topics are, for
instance, the comprehension of pathological mechanisms in human cells, tissues
and organs, the functioning of cell signalling, or how diseases interact with each
other [23]. It is possible to discover new, useful biomarkers, to personalise thera-
pies or to suggest potential targets to develop new drugs.
Personalised medicine is a discipline that is emerging and aims at addressing
diseases at a single individual level. New analytical tools and new approaches to
the study of human pathologies is guiding medicine towards this new and par-
ticipatory approach. It could be summarised by using four terms that are predic-
tive, personalised, preventive and participatory. Predictive in the sense that it aims
at finding factors that increase the risk of developing specific diseases, like for
instance, genetic predisposition to certain pathologies. Personalised means that
the medicine should be tailored to the single individual by defining therapies and
treatments that depend on the individual background. Predictive in the sense that
developing tools that aim at obtaining an early diagnosis are necessary in order to
tackle diseases while they are still in their first stages. Finally, participatory be-
cause this new approach requires that the individuals take an active participation
becoming an integrating part of the whole diagostic and therapeutic path [24]. It
is more and more clear that the current approach based on the use of drugs suffers
because of the intrinsic complexity of the human organism. Not all the people
have the same response to a drug. Pharmacokinetics greatly varies between differ-
ent individuals and these variations affect the effect a drug has with respect to a
specific tissue, organ or disease. For some people a drug may cause light or heavy
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side effects, for some other people it may lose its therapeutical function, and for
some other it works as it is expected. Personalised medicine aims at overcoming
these limitations, taming the great uncertainty that is one of the main limitations
of the current medicine.
Personalised medicine could be considered as the future of the medicine and,
in this sense, it is possible to foresee that technological advancement will give a
very strong support to the personalised approach [25, 26]. At a high level we
think about wearables like, for instance, watches that are able to measure body
temperature, hearth rate, body weight, and several other parameters, are becom-
ing more and more affordable. Personal technologies that check health-related pa-
rameters are becoming part of our daily lives. These instruments create a wealth
of data that is very useful in generating information and predictive models to
tackle unhealthy behaviours. On the other hand, they allow measuring how
healthy a person is. At a low level researchers are becoming more and more able
to model specific pathologies by considering the interactions between molecules
like proteins and genes. By doing so it is now possible to investigate the role
of a specific player in the development of a disease and it is possible to simulate
biochemical variations at different time points.
In this context, Systems biology plays a very interesting role. This emerg-
ing approach, that conjugates very different subjects, allows creating very specific
models that permit to investigate human diseases as a complex systems. By do-
ing so it is possible to highlight emergent properties and complex behaviour that
are the result of the interaction of several parties that cannot be unveiled by us-
ing the classic, reductionist approach. In this sense new methodologies that are
able to create better representations of the biological process are needed. New
models, faster algorithms, user friendly softwares are required in order to allow
researchers from different backgrounds to exploit the advantages of the systems
biology approach. In this panorama, our work aims at creating a new network
model that is able to represent the individual variation, to create a simple work-
flow that allows creating a network from a set of proteins, to allow the investi-
gation of the network properties through a comparison between different classes
of network and, finally, to validate the experimental results by using a random
network based approach.
1.3 Graphs
Systems Biology takes great advantage from graph theory. Graphs was firstly in-
troduced by Leonard Euler [27]. In his paper, Euler, used for the first time, two
terms that are vertex and edge. Here, the idea of graph was used to model the city
of Königsberg in order to address the famous problem related to the city’s bridges.
The question, addressed by using a graph-based approach, aimed at finding a path
through the city that would cross each one of the seven bridges once and only
once. Euler demonstrated that the problem does not have a solution and opened
a new field related to the study of graphs and their mathematical properties. Cur-
rently, graphs are used to model complex systems like, for instance, communities
and social interactions, biological processes, and the web. Also they are studied
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from a theoretical point of view and are used to solve algorithmic problems.
In mathematics, a graph G(V,E) is a set that contains a set of vertices and a
set of edges edges. We denote the set of vertices by V (G) and the set of edges by
E(G). The cardinality of V is denoted by n and the cardinality of E by m. A
vertex, also called node, represent an abstract and featureless object that describes
a particular entity in a specific context. An edge is a connection, e.g. a link,
between two vertices and connects them. Two vertices that are linked by an edge
are said to be adjacent and we call them neighbours. Two vertices joined by an
edge are called the endvertices for that specific edge.
Graphs can be undirected or directed. In an undirected graph the edges uv and
vu are the same edge and they are denoted by (u, v) or (v, u) without difference.
In a directed graph each edge has an origin, i.e. a source, and a destination, i.e.
a target, and these two specific nodes form an ordered pair. Hence, the edge
uv, (u, v), is different from the edge vu, (v, u) since their origin and target are
different.
Figure 1.1: An example of graph, where Nodes and edges allow the emergence
of complex properties that are not peculiar of the single actors alone but are a
consequence of their interaction. The different kinds of lines indicate two differ-
ent shortest paths. They differ because of the node involved in the path but not
in the length. Hence they are considered, in terms of distance, the same path.
They are different in terms of node composition since the first path, the dashed
one, starts from the Node 5 and passes through the Node 3, Node 1 and reach
the Node 4. The other path, i.e. the dotted line, starts from the Node 5 and
passes through the Node 3, Node 6 and reach the node 4. In this sense they are
considered different paths.
An edge can be associated to a numerical value, that can be defined weight.
Weights can be represented by a function ω : E → < that assign a value ω(e)
to each edge e ∈ E. Edge weight describes a specific feature, depending on the
context. For instance, weights can abstract the cost that is necessary to travel
from u to v, they may represent a distance or, finally, the strength of a chemical
bond.
Nodes have some specific properties that emerge from the topology of the
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network and that can be investigated by means of specific mathematical tools.
In an undirected graph the Degree, denoted by d(v), is the number of edges that
have v as an endvertex. In a directed graph the out-degree, denoted by d+(v), is
the number of edges that have an origin in v and the in-degree, denoted by d−(v),
is the number of edges that have v as a destination. Nodes that have very high
values of Degree, if compared to the other nodes in the network are said hubs.
A graph could be defined through a matrix-based notation. The adjacency
matrix Ai,j is a 0-1 matrix that describes the connections between the nodes. It
has only zero on the diagonal and is symmetric if the graph is undirected. The
position (i, j) is equal to 0 if there is no edge connecting the node i and j, 1
otherwise. The adjacency matrix that represents the graph in Fig. 1.1 is:
A =

0 0 1 1 0 0 0 0
0 0 0 1 0 0 0 0
1 0 0 0 1 1 0 0
1 1 0 0 0 1 1 0
0 0 1 0 0 0 0 0
0 0 1 1 0 0 0 0
0 0 0 1 0 0 0 1
0 0 0 0 0 0 1 0

By using the edges it is possible towalk around the graph and connect different
nodes by means of paths. Let e1, e2, . . . , en− 1 be a sequence of elements of E(G)
for which there is a sequence v1, v2, . . . , vn of distinct elements of V (G) such that
φ(ei) = ai, ai+1 for i = 1, 2, . . . , (n − 1). This sequence of edges is called a path.
There are different kinds of paths depending on their characteristics. A shortest
path is a path, chosen by a set of paths, that minimises the number of steps that
are necessary to connect two nodes. A mathematical properties that depends on
the paths is called diameter and represents the longest path between two nodes in
the graph.
There are also different kinds of graphs that have very different properties.
In the time, some theoretical models were proposed and aims at describing some
characteristics of some real world graphs. For instance the world wide web was
abstracted as a graph and it was found to have a very peculiar property that de-
pends on the Degree of the nodes that compose the network. This property,
that show a specific Degree distribution that has a power-law trend, is now called
scale-freeness [28]. The theoretical models that describe scale-free networks is
called Barabàsi-Albert model. There are some other model like Erdős–Rényi or
Watts-Strogatz that have their specific properties.
1.4 Biological Networks
Graphs, as mathematical objects, are used in order to model complex biological
processes that involves different kinds of objects. It is possible to imagine a living
cell as a set of interacting subcellular components like, for instance, membranes,
cytoskeleton, genetic material, i.e. the nucleus, and several kinds of organelles
Chapter 1. Introduction 9
that are necessary to maintain the cell a living component for tissues and for or-
ganisms. Also it is possible to model the interactions between different cells like
neurons in order to model the complex structure that originates all the complex
tasks our brain daily carry out. Physiological interactions and pathological inter-
actions are all faces of the same system and as the model become more and more
detailed, we gain more details that permit to investigate its properties.
From the point of view of the single components, i.e. the nodes, that in
biology is a molecular point of view, it is possible to observe how a lot of dif-
ferent, interacting components that are proteins, metabolites and other kinds of
molecules give rise to complex networks that have significant emergent proper-
ties. Indeed, different networks work together at different levels in order to keep
the homoeostasis, that is the necessary equilibrium that allows life. These differ-
ent layers are strictly connected and it is impossible to define where a network be-
gins and where it ends. Cell signalling, metabolic pathways, genetic background
work together and cannot be separated. Of course, for carrying out research it is
necessary to obtain a model of the process which is under investigation like, for
instance, a specific pathology but it is important to consider that this is just a tile
in a very big and complex puzzle.
On the other hand, it is possible do define a sort of hierarchy or to describe
some general, and common, set of biological networks depending on the kind of
molecules involved. So, for instance, starting from the genetic level it is possible
to define gene interactions networks as those networks that are used to describe
the interactions between DNA and RNA sequences. Genes constitute the basis
for encoding the aminoacids, that are the smaller blocks that build proteins. Then
we have protein-protein interaction networks that are those networks depicting
how proteins interact each other in different metabolic and regulatory networks.
Finally, it is possible to define a set of networks that consider different kinds
of molecules. These networks model the complex interactions that give rise to
their life-cycle and consider chemical reactions and compounds. In this sense,
metabolic networks are used to describe the reactions that occur between a set of
very different molecules.
The idea of a cell like a set of different networks that interact each other
could be used to define a sort of dependency. Starting from the lowest level,
that is represented by the genetic information stored in the genes, to the high
level, represented by the duties carried out by the proteins. In this context, the
aim of our work is to investigate the topological characteristics of these protein-
protein interaction (PPI) networks in order to extract information starting from
experimental data[29] to comprehend how the interactions give rise to complex
properties. Also, we are looking for shared characteristics that may shed a light
on whether similar biological mechanisms are shared between similar classes of
networks.
When we refer to biological networks it is important to note that each kind of
them, i.e. genes, metabolic or protein, has a specific aim and describe a different
kind of interaction. Indeed, there is a great difference between signalling networks
and metabolic networks. The aim of the cell signalling is the transport of a signal
from a source S to target T that regulates a specific process. On the other hand
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a metabolic network aims at representing the flow of mass and energy that takes
place in a specific chemical reaction. Generally speaking, there are differences
also from the point of view of the mathematical model used to represent these
processes. If we consider a signalling pathway it is easy to understand that the
direction of the edges in the network is a fundamental information since chemical
reactions have a very specific input and output. On the other hand, an interaction
between proteins does not have, necessarily, a direction so the edges we use to
model it can be both directed and undirected.
Finally, it is important to note that, even though from a theoretical point of
view it is easy to separate a PPI network from a metabolic network, then in the
real world this separation does not exist. In biology there is a single network that
comprises different subnetworks, subunits, subparts that aim at solving a specific
task that do not work alone. All these parts work togheter and it is important
to consider them as a whole, even though the current knowledge, technologies,
methods and algorithms do not allow to model a comprehensive view of this
complexity.
Protein-Protein interaction networks
This kind of networks, also known as PPIs networks, aim at modelling interac-
tions between proteins. Proteins are aminoacidic sequence that are generated by
translating the DNA strand into specific kind of RNA. Each protein has different
levels of structure, from a linear to a three-dimensional structure, that define the
role it plays and its duties and, as a consequence, its interactors. Proteins tend
to interact since their functions are usually the result of some sort of regulation.
These interactions happen by means of electrostatic forces and, sometimes, by
means of covalents bonds. An interaction can be stable or transient, depending
on its duration over time. Stable inteactions generate complex structure where
each subunit, i.e. the protein, has a structural or functional duty. These com-
plexes may be homo or hetero-holigomeric depending on the number of different
subunits. An homo-holigomeric complex has only a kind of protein that aggre-
gate togheter. Hetero-holigomeric complexes have different proteins constituing
different subunits. Transient interactions are, by definition, short and reversible
and generate rapid modifications. Proteins interact by means of specific domains
that determine whether two different proteins are able to share, or not, a link.
To infer protein-protein interactions there are many experimental methodolo-
gies, i.e. yeast-two-hybrid screening [30] (Y2H) and affinity purification-mass
spectrometry [31] (AP-MS).
Gene regulatory networks
Genes regulatory networks are defined through the set of molecules that, inter-
acting with each other, cause the expression of a gene. This kind of network
comprise receptor proteins, transcription factors, inhibitory factors, mRNA and
several other molecular actors that are required in order to let a gene being ex-
pressed. Other kind of networks that comprise genes are gene co-expression
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networks that are, usually, inferred from an expression array. The interactions
between the set of genes that are considered of interest may represent, for in-
stance, the level of co-expression between the genes in the array. In this sense it is
possible to generate a network of interacting genes and investigate its properties.
A gene that is expressed generate, through a chain of biological events, a final
product that is a protein. The production of proteins changes in different kind of
cells so a neuronal cell express different genes with respect to a liver cell. Genes
can also be expressed as a consequence of a stress, like for instance heat shock,
or because of some environmental stimuli that, somehow, affect the behaviour
of a specific kind of cells. All the expressed genes interact and give rise to genes
regulatory networks that can be investigated.
Generally speaking, the nodes in a gene regulatory network are genes, but
some other actors may be involved in this kind of network like, for instance, dif-
ferent kind of RNAs or enzymes involved in RNA transcription and translation.
The edges between these actors represent the activation or inhibition of reactions
and can also be represented by boolean functions. It is also possible to model
gene co-expression networks where the links represent the interaction between
two genes whose expression is related.
Metabolic networks
Metabolism is represented by the set of chemical reactions that take place in an
organism. Thanks to these enormous amount of biochemical transformations
like, for instance, the citric acid cycle (see Fig. 1.21) a series of biological functions
ranging from growth, reproduction, and maintenance of cellular structures allow
to respond to environmental stimuli.
Metabolism is a general term that includes two kinds of chemical reactions
depending on the input and the output. Catabolism aims at producing energy
by breaking down organic matter. On the other hand, anabolism uses energy to
build cellular components like, for instance, proteins. So, a metabolic network
is useful to describe pathways that are sets of chemical reactions that transform
a component into another. Here, nodes are chemical components and edges,
i.e. directed edges, are chemical reactions. The molecular components that are
involved in this kind of network are aminoacids, proteins, lipids, carbohydrates,
nucleotides, co-enzymes, minerals and cofactors.
1.5 Related Works
In literature it is possible to find a lot of different works, whose goal is to ad-
dress different biological questions, that take advantage from network-based ap-
proaches. PPI network and, more generally, network-based methodologies are
attracting a lot of interests and a lot of works are taking advantage from these
techniques. A brief discussion about the current methodologies and the current
1https://commons.wikimedia.org/wiki/File:Citric_acid_cycle_with_
aconitate_2.svg
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Figure 1.2: Krebs Cycle depicted as a network. The nodes represents different
kinds of molecules. The edges are directed, since a chemical reaction has a very
specific direction.
research that is carried out is necessary in order to place our work in this impor-
tant and challenging field.
Generally speaking it is possible to affirm that current approaches and appli-
cations of network biology are strongly related to the field of biomedicine. A
lot of efforts are carried out in order to investigate the molecular mechanisms
that underlie the insurgence of the pathological state. All kinds of cancer, neu-
rological disorders, metabolic disfunctions are currently modelled as networks of
interacting metabolites, genes, proteins, in order to investigate their properties
and dynamics. These are works that take advantage of several methodologies like
-omics technologies, laboratory experiments and in-silico models in order to ob-
tain a comprehnsive view of a disease. There are also more theoretical works,
since graph theory is an hot topic not only in the biomedical field. Computer
scientists are also working on new softwares and analysis to make them more
accessible to the broader audience. In this sense, it is possible to create some
subsets of works that result in different classes of papers. Major topics could be:
introduction to systems biology, biological network analysis, biological network
modelling, applications in biomedicine, softwares and databases.
A very interesting set of papers, that can be considered as manuals for the net-
work analyst, refer to those manuscripts that aim at giving a guide for the readers
throguh the main methodologies that could be used to infer the networks proper-
ties. There are a lot of this kind of works. For instance, the work of Pavlopoulos
et Al. [32] aims at summarising all the mathematical properties that are peculiar
of graphs and how they can be used in order to investigate, in a context of bio-
logical networks, the specific properties of set of interacting molecules. There are
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very different kinds of properties that interest a network. These properties can
be global and are computed over the whole network, or local and consider the
characteristics of a single node. Also it is possible to infer properties that arise
from the interaction of set of nodes like clustering and network motifs.
Other examples of these kind of works are [33, 34, 35] that have a main fo-
cus on mathematical properties of the networks and describe several graph-based
techniques that allow extracting networks properties. Generally speaking, it is
possible to affirm that graph theory allows to model different kind of biological
processes and permits to investigate their topological characteristics to rank the
nodes in terms of topological importance, to extract specific subset of interacting
nodes which may form complex biological entities, and so on. This subset of
papers include some other works like [36, 22, 37]. They aim at describing the
possibilities that systems biology offers by giving some, very interesting perspec-
tives about this emerging field. It is important to note that these papers, like many
other published works we are not including here, were published some years ago,
when network-based methologies were still emerging as a new approach to study
molecular interactions. Indeed, systems biology moved its first steps in the late
1900 and became an established field of research in between the last decade of
1900 and the early 2000. The works we listed belong to this period and should be
considered as introductory to the field of network medicine.
Another very interesting class of works, related to the field of biological net-
work analysis, also based on the investigation of networkmathematical properties
refer to the studies of the emerging properties and network modules. The, prob-
ably, most famous work about network motifs was written by Milo et Al [38].
Here the researchers investigated a wealth of different networks, ranging in a lot of
different fields like biochemistry and engineering. What they found refers to the
so called network motifs. Network motifs are recurring patterns of interactions
that appeared in all the networks they analysed. These motifs represents different
ways, that are shared between different kinds of networks, to process informa-
tions. Feed-forward loops, chains, and triads appeared as patterns of interactions
allowing the proper functioning of the networks. Another, very important paper
from Bhalla et Al. [39] refers to the emerging properties of biological networks.
Here, researchers highlighted the role of emerging behaviours that are strictly
dependent from the interactions between the nodes. They described how the sig-
nal is processed in different kind of signalling networks and they affirmed that
the biochemical response to stimuli are stored into these networks of interacting
molecules and give rise to complex responses that enable biochemical activities.
Some other works, i.e. [40, 41] focused on the emergence of network modules
and other recurring patterns in networks that allow understanding the role of the
nodes and the interactions between different parts of the network.
Modelling of biological networks that comprise the highest and more detailed
set of interactions is a hot topic. A very interesting project that aims at map-
ping the whole interactome in several organisms is currently ongoing. The first
paper describing this effort, i.e. [42], shows how researchers are mapping the
human interactome by using high quality interactions that are generated through
an experimental approach. All these data are avaiable on the project website. In-
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teractome is a term that indicates the whole set of molecular intractions that take
place inside a specific cell. In this sense it is possible to dissect the term in different
meanings. There exist protein interactomes, e.g. proteome, disease interactomes,
e.g. diseasome, etc. . . . A lot of works appeared, aiming at giving directions about
the investigation of interactomes.
An interactome that aims at investigating the interactions between different
diseases becomes a diseaseome, like the one described in the work from Janjić et
Al. [43]. Here the researchers carried out a survey in which they describe differ-
ent kinds of associations between diseases. What emerges from this paper is that
diseases could be linked through shared metabolic processes, miRNAs or genes.
The idea is to link two disease if they have something in common and then, to
investigate the properties of the generated network in order to uncover the rela-
tionships between pathologies and the main actors involved in these connections.
Huge protein-protein interactions networks become proteomes like the net-
works described in the work from Yook et Al. [44]. In this work the researchers
aimed at comparing four different interactomic databases in order to evaluate the
large-scale properties of the interactions occurring in yeast, i.e. Saccaromyces cere-
visiae. What they suggest is that the networks constructed from the different
databases share a common, large-scale topological structure. Also they found that
manually curated datasets show a stronger relationship between topological role
of a node and its function/localisation. What emerge from these two works is
that they are not focused on a particular biological process. The goal here, is to
uncover the general properties of these huge networks and to investigate similar-
ities and differences between the interactome in different organisms.
Other works that take advantage from the interactome-based approach were
written by Liang et Al. [45] and by Sharan et Al. [46]. Here the point was
to compare different interactomic networks, based on protein interactions, of
different organisms in order to investigate the similarities. Liang and colleagues
defined a pipeline that allows comparing these kinds of networks while Sharan
and colleagues applied different methods for network alignments. What came out
is that different networks share common characteristics in terms of evolutionary
conservation at network level. These two examples show how these approach
should be used in order to infer general insights and are not useful when it comes
to infer particular molecular target that could be useful in specific diseases.
But, as we said, networks could be applied to a lot of different fields and in bi-
ology they can be used to model any kind of process and to perform very different
kinds of analysis. For example in Scardoni et Al. [47] a semi-dynamic approach
was used to simulate the inhibition of proteins. Scardoni introduced the notion
of Interference to investigate the topological effects that are caused by the removal
of one, or more, node in a network. In the paper they give some interesting exam-
ples of positive and negative Interference and describes its reverse side that is the
Robustness. Biologically the interference process can be associated to the inhibi-
tion of a specific protein and, in this work, such kind of knock-out experiment
were applied to a a protein-protein interaction network. They studied the prop-
erties of the network that is involved in the regulation of the integrin activation
in human primary leukocytes with a specific focus on the Betweenness Interfer-
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ence of three kinases: SRC, HCK, FGR and JAK2. This choice was related to the
fact that these kinases are negative regulators of the integrin affinity maturation
and also because several specific inhibitors are available: they enhanced the value
of their predictions by comparing the results with the known effects described
in literature. The results show how the four proteins are highly involved in the
process they studied and corroborate the utility of such approach. The described
workflow is very interesting and could be used as a promising methodology when
a knock-out experiment is needed, allowing the scientists to perform all the tests
in-silico.
In Li et Al. [48] the researchers performed a system-level study that was aim-
ing at uncovering the pharmacological effects of a compound, i.e. Compound
Danshen Formula (CDF) currently used in the traditional Chinese medicine as
a treatment for cardiovascular diseases. They proposed a complex model that
combines bio-availability prediction with multiple drug-target predictions and
network pharmacology techniques. Different type of data, i.e. genetical, phys-
iological and biochemical, were used in order to build the model under study.
They identified some potential molecular target, i.e. protein. Then, by using
molecular dynamics they were able to validate the compound-target associations.
Also, the researchers used all the chemical compounds and their targets to build
an interaction network. Finally, they used such network to perform a topolog-
ical analysis in order to uncover all the non obvious relationships between the
pharmacological actors and targets involved in the CDF treatment.
Another kind of very interesting application is described in Nair et Al. [49].
here the researchers show a network-based approach that was used to investigate
all the complex processes involved in the development of inflammation-driven
atherosclerosis. The first step required the identificaion of two sets of those genes
that are related to inflammation. Over these two sets, 124 candidate genes were
extracted and then used as seed proteins in order to build a network. The con-
struction step was performed by using the STRING databse as a reference. Then
the network was analysed and the topological information was extracted. Then
they built a regulatory network by using the transcription factors (TF) that are
related to the hub genes previously identified. In conclusion the researchers were
able to identify five genes that play a central role in atherosclerosis by using a
network-based analysis and three transcription factors was shown to be highly
involved in the network. In this example Nair and colleagues were able to obtain
comparable results by using two completely different approaches that are in-vivo
and in-vitro.
Generally speaking it is possible to affirm that the topological analysis of bio-
logical networks is widely applied in biology for many different reasons like, for
instance, finding drug targets, highlighting the more important nodes, comparing
network topological properties, and to many different kinds of biological data.
Micoarray data, proteomic data, database data could be used to model a network
and obtain interesting and useful insights. We decided to start from the existing
models and technologies to define a new, network and topology-based approach
that allows creating personalised biological models. Indeed, current models are
not able to include numerical information in terms of copy of nodes. The model
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we propose reflect the need of a model that move the current research to a more
personalised medicine approach.
1.6 Our approach
In the field of Network Medicine, static networks are used to model and to in-
vestigate the complexity of the human maladies. Inferring the topology of these
networks allows computing several properties like, for instance, clustering coef-
ficient and nodes centralities. The aim is the study of emergent properties [39]
and the role of the nodes in the system. In this scenario, that is the topological
analysis of the network, there exist some metrics that allow the categorisation of
the nodes by the role they play in the network [50]. These metrics are called
topological indexes or centralities, and are computed by using the information re-
lated to the paths between the nodes in a network [51]. These values allow i)
to depict the role a node plays in the network, and ii) to describe the properties
of the network like, for instance, its clustering coefficient, i.e. the tendency of
a network in creating highly connected subsets of nodes, its sparseness, i.e. the
number of edges compared to the number of the total edges, or the scale-freeness,
i.e. a property that make the network robust and fault tolerant thanks to a hub-
based topology. These are only a few examples of topological characteristics that
allow obtaining a mathematical description of the process. There are a number
of other indexes that are node-specific that permit to study the properties of the
network at a single node level. The most known indexes are Degree, Betweenness
and Closeness but there are many other metrics that are commonly used in social
and economics network analysis, that permit to define nodes characteristics.
In this work we focused on protein-protein interactions (PPI) networks since
it appears that proteomics and protein-protein interactions are a very promising
field of research [52, 53]. The protein composition of a sample, e.g. a tissue,
provides a snapshot of the state of an individual in that particular organ. The
biochemical activity of a tissue results from the interactions between proteins,
environment, metabolites, genes. . . . Currently, it is not possible to construct a
comprehensive model that is able to take into account all the mentioned factors
but some steps in this direction were done. Studying networks of interacting
molecules allows for a more systemic view, i.e. the holistic approach, of a dis-
ease and using PPI networks allow us creating a very precise map of a disease
and the proteins that are, at different levels, involved. Each protein has its own
structure and functions and carry out its duty as a single unit or as part of a big-
ger mechanism. If the mechanism is disrupted a pathological state emerge and
that is why, we believe, studying the interactions between proteins is fundamen-
tal to understand what happens when a disease emerges. PPI networks can be
abstracted as graphs that describe how these biological bricks interact in order to
generate complex biological functions, e.g. DNA replication, to work as trans-
porters and carriers or as receptors in order to respond to a specific stimulus.
There are different kinds of protein-protein interactions and there are different,
cellular and extracellular, locations where proteins interact with different proper-
ties. Once we model a specific biological process it is important to consider the
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biological role a protein is playing in that specific context. One of the analysis
that can be performed over a network consists in enriching the network itself,
using biological information. This step could be very useful in order to define
the boundaries of the analysis. When studying the mechanisms behind a complex
biological process like signalling, it is fundamental to understand that there is
different locations where signalling takes place. Intracellular signalling and inter-
cellular signalling are necessary to one another but in PPI networks they could be
studied separately. Signals that are sent from a cell to another give rise to cascades
of reactions into the receiving cell but the network of molecules involved in these
cascades could be considered separately from the complex mechanisms that allow
cells communications. These reactions occurs at different time points since the
intracellular cascade takes place only when the extracellular receptor received and
processed the message. A lot of other biological process takes place at different
time but can be modelled in the same network. The amount of data available
makes it possible to build bigger network without considering these aspect but it
is crucial to consider the biology behind the model.
Current experiments produce huge amounts of datasets that are described in
literature and stored in different databases and file formats. Some of the available
databases are STRING [54], BioGrid [55], MINT [56], HPRD [57], MIPS [58],
DIP [59] and PINA2 [60]. By using this information it is possible to build com-
prehensive and reliable networks but, currently, this is not enough. Indeed, a
network may, for instance, tell us which component is more susceptible to failure
and which one is replaceable. But, in order to obtain a better understanding of the
system, what we need is to develop new tools and analysis that gives to the results
a strong statistical and numerical support [61]. Also experimental validation is
fundamental, but it comes after the data analysis phase which is, currently, one of
the main focus in biology. There is a rather consistent literature that describes bi-
ological networks investigation by using topological indexes [62, 43] but, there is
not a standard approach defining how to extract biological information. The fact
that topological analysis are somehow preliminary and do not provide solid find-
ings suggests that there is substantial room for improvement [63]. Improvements
may come from novel approaches to the network analysis, or new centralities.
Advanced methodologies exploit the biological knowledge to add an important
layer of information. In this sense, new models may be useful to link the bio-
logical aspect, for instance the experimental results, to the topology. A number
of published articles ascribe to molecular network topology a central role in the
global functioning of living organisms [64, 65]. In this sense, a current network
analysis aims at investigating the functional outcome of biological phenomena by
identifying the nodes that are more likely to be critical, or central, to cell path-
ways regulation. It appears that the topological role a node, i.e. gene, protein or
metabolite, plays in a network de facto reflects its biological function [66, 67].
Notably, current methodologies of network topological analysis focus on static
models representing sets of well-defined edges and nodes, but are not designed to
incorporate the quantitative variability of molecular functional states, occurring
during the experiments, or characterising individual subjects, such as different pa-
tients [68]. This fact implies that the information stored in the quantitative vari-
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ation of a biological event is simply not considered and it is lost by the analysis,
thus affecting the predictive power of the model. In this sense, current networks
can be used to infer general insights about their global structure and functioning
but are not actually useful to model, for instance, the disease onset and evolution
in a specific subject [69]. This limitation currently hampers the application of
network analysis to personalised medicine.
The approach we propose for inferring network properties and useful biolog-
ical insights, is based on the topological information that is extracted, by using
specific metrics, from a new kind of static network. These new networks, that we
called potentiated or personalised networks, allow incorporating numerical infor-
mation into the graph structure. This means that, for instance, in a biomedical
context we are able to incorporate the biochemical variations that occur between
different subjects, into a shared network, obtaining a number of new, person-
alised networks. The idea is to investigate the properties of the network at the
individual level incorporating the single subject biochemical information. By do-
ing so we are now able to exploit such potentiated network by using some, well
established, methodologies [70] like topological network analysis and machine
learning. The approach for creating personalised networks is very general and
may apply to any kind of network. It allows modelling very different kinds of
interaction between any kind of actor like, for instance, proteins or genes but also
non biological networks too.
We focused on the properties of human pahologies. Main goal is to under-
stand whether the topological centrality indexes can actually improve our pre-
dictive power in terms of highlighting useful biomarkers. To reach this goal, we
combined the biological information, form different high-throughput datasets,
into complex, topological structures obtaining 183 potentiated networks. Then,
we used such potentiated networks to investigate the centrality-based informa-
tion. To extract information from the topological data we took advantage of
machine learning. Through a feature selection algorithm we extracted the most
informative topological centralities, and then by using a classification algorithm
we verified the existence of similarities, and differences, between different classes
of subjects, i.e. healthy and unhealthy. The workflow we designed allows recon-
structing and analysing potentiated biological networks in a context of person-
alised medicine.
Finally we proposed a methodology which allows creating a validation bench-
mark based on random networks, and a new application, specifically developed
for the Cytoscape [71] [72] [73] [74] users, that allow generating and randomis-
ing networks. The application, which is NetworkRandomizer, allows generating
random network and randomising existing networks. Our framework was val-
idated in four experimental datasets, each one consisting of two classes, respec-
tively healthy subjects and unhealthy subjects, and including proteomic datasets
of amyloidosis (AM), myocardial infarction (MI), a phosphoproteomic dataset of
Chronic Lymphocytic B-Cell Leukaemia (B-CLL), and a gene expression profiles
dataset of pancreatic endocrine tumours (PET). We carried out several experi-
ments based on randomly created datasets in order to understand which random
model better fits our need. Finally some utilities were developed by using the R
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statistical language, in order to improve the existing IGraph functionalities and
to let more advanced users being able to perform some of the functions that are
present in the NetworkRandomizer and in the PeSca [75] Cytoscape’s apps.
In this thesis we will use the terms healthy subjects and controls with the same
meaning. The same apply for unhealthy subjects and patients. The network cen-
tralities and the main algorithms we used are explained in the proper sections. A
brief biological introduction for each dataset we analysed is used as introduction
for each dataset’s description. In the Appendices, we show the main class of the
NetworkRandomizer app and the R code we developed.
1.7 Contributions and other works
Contributions Summarising, our contributions are several and provided theo-
retical and application-driven results. We:
1. defined and exploited a new network-based model that allows the integra-
tion of experimental, quantitative data into complex biological networks;
2. obtained a mathematical proof that supports our model;
3. designed a pipeline that exploits the possibilities offered by the model;
4. validated the pipeline using four pathological, experimental datasets;
5. designed and developed a Cytoscape app that allows creating random net-
works to validate in-silico results;
6. created three multiplied random networks models for validating the results;
7. analysed and compared the multplied randon models with the results we
obtained in the pathological contexts;
8. developed a set of functions, using R, that allow to exploit the multiplied
model and another Cytoscape app, i.e. PeSca;
Our pipeline, see the points n. 1-4, is presented in a manuscript we are writing.
The Cytoscape app we developed, see the point n. 5, was described in a
manuscript published, in F1000 Research [76]. Currently the app has reached
more than 800 downloads. It was released 7 months ago.
The R code, see points n. 8, was presented, as a poster contribution, at the
NetSciX conference in Wroclaw in January 2016.
The point n. 6 and 7 are still under evaluation since the results we obtained
are still not suitable for a publication.
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Other works Some other network-based works were done. One of them con-
cerning networks of miRNAs was accepted for publication, in Oncotarget, in
December 2016. Another work related to miRNA is ongoing. These two works
were/are carried out with a research group based in Verona.
A third project is ongoing, and is part of a joint project with an Irish research
group. The project aims at studying the Burning Mouth Syndrome, and other
mental disorders, through an in-vitro and an in-silico approach. We are working
on the network-based analysis.
Finally, the work that inspired the random networks simulation, required
the development of an algorithm, precisely a Monte Carlo Simulation, for the
validation of some biological findings related to the Alzheimers’ disease that was
published in Nature Medicine [77]. It was done in conjunction with a research
group based in Verona.
Part I
Analysing multiplied networks
using topological centralities
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Chapter 2
Multiplication model
2.1 Introduction
The core of this work rely on a new network model which consists of a potenti-
ated topology. This is achieved by using quantitative experimental values that are
integrated in the network as nodes attributes. The starting criterion of the study
is based on the consideration that the topological structure of a PPI network is
essentially determined by the interactions between protein domains [78]. Since
the specific structure of a protein domain is genetically determined [79], then
the network topology is genetically determined as well. Consequently, given
an invariant protein composition in different datasets obtained by analysing the
functional state of defined set of proteins, in different experimental conditions
the inferred PPI network will be invariant too. Thus, the topological analysis of
the reconstructed network will generate identical results even though the datasets
provide subject-specific molecular fingerprints. This fact prevents considering
the quantitative variation of molecular states, often related to individual genetic
background, as part of the topological analysis leading to an informational loss.
To enhance the predictive power of network topological analysis and improve
its application in the context of personalised medicine, we treated experimental
quantitative data as a metric allowing the multiplication of static network topol-
ogy. The multiplication procedure allows incorporating the molecular activation
level, derived from the experimental evidences, into PPI graph models thus ac-
counting for the specificity of the individual biochemical background. In the field
of personalised medicine the multiplied networks aim at modelling what actually
happen between proteins, metabolites and all the molecular actors. Indeed these
actors are responsible for the homoeostasis and for the pathological mechanisms
that induce altered states. Each protein, in each tissue, has a very specific expres-
sion level that determines the number of molecules. The amount of molecules
defines and modulates the effect a protein has in that specific context. The num-
ber of proteins present and the level of expression of a gene are two example of
biological parameters that are fundamental and that determine the correct func-
tioning of all the biological processes that take place in a healthy cell. Even a
small modification that alters this equilibrium may result in a pathological state
that potentially affects the whole system, i.e. the biological and biochemical ac-
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tivity of the organism. So, modelling these variations become fundamental in
personalised medicine since it aims at creating individual models that allow in-
vestigating the properties of a single person. By using the experimental values,
obtained by single subject experiments or analysis, we are now able to abstract
the biological state in form of a multiplied, i.e. potentiated, network and then
investigate its properties by using the pipeline we defined.
The current, static interactome is a huge PPI network that contains thousands
of nodes and hundred thousands interactions. It aims at describing the whole
set of interactions that take place inside a human, healthy cell [80, 81]. Several
projects, that can be compared to the Human Genome Project, aim at obtaining
the most comprehensive view of the interactions between the proteins that are
present in an organism. This task is not easy at all since the interactions change
in time and since the technologies that allow retrieving a real, physical interaction
require experiments, expensive tools, time and money and have different level of
accuracy. Importantly, not all the interactions take place in a cell at the moment
we are experimenting. Finally, it is important to consider that the estimated num-
ber of proteins is around 20000, and many of them are not considered as priority
proteins since they are not involved in the most studied and well known patholo-
gies. Indeed, they suffer of a lack of consideration and may not be included in
expensive experiments or may not be considered important in a pathology since
there is a lack of evidences. It is important to note that there are different kinds
of interactions and that interactions can be retrieved in different ways and, as we
said, they have different levels of reliability. For instance, by using an algorithmic
approach it is possible to infer interactions from the literature, i.e. text mining.
In this sense it is possible to define, under certain user-defined conditions and
filtering options, an interaction if two or more, proteins appear in the same pub-
lished manuscript. Also co-expression could be a parameter that is used to infer
protein-protein interactions. If two genes are co-expressed in a sufficient num-
ber of experiments then the two protein are said to be interacting. It remains of
primary importance to know the sources of information that are used to build a
network and how a specific interaction is obtained. This is particularly important
when considering non physical or experimentally validated interactions.
Generally speaking, it is possible to say that an hypothetical proteome, rep-
resenting the whole set of protein-protein interactions, is not useful in the field
of personalised medicine. Indeed, this kind of interactome represents a very gen-
eral model describing the interactions that take place in a specific cell in a human
organism. In other words, if we consider different subjects, the proteome they
share is represented by a network involving the same amount of proteins where
a protein corresponds to a node. A model like the one we just mentioned could,
potentially, represent the whole set of molecular interactions but, clearly, lacks of
the personal layer that enable the personalised medicine approach. In this sense,
a personalised network analysis is not feasible since such interactome lacks of
the personal, biochemical information. This is a substantial limitation since each
person has his own peculiarities, his own biology and metabolism that are repre-
sented by the activation and expression level of the proteins. Since the study of
the whole biochemical activity that takes place in an organism is not yet feasible,
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we decided to focus on the protein-protein interactions. Moreover, we decided to
add the missing informational layer, to the static network analysis, by consider-
ing the experimental data available that are, in our opinion, a fundamental source
of information. Indeed, the current high throughput techniques allow obtaining
more and more personal data at decreasing prices and are becoming a very reli-
able tool to predict disease at their very early stages. Hence a new network model
that is able to weigh the networks, by multiplying the nodes, thus obtaining the
potentiated networks that model a specific experimental condition, is currently
required. The aim is to enhance the research at the single subject level and to
make personalised medicine effective.
2.2 How it works
Our approach is based on the idea that, in the context of PPI network analysis,
two concurrent informational components exist: i) static, invariant, component,
represented by the network topological architecture; ii) variable component rep-
resented by the biochemical status, i.e. activation or inhibition, of the proteins
participating to the network. The level of biochemical activity, for instance the
level of phosphorylation, is normally considered a further dimension, i.e. a layer,
of information, but is excluded from the generation of the network topological
structure. This is a problem since, in principle, the more a protein is activated
the more it is involved, in terms of copy number, in the regulation of a spe-
cific network, thus implying a dominant topological role linked to its increased
biochemical activity. Furthermore, the absolute copy number of molecules func-
tionally involved in a specific biological process changes depending from individ-
ual genetic background and biochemical status and, thus, represents individual
molecular fingerprint that must be considered in a context of personalised analy-
sis. To achieve this result, it becomes necessary to add new nodes and edges. In
particular:
1. a new edge is added for each copy of the node that will be multiplied. Each
edge connects the source with its new copy;
2. each copy must have the same neighbours as the original, which means that
each copy should be connected to each one of the neighbours the original
node has;
3. each copy must be connected to all the other copies a node has.
The last point of the list, i.e. connecting each copy with all the other copies, is
fundamental in order to not generate new shortest paths. If two copies of a node
are not directly linked using a new edge, then a new short path, not belonging
to the original network, is generated from a copy to another copy. This path
will pass through the original node causing an incorrect increase of some of its
centralities. For example adding ten copies of a node and not connecting them
through an edge will lead to an augmented Stress and Betweenness of the original
node. Indeed, 90 new shortes paths arise between the ten new nodes, and all of
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them will pass through the original node. Linking the copies makes sure that this
incorrect behaviour does not emerge and keeps the topology of the network safe
from the emergence of wrong paths.
The correctness of the approach was proven by means of a mathematical the-
orem. This method could be applied to several kinds of data. We took advantage
from three different high-throughput technologies for modelling personalised net-
works. Two dataset are obtained using a proteomic profile, one dataset is derived
from gene expressionmicroarray and one dataset is derived from phosphorylation
microarray. We must say that the model could potentially be used for describing
a lot of different data sources. Indeed, it is not important that the model deals
with pathological datasets describing set of healthy and unhealthy networks. The
nodes of the modelled network may represent any kind of object and, as long
as the data available allow the nodes multiplication, the methodology could be
applied to a lot of different fields. For instance, it is possible to imagine that the
model could work with temporal data. Each multiplied network could represent
a specific time point and analysing different time points, i.e. different networks,
and comparing them allows obtaining a sort of semi-dynamic representation of
the same system through time. These simulation can be seen as a sort of evolu-
tion of a systems in which numerical variations, in terms of numbers of copies of
a node, appear. It is important to note that the relationship between the different
transitions, i.e. the time points or the networks, and their differences, or similiar-
ities, must be liked through some meaningful measures or parameters. Indeed, it
is possible to foresee that, for such applications, further assumptions are required
even though the model could surely aid these kinds of investigations.
In Fig. 2.3 a static, non multiplied network is shown. It consists of four ob-
jects, e.g. biological entities, that are represented by four nodes, one for each ob-
ject. Two of these objects, in particular the Node 2 and the Node 3, are weighted.
The Node 2 has 2 copies, the Node 3 has 3 copies of it. So, we multiply the topol-
ogy of the network in order to better model its peculiarities. In Fig. 2.3 there
are different colour for nodes and edges. The green nodes represent the original
network. The orange nodes represent the copies we added. The edges represented
by a red, dashed line, are used to connect the original node with its copies and
the copies are also linked together. The blue, dotted edges represent the edges
between each copy and all the neighbours of the original node. These edges are
required in order to let the shortest paths unchanged, in terms of length as the
theorem proof (see Section 2.2).
By adding new nodes we are not weighting a network. A weighted network
requires that the edges, or the nodes, have an associated numerical value that
represent a characteristic of the relation. The edge weight could be a distance, the
strenght of a chemical bond, a co-expression value or an activation energy. The
weight over a node represents, like in the case of binary search trees, the label of
that node or the content of a node, since this kind of trees are used to abstract a
data structure storing items. Weighted edges will result in an adjiacency matrix
with values that are different from 0 and 1. Weighted nodes will result in an
adjiacency matrix with a diagonal that contains values that are different from
0 and 1 (1 in case of loops). By adding these numerical values we could not
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achieve the same goal we are pursuing, or if we can we haven’t found how to
do it, yet. Indeed, what we are doing is totally different. We are not weighting
nodes neither we are weighting edges. We are adding new nodes and new edges to
better represent the biochemical activity of the modelled interacting molecules.
By doing so, we are introducing new paths that modify the whole topology of
the network withouth disrupting the original structure and making the network
a finer model to achieve the required level of personalisation.
The multiplication pipeline
The multiplication model offers the possibility to investigate a new kind of net-
works. To let other researchers exploiting the methodology we propose, we
defined a workflow that allows the creation of the potentiated networks and a
straightforward analysis. The workflow can be summarised in some steps. Start-
ing from a quantitative dataset that defines the amount of detected proteins, or
another molecule, the first step concerns the extraction of a list of those proteins,
i.e. the probe, that feature a non-zero value, for each sample. In this work the
samples are healthy and unhealthy subject. A protein with a value equal to zero,
i.e. that was not detected in the sample, clearly cannot be represented by a node.
Hence, these proteins are excluded from the network.
Once the probes are created, one for each sample, it is necessary to merge
them in order to obtain the list of proteins shared into a specific class, i.e. a list of
shared proteins for healthy subjects and a list for unhealthy subjects. It is interest-
ing to note that, if a protein is missing in one subject, it is excluded. Importantly,
while dealing with subjects, it must be considered that it is possible to have dif-
ferent kinds of unhealhty subjects, depending on the clinical characteristics of the
disease. For instance the patients, affected by amyloidosis, in the AM dataset we
analysed, could be divided in κ or λ amyloids. Here, we decided to extract an
average list of proteins for each subclass by intersecting the probes for each subset
of unhealthy subjects. By doing so we were able to obtain very specific models,
even though they are, in the end, all labelled as "unhealthy". Finally, we obtained
a probe of shared proteins for each class, i.e. healthy and unhealthy, for each
dataset.
After the merging phase, a mapping of the probes into a bigger PPI network
permitted the construction of several networks, one for each subject, represent-
ing the interactions between the proteins in each probe. To achieve this goal,
each average network, i.e. the result of the merging phase, was mapped into the
Human Interactome. The matching proteins are extracted with their edges, in
order to create a subnetwork of the interactome that consists of the proteins in a
probe. We obtained an average network for each class of subjects. It is important
to note that all these networks consist of only one connected component, which
is mandatory in order to carry out a proper topological analysis. The interactome
used for the mapping phase includes only proteins with a valid Gene Ontology
(GO) name, thus permitting an easy identification of each node. The complete
GO annotations, i.e. the .goa file, were validated on April 3, 2015. This net-
work is a human interactome comprising 14960 nodes and 291952 interactions.
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These interactions are physical and the network was compiled by using differ-
ent databases, i.e. PathwayCommons_hs, MiMI, BCI, DIP, BioGRID, HPRD,
HiNT, UniHI, ConsensusPathDB, and information from literature [82].
Finally, by multiplying the average networks using the experimental informa-
tion, we were able to construct the potentiated networks. Each protein, of each
network, has its own quantitative value that depends on the experimental condi-
tions. It is important to note that each value was augmented by a unit in order
to let the values in the range 0 < value < 1, to become, when rounded, at least
equal to one. Indeed, the minimum number of copies a node could have is one,
so values that are lower than 0.5 would be rounded at zero thus resulting in a
missing node.
Once the network construction and analysis was done, the machine learning
phase took place. To perform a meaningful comparison, we extracted a list of
those proteins that are shared between the healthy and the unhealthy subjects,
for each dataset. This allowed the extraction of a set of features that refer to those
proteins that are shared between the two average networks. Indeed, the use of
these proteins as a common reference enabled us investigating the similarities and
the differences that occur between the two classes of networks.
Why it works, a mathematical proof
In order to let the multiplication methodology being sound and mathematically
solid we proved, by means of a mathematical theorem, that the addition of copies
of existing nodes, to the original topology, does not affect the global properties
of the network, if the addition follows some defined conditions.
The idea
Figure 2.1: Some cliques, are presented in this network containing two different
set of fully connected subgraphs. Here, they are shown through the grey nodes
and the black, solid lines represent the interactions.
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Multiplying nodes allows creating potentiated networks whose goal is mod-
elling a subject, i.e. a person, or a specific process. More interestingly, the method-
ology allows investigating the quantitative variation in terms of total amount of
objects that interact. It is very important to note that when adding copies of
nodes to an existing network, under certain conditions, we are not modifying the
basic topological structure in terms of shortest paths length. Even though the
length of the path is not affected, properties like the average distance:
lG =
1
n · (n− 1) ·
∑
i 6=j
d(vi, vj)
are affected since the sum of the distances, i.e.
∑
i 6=j d(vi, vj), increase as the
number of nodes increase, i.e. n, hence the average value varies accordingly. By
adding new nodes while keeping the shortest paths length fixed does not guaran-
tee that all the properties of the network are fixed. The shortest paths, intended
as sequences of nodes, between the nodes remain unchanged but, as shown, some
other characteristics, highlighted by many established topological centralities, be-
come peculiar of a specific, multiplied topology, i.e. average path length, Stress,
Betweeness and all the shortest path based centralities in general. These two as-
pects allow to study the actual topology of a specific process but, at the same time,
allow the integration of the fingerprint representing, as we intended, the single
subject biological state.
Figure 2.2: An incorrect multiplication is shown in this network. The grey
dotted-dashed lines represent two new shortest paths that emerged because the
new copies were not connected to each other and to the original node. These
new short paths do not belong to the original network and lead to a disrupted
topology.
In graph theory what we are representing as a multiplied node, i.e. a set of
nodes that are fully connected, is called clique (see Fig. 2.1). Cliques are subgraphs
in which every two vertices are adjacent and are structures that are investigated
in graph theory. More formally a clique C in an undirected graph G = (V,E)
is a subset of V such that C ⊆ V , where every two distinct vertices are adjacent.
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Finally, there are some theorems that concern the properties of these cliques but
we were not able to find a link between these kind of subgraph and the length of
the shortest paths. Because of this missing information, we decided to prove our
own hypothesis. This result should be considered as an additional evidence that
supports our methodology.
Our theorem basically prove how, by adding copies of nodes to an existing
topology we are not modifying the length of the shortest paths, hence we are
somehow keeping the underlying structure comparable between different sub-
jects. This is fundamental in order to define and analyse a network which is
shared between a set of subjects or biological process belonging to the same class.
The number of copies, for each node, vary depending on their biology and it can
be considered the fingerprint for that specific subject, or sample. To prove our
theorem we used a proof by contradiction.
Definition
Given v ∈ V , define a graph G′ = (V ′, E ′) with k copies of v by:
V ′ = V ∪ {v1, . . . , vk−1},
E ′ = E ∪ {(v, vi) | i = 1, . . . , k − 1} ∪ {(vi, vj) | 1 ≤ i, j < k, i 6=
j} ∪ {(vi, w) | (v, w) ∈ E)}.
Proposition
By adding k copies of v to G, we are not creating new shortest paths in G′
that are shorter, or longer, than any of the shortest paths already existing
in G.
Proof
Assume that exists a shortest path p′ ∈ G′ between some u, u′ ∈ V such
that length(p′) is less than the length of any path between u and u′ in G.
Necessarily p′ passes through one of the vi, and two of its incident edges,
such that p′ = (u, . . . , x, vi, y, . . . u′), for some x, y ∈ V .
Now define p = (u, . . . , x, v, y, . . . , u′) ∈ G, which is a path in G. Note
that the edges (x, v) and (v, y) exist in G since (x, vi) ∈ E ′ and (vi, y) ∈ E ′.
Clearly length(p) = length(p′) hence the assumption must be wrong.
It is important to note that the addition of a set of edges that connect all the
copy nodes is trivial. If we are not adding these edges then new shortest paths will
pop-up and allow the new copies of each original node to communicate together
and with the original source (see Fig. 2.2). This fact have to be avoided since
a multiplied network that does not respect the assumptions we exposed becomes
totally different from the starting network andmust be considered as a completely
unrelated network. In these cases the multiplication and the analysis become
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pointless. By adding the edges between each copy and the original node we are
creating an interaction that prevents the emergence of new, different in terms
of involved nodes and length, short paths and this allow to reshape the original
network while considering the numerical variation of its interacting objects.
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Figure 2.3: The multiplication pipeline, consists of a network which is not yet
multiplied, an experimental output that is used for the multiplication step and,
finally, the same plain network after the multiplication step. To stick to the
biological application we are describing in this thesis, we assume that this network
represents the Human Interactome. It is important to note that a network like
the plain one is created to describe all the protein-protein interactions in a cell
and not to fit an individual interactome. Hence, to exploit the multiplicative
approach, in a context of personalised medicine, it becomes necessary to multiply
the nodes according to the experimental values. We presented only four nodes and
two of them resulted in more copies after the multiplication. More specifically,
the Node 2 is present in two copies while the Node 3 has three copies. The
Node 1 and Node 4 has only a copy which means that the original node is the
only copy present in the network. Each copy share the same neighbours of the
original node and have an edge in common with both the original node, that is
highlighed as a dashed-dotted line, and all the other copies. This methodology
allows creating weighted network starting from a common backbone, i.e. the
Human Interacome, and to effectively tackle the questions that the personalised
medicine poses.
Chapter 3
Real data experiments
3.1 Introduction
Four different datasets obtained through high-throughput technologies were anal-
ysed, in this work. In particular, AM and MI data were obtained by using pro-
teomic profiles and a mass spectrometry analysis. BCLL data were obtained
through antibodies microarrays for the investigation of proteins phosphoryla-
tion levels. Finally, PET data were obtained from gene expression microarrays.
More specifically, the AM set is composed of 11 healthy and 24 unhealthy subjects
affected by systemic amyloidosis [83]. The MI dataset is composed of different
samples of cardiac tissue derived from the left ventricle of 18 farm pigs, i.e. Sus
scrofa. The BCLL dataset contains 10 healthy subjects and 31 affected patients.
The antibody microarrays data, inclusive of Z-scores and ratios, were previously
filtered and analysed by Kinexus. The PET dataset included of 71 primitive pan-
creatic endocrine tumours of which 46 samples with an histological grading of
G1 and 25 with a G2 grade [84, 85]. We modelled healthy and unhealthy average
networks since it permitted us to build, and hence analyse, bigger networks in
terms of number of participating proteins. Finally, only the nodes that are shared
along all the networks, for each specific disease, were used for the classification
step.
The interactome used for the mapping phase includes only proteins with a
valid Gene Ontology (GO) name, thus permitting an easy identification of each
node. The complete GO annotations, i.e. the .goa file, were validated on April 3,
2015.
Myocardial Infarction dataset
Myocardial infarction, commonly known as hearth attack, is one of the major
cause of death in the world. The term infarction refers to the irreversible necrosis
of the heart muscle caused by an ischaemic event. The term ischaemia describes an
insufficient blood supply to tissues that causes a lack of oxygen and glucose lead-
ing to the necrosis of the affected tissues. In the case of the myocardial infarction,
the ischaemia causes the death of the myocites, that are the cells that compose
the hearth tissue. The insufficient blood supply, in the case of the myocardial
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infarction, may be caused by the rupture of an atherosclerotic plaque that blocks
the blood flow through a coronary artery. Also coronary artery spasms are con-
sidered a cause of myocardial infarction. It is important to note that an ischaemic
event does not affect myocardial tissues only but it may happens to several other
tissues. This pathology is related to several factors like the high blood pressure,
smoke, diabetes, obesity, and high levels of cholesterol. This pathology is highly
dependent on the life style of the individual but some other diseases, like for in-
stance diabetes, are risk factors. Gene variants were also related to myocardial
infarction.
The dataset we are investigating was obtained from myocardial tissues in the
context of a study whose goal was testing the effects of the implantation of hu-
man stem cells in an animal model, i.e. Sus scrofa. The healthy (N) samples were
collected from normal tissues while the 18 unhealthy samples were collected from
tissues that were affected by myocardial infarction. The infarctuated samples were
divided in three groups depending on different treatments. Group U was treated
with Phosphate Buffered Saline (PBS); group F with pre-treating placenta-derived
human mesenchymal stem cells (FMhMSCs); group Hwith FMhMSCs precondi-
tioned with a mixed ester of hyaluronan, butyric and retinoic acid [86]. Since not
enough interactomic information were retrieved for the organism Sus scrofa, we
decided to map the proteomic expression profiles over the Human interactome,
since the pig is used as animal model for studying several human diseases [87, 88]
and due to the fact that these two organisms are genetically very similar [89]. We
checked the protein names using the STRING database in order to validate their
names across the human and the pig.
The data come from a proteomic profile obtained through a gel-free, multidi-
mensional protein identification (MudPIT) technology [90]. This methodology
permits the identification of the proteins that are present into a complex mix-
ture of peptides. These mixtures are proteolised causing the generation of a huge
number of peptides. These peptides are separated by using a bi-dimensional liq-
uid chromatography and, finally, analysed through the mass-spectrometer. More
specifically, once the sample is collected, it is loaded into a specific column that is
placed in-line with a mass spectrometer in order to obtain the data that are used,
by computational algorithms, to determine the original content of the sample of
interest.
This proteomics datasets was normalised by using the molecular weight of
each protein, in order to let the amount of a protein being comparable within
the subjects. Nonetheless, this is not enough to be able to compare the amounts
of distinct proteins for a specific subject. This happens since the proteins have
different molecular weights and it is not correct to compare two values that are
normalised with different weights. This fact could potentially affect the analysis,
since we are comparing a protein over the subjects we just needed a common
reference along all the subjects, and finally we decided that using the molecular
weight was the best solution.
The MI dataset required to construct four different probes, one for the healthy
subjects, i.e. H, and three for the different kinds of patients, i.e. H, F and U,
depending on the different treatment, by following the general work-flow listed
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above. Since the data are, again, originated by using proteomic profiles, then the
normalisation was performed by using the molecular weight. No further normal-
isation or node addition was performed. Four average networks were built, one
for the healthy subjects and three for each subset of treatments in the unhealthy
subset.
The nodes involved in the six subjects that we modelled, for the F subset:
• PKM, SPTBN1, CFL2, ATP5A1, ALDOC, ATP1A1, ACO2, HSP90AB1,
TUBB, EEF1A1, SOD2, ACTN1, TUBA1C,HBB, ACTB, VIM, COL1A1,
PGK1, PGAM1, TGM2, VCL, HBD, MYL3, ACTG1, ACTC1, CYB5R3,
CDC42, MDH2, MYH2, ACTN2, APOA1, DPYSL2, LAMC1, IDH3A,
PARK7, HSP90AA1, COL6A3, HIST1H4A, YWHAE, PGAM2, COL6A2,
DES, PDLIM1, HSPB1, HADHB, MYH7, MYH1, C3, ENO1, ANXA2,
CAV1, GAPDH, EEF2, MYL1, FH, TPM1, IDH2, ACTA1, YWHAZ,
MDH1, TPI1, LUM, ACTG2, HSPA1A, AHNAK,HSPG2, CRYAB,HADH,
HK1, ENO3, SLC25A5, PDHB,HSPD1, HSPA1L, LDHB, LMNA, PDIA3,
HNRNPK, UBA52, HADHA, ETFA, TPM3, HSPA8, PGM1, SPTAN1,
HIST1H2BC, GPI, ATP5B, TPM4, TPM2, HIST1H2AB, HSP90B1, AL-
DOA.
The nodes involved in the six subjects that we modelled, for the H subset:
• ANXA5, ATP5A1, PRDX6, TNNI3, TPM2, ATP5B, ETFA, VIM,HSP90B1,
EEF1A2, MSN, ATP5F1, TTN, DES, HIST1H1D,MYH9, ALDOA,MYH3,
OGDH, MYH2, ACTN2, ACTG1, NDUFS2, TPI1, HADH, CRMP1,
MYL1, CS, EEF1A1, CP, SOD2, SLC25A3, COL6A2, COL6A1, HSPA2,
GDI1, ACTB, SPTB, MYOZ2, LGALS1, C4A, GDI2, FGA, SERPINA3,
COL1A1, TGM2, TUBB, PRDX3, CAMK2G, PGM1, MYL2, ACTG2,
AK1, MDH2, HSPA5, MYL3, HP, UQCRC1, MYH11, PGK1, PGAM1,
YWHAZ, VDAC2, COL6A3, ENO3, LAMC1, ATP2A2, HIST1H2BC,
PDIA3, C3, LDHB, FN1, IDH2, ATP1A1, CLTC, CSRP3, ITIH2, SEC23A,
SPTBN1, TLN1, MYBPC3, IDH3A, TNNT2, CRYAB, ACTN1, ENO1,
ATP5O, FLNC,HNRNPU, TUBA1C, ACTN4, HNRNPK, GPI, HSPD1,
PHB2, LMNA, SLC25A5, TPM3, HIST1H4A, ACADL, CALU, COX5A,
HIST1H2BN, A2M, LUM, PGD, AHCY, ACTC1, PKM,HADHA, APOA1,
HSPA8, EZR, SPTAN1, DPYSL2, ANXA1, HSPA1A, TNNC1, COMT,
AHSG, CYCS, VCL, ACO2, ORM2, ACAA2, CFL2, FH, HSP90AA1,
MYL6, DLD, HSPA1L, UBA52, YWHAE, VDAC3, TPM1, ALB, HBB,
NNT, SRSF2, ACTA1, PDLIM1, TXN, MYH1, TPM4, ANXA2, TF,
HSPB1, P4HB,MYH7, ITIH4, VDAC1,WDR1, DPYSL3, GAPDH,MDH1,
ACADM, DLAT, CTNNA1, HADHB, SDHA, LDB3, GSN, UQCRC2,
HBD, SLC25A4.
The nodes involved in the eighteen subjects that we modelled, for the N sub-
set:
• LMNA, UBA52, ACTN2, MYH2, ACTG1, HIST1H4A, TPM2, DES,
ANXA5, VCL, YWHAE, IDH2, HIST1H1D, VIM, PGAM2, HNRNPA2B1,
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LDB3, HIST2H2AB, GSN, APOA1, CP, FABP4, DPYSL2, GDI1, ENO3,
A2M, GDI2, CLTC, CFL2, C3, DPYSL3, TF, LUM, ALDOC, MYL3,
TPI1, HIST1H2BN, HBB, SPTBN1, TUBA1C, ACO2, TUBB, EEF1A2,
ETFA, ACTB, ACTN1, HADHB,HIST1H2BC, ACTN4, HADH, ACTG2,
LDHB, EZR, ANXA1, HSPA1L, HADHA, CAMK2D, HSPA8, ALB,
TPM4, PGK1, PRDX6, PGAM1, HSPA5, MDH2, HP, SPTAN1, HSPA9,
HSPD1, HSPA1A, YWHAZ, ATP5A1, TPM3, HSP90AA1, ACTA1, ATP5B,
VDAC1, SOD2, EEF2, GAPDH, ATP5J2, TPM1, GPI, COL1A1, TGM2,
P4HB,MYH7, VDAC2, MYH1, FGA, COX5A, ANXA2, HBD, LGALS1,
CRYAB, CS, HSPB1, ACTC1, PKM.
The nodes involved in the six subjects that we modelled, for the U subset:
• MDH1, ETFA, PGK1, APOA1, FGA, ANXA5, HSPA5, PGAM1, MDH2,
COL6A2, HSPA8, HIST1H1A, PRDX6, HBD, ACTG1, MYH2, DPYSL2,
ACTN2, IDH2, TGM2, HBB, MYBPC3, LGALS1, ATP1A1, LAMC1,
FHL1, PKM, COX5A, MYL3, TPM2, CALU, HSPA6, HSP90B1, OXCT1,
ACTC1, YWHAZ, HIST1H1D, ATP5B, DES, PDLIM1, A2M, PGAM2,
ATP2A2, ALDOA,ORM2, VIM,HSPA1A,MYL6, TTN,HADHA, CFL2,
CRYAB, PDHB, HADH, VDAC1, FH, S100A1, HP, LDB3, GPI, LMNA,
HNRNPK,HMGB1, HSPB1, ACTB, ACTA1, TPM1, FLNC,HIST1H2AB,
PDIA3, ANXA2,WDR1, EEF1A2, YWHAE, VCL, LDHB, TPM4, ACO2,
HSP90AA1, EEF1A1, GAPDH, NME2, SOD2, IDH3A, DLAT, H2AFZ,
ACTG2, TPI1, MSN, TUBA1C,HIST1H2BN, CLTC, ATP5A1, HIST1H2BC,
HSPD1, FGG, UBA52, HIST1H4A, RAP1A, TUBB, TPM3, COL6A3,
ACTN1, SPTBN1, MYL2, COL6A1, AHSG, TF, SPTAN1, C3, ALB,
MYH7, CAPNS1, CP, HSPA1L, ENO3, MYH1.
Amyloidosis dataset
Amyloidosis is considered a rare disease since it affects less than 200,000 people
in the U.S. population1. The term amyloidosis refers to a various set of patholo-
gies that are characterised by an abnormal production of a specific protein that
is called amyloid. An amyloid appears when some proteins aggregate and stick
together. Usually these proteins lose their physiological function and form these
unhealthy aggregates that look like fibrils. These protein fibers accumulate into
organs and tissues and cause an augmented risk of functional failure. The more
they accumulate, the higher the risk for the health and the organ dysfunction.
More than 20 different known human pathologies are associated to the accumu-
lation of these amyloids. Some examples are Atherosclerosis, Diabetes mellitus
type 2 and Alzheimer’s disease.
Amyloidosis can be systemic or localised, depending on the site where the
amyloids are accumulating. If it occurs in several places in the body then we
are talking about systemic amyloidosis. If they concentrate in a single organ
or tissue, the amyloidosis is said to be localised. Also there are different kinds
1http://www.amyloidosis.org/facts/
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of amyloid proteins. Depending on these kinds of proteins the most common
systemic amyloidosis can be divided in i) AL, where L stands for Light Chain, ii)
AA where A stands for the Serum A Protein and, finally, iii) ATTR where TTR
represents the Transthyretin protein. The dataset we analysed refers to the AL
amyloidosis. It is caused by a bone marrow disorder and the production of plasma
cells. Plasma cells belong to the immune system that has the duty of fighting
infections through the production of antibodies. Immunoglobulin comprehend
different proteins that act as antibodies and are composed of four protein chains.
An immunoglobulin has two light chains, either kappa or lambda light chains,
and two heavy chains, of which there are several types. A subject affected by
AL amyloidosis produces abnormal antibodies. More specifically we are focusing
on ALλ and ALκ amyloidosis, with Congo red score greater or equal to 3+.
AL amyloidosis is caused by misfolded monoclonal immunoglobulin light chains
that can be both λ and κ. The data were obtained by using the same MudPit
technology described for the MI dataset.
This proteomics datasets was normalised by using the molecular weight of
each protein, in order to let the amount of a protein being comparable within
the subjects. Nonetheless, this is not enough to be able to compare the amounts
of distinct proteins for a specific subject. This happens since such proteins have
different molecular weights and it is not correct to compare two values normalised
by using different weights. This fact could potentially affect the analysis, since we
are comparing a protein over the subjects we just needed a common reference
along all the subjects, and finally we decided that using the molecular weight was
the best solution.
The following step concerns the retrieval of a set of proteins shared between
the different classes under study, i.e. the healthy subjects and the unhealthy sub-
jects. This goal was achieved by extracting a probe for each subject. In the AM
dataset, three different average probes were obtained, one for the healthy subjects
and two for the two different subsets of patients (ALλ, ALκ). The mapping step
highlighted the fact that the average probes, in the case of healthy subjects, are
very small in terms of nodes and edges. Merging the probes leaded to only eight
shared proteins that are connected into a single component. In order to overcome
this limitation, a supplementary set of proteins for each subject was added, both
for healthy and unhealthy average networks. The supplementary set of proteins
was obtained by considering the first neighbours of the shared protein. Once
the probe is mapped in the interactome, the selection is extended to the first
neighbours and the resulting network extracted. From this average network, we
computed a network for each subclass, we performed a further sampling. Only
those nodes that are present in a probe, i.e. a subject, are considered. The first
neighbours that do not belong to a probe were discarded since it was not possible
to associate an experimental value.
The nodes involved in the healthy subjects we modelled:
• FABP4, S100A10, ANXA2, ANXA1, TUBA1C, VIM, CAV1, ACTB, LMNA,
BANF1, MYH9, SPTBN1;
• STOM, APOC1, SPTBN1, TUBA1C, ANXA2, HBG1, HBA1, HBD,HBB,
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ANXA1, VIM, LMNA, ACTB,MYH9, APOA1, FGG, FGB, FGA, SLC4A1,
ANK1;
• CRYAB, SPTBN1, APOA1, APOA2, TUBA1C, S100A10, ANXA2, HBA1,
HBD,HBB, FABP4, PTRF, PLIN1, CAV1, ANXA1, VIM, LMNA, ACTB,
MYH9;
• TUBA1C, BANF1, LMNA, FABP4, MYH9, SPTBN1, S100A10, VIM,
ANXA1, ACTB, ANXA2;
• TUBA1C, PTRF, CAV1, LMNA,MYH9, SPTBN1, S100A10, VIM, ANXA1,
ACTB, ANXA2;
• CAV1, SPTBN1, PLIN1, MYH9, TUBA1C, ANXA1, ANXA2, VIM, LMNA,
ACTB;
• FABP4, S100A10, TUBA1C, LMNA, RPS15A, ANXA2, VIM, ANXA1,
RPLP1, ATP5J, MYH9, SPTBN1, ACTB, NDUFA4, ATP5I;
• FABP4, S100A10, ANXA2, ANXA1, TUBA1C, VIM, LMNA, PRKCDBP,
ACTB, MYL6, MYH9, SPTBN1;
• FABP4, HBD, S100A10, ANXA2, APOA2, ANXA1, TUBA1C, VIM,
LMNA, ACTB, CRYAB, APOC1, DCD, HBA1, APOC3, HBB, APOA1,
MYH9, SPTBN1;
• TUBA1C, PTRF, LMNA, CAV1, CALM1, MYH9, SPTBN1, VIM, ANXA1,
ACTB, ANXA2;
• TUBA1C, S100B, S100A11, LMNA, FABP4, MYH9, SPTBN1, VIM, ANXA1,
ACTB, ANXA2.
The nodes involved in the λ-Amyloidosis subjects:
• LGALS1, HBD, SAA1, HBB, HBA1, FABP4, S100A11, ATP5B, FGB,
VTN, FGG, APOA1, APOC3, FGA, APOA4, S100A10, ANXA2, ACTB,
VIM, APOE, TTR;
• LGALS1, HBD, HBG2, HBB, HBA1, FABP4, ATP5B, FGB, VTN, FGG,
APOC3, APOA1, APOA4, FGA, S100A10, ANXA2, ACTB, VIM, APOC1,
APOE, F2, TTR;
• HBD, HBB, HBA1, FABP4, ATP5B, APOA2, FGB, VTN, FGG, APOA1,
APOC3, FGA, APOA4, CAV1, S100A11, ANXA2, ACTB, VIM, APOE,
TTR;
• UQCRH,HBD,HBB, HBA1, FABP4, ATP5B, APOA2, FGB, VTN, FGG,
APOC3, APOA1, FGA, APOA4, S100A10, ANXA2, ACTB, VIM, APOC1,
APOE, TTR;
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• HBD, SLC4A1, ANK1, HBB, HBA1, FABP4, ATP5B, FGB, VTN, FGG,
APOC1, APOA1, APOC3, FGA, DCD, APOA4, VIM, ACTB, ANXA2;
• LGALS1, HBD, PTRF, HBB, HBA1, FABP4, ATP5B, FGB, VTN, FGG,
APOE, APOA1, APOC3, FGA, APOA4, S100A11, CAV1, CALM1, VIM,
ACTB, S100A10, ANXA2LGALS1, HBD, PTRF, HBB, HBA1, FABP4,
ATP5B, FGB, VTN, FGG, APOE, APOA1, APOC3, FGA, APOA4, S100A11,
CAV1, CALM1, VIM, ACTB, S100A10, ANXA2;
• COX5A, LGALS1, HBD,HBB, HBA1, FABP4, CAV1, ATP5B, FGB, VTN,
FGG, APOE, APOC1, APOA1, APOC3, FGA, APOA4, VIM, ACTB,
ANXA2;
• LGALS1, HBD, SLC4A1, HBB, HBA1, FABP4, S100A11, ATP5B, APOA2,
FGB, VTN, FGG, APOA1, APOC3, FGA, APOA4, VIM, ACTB, ANXA2;
• LGALS1, HBD, HBB, HBA1, FABP4, ATP5B, FGB, VTN, FGG, APOE,
APOA1, FGA, APOA4, VIM, ACTB, S100A10, ANXA2;
• LGALS1, HBD, PTRF, HBB, HBA1, FABP4, CAV1, CRYAB, ATP5B,
FGB, VTN, FGG, APOE, APOA1, APOC3, FGA, APOA4, VIM, ACTB,
S100A10, ANXA2;
• LGALS1, HBD, HBB, HBA1, FABP4, ATP5I, APOA2, FGB, VTN, FGG,
ATP5B, ATP5J2, IGHG1, APOE, APOC1, APOA1, FGA, APOA4, VIM,
ACTB, S100A10, ANXA2;
• LGALS1, HBD,HBB, HBA1, FABP4, ATP5B, APOA2, FGB, VTN, FGG,
APOE, APOC1, APOA1, FGA, APOA4, S100A10, ACTB, ANXA2, VIM,
RPLP1, ATP5I, ATP5L;
• HBD, SLC4A1, HBB, HBA1, FABP4, ATP5B, FGB, VTN, FGG, APOE,
APOA1, APOC3, FGA, APOA4, VIM, ACTB, ANXA2.
The nodes involved in the κ-Amyloidosis subjects:
• MYO1C, ATP5A1, S100A11, TUBA1C, SPTAN1, HBD, ANXA1, S100A10,
ANXA2, HBB, APOC3, APOE, SAA1, CLU, HBA1, ATP5B, APOA1,
MYL6, ACTB, VIM, FABP4;
• MYO1C, ATP5A1, TUBA1C, SPTAN1, HBD, APOA4, ANXA1, S100A10,
ANXA2, HBB, APOE, CLU,HBA1, ATP5B, APOA1, ACTB, VIM, FABP4;
• MYO1C, ATP5A1, TUBA1C, SPTAN1, HBD, APOA4, ANXA1, S100A10,
ANXA2, HBB, APOE, SAA1, CLU, HBA1, ATP5B, APOA1, ACTB,
VIM, FABP4;
• FGB, MYO1C, ATP5A1, TUBA1C, SPTAN1, SLC4A1, HBD, APOA4,
ANXA1, ANXA2, HBB, TTR, APOC3, APOE, CLU, HBA1, ATP5B,
APOA1, ACTB, VIM, FABP4;
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• MYO1C, ATP5A1, TUBA1C, SPTAN1, HBD, ANXA1, S100A10, ANXA2,
HBB, APOE, IGHG1, CLU, HBA1, TTR, ATP5B, APOA1, ACTB, VIM,
FABP4;
• SLC4A1, HBD, PLIN1, PTRF, HBB, APOE, CLU, FGG, APOA1, FGB,
MYO1C, ATP5A1, CAV1, FGA,HBA1, ATP5B, TUBA1C, SPTAN1, ANXA1,
S100A10, ANXA2, ACTB, VIM, FABP4;
• CALM1, MYO1C, ATP5A1, TUBA1C, SPTAN1, HBD, PTRF, CAV1,
S100A10, ANXA1, ANXA2, HBB, APOC1, APOC3, APOE, CLU,HBA1,
ATP5B, APOA1, ACTB, VIM, FABP4;
• MYO1C, ATP5A1, TUBA1C, SPTAN1, S100B, S100A11, HBD, PTRF,
CAV1, S100A10, ANXA1, ANXA2, HBB, APOC3, APOE, CLU, HBA1,
ATP5B, APOA1, MYL6, ACTB, VIM, FABP4;
• SLC4A1, HBG2, HBG1, HBD, HBB, APOE, CLU, FGG, APOA1, FGB,
MYO1C, ATP5A1, FGA, APOC3, HBA1, ATP5B, TUBA1C, SPTAN1,
S100A10, ANXA1, ANXA2, ACTB, VIM, FABP4;
• MYO1C, ATP5A1, TUBA1C, SPTAN1, SLC4A1, HBD, CAV1, ANXA1,
ANXA2, FGB, FGG, FGA, HBB, APOC3, APOE, CLU, HBA1, ATP5B,
APOA1, ACTB, VIM, FABP4;
• MYO1C, ATP5A1, TUBA1C, SPTAN1, SLC4A1, HBD, CAV1, ANXA1,
ANXA2, FGG, FGB, FGA, HBB, APOC3, APOE, APOC2, CLU, HBA1,
ATP5B, APOA1, ACTB, VIM, FABP4.
B-Cell Chronic Lymphocytic Leukemia dataset
BCLL, also known as Chronic lymphocytic leukemia, or CLL, is a blood neo-
plasia, that affects a specific kind of white blood cells, called B-lymphocytes or B-
Cells. These cells have the task of producing immunoglobulins to fight infections
and disease. In CLL neoplastic conditions these cells show an altered behaviour,
characterised by alteration of apoptosis, thus leading to uncontrolled progressive
accumulation in bone marrow, secondary lymphoid organs and blood, causing
altered immune system and other tissue functionalities. Leukemic cells, i.e. the
affected lymphocytes, are generated by the bone marrow and have specific char-
acteristics. These cells lose their immunocompetent function and do not mature
like normal cells. They have an higher rate of growth in terms of number of
cells and an altered life cycle which help them surviving for longer time period if
compared to the normal lymphocytes. All these facts allow an increased amount
of these altered cells accumulating in the bone marrow until they are released in
the blood causing an abnormal number of white cells in the flow. Leukemia can
be chronic, as in our case, or acute.
The technology used for obtaining the data is based on the Kinexus antibody
microarray. These arrays includes more or less 500 panspecific and about 350
phosphosite-specific antibodies for each chip. They are present in duplicate in
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order to enhance the reliability. This kind of analysis covers some proteins that
regulate some of the cell common behaviour like, for instance, the proliferation,
apoptosis, stress, adhesion, secretion, and motility. The data were normalised
with respect to the control conditions, i.e. healthy B-Cells, and filtered by using
a z-score and a ratio between signal and rumour which is greater than 1.1. All the
subjects were treated with Stromal cell-derived factor 1 (SDF-1).
These data required a different normalisation, since the data used to weigh
the personalised networks represent phosphorylation levels. These values are Z-
ratios obtained by comparing the Z-scores for each subject before and after the
SDF-1 treatment. Since these values derive from microarrays, they refer to the
intensity of the spots, for each protein and each antibody; only the spots that met
the quality criteria in accordance to the Kinexus guidelines [91], were used.
Another issue was related to the fact that Z-ratios can be either positive or neg-
ative. Hence, since a node cannot be represented by a negative number of copies,
we computed the absolute value for each ratio. Moreover, since a protein has
more than one phosphosite that could be recognised by more than one antibody,
we decided to consider the highest values among the absolute Z-ratios, for each
protein. Finally, the set of probes was used to construct the average networks for
both healthy and unhealthy subjects.
The nodes involved in the healthy subjects, used as controls:
• CREB1, KIT, GSK3A, GFAP, AKT1, GRIN1, ATF2, BRCA1, MAP2K4,
SRC, PRKCD, PRKCB, JAK1, PRKCE, EIF4E, PDGFRA, SOX9, LCK,
MAP2K6, MAPK14, PEA15, PRKCA,MET, DAB1, PTPN11, FOS, FOXO3,
HTT,MAPKAPK2, AKT1S1, PTK2B, ZAP70, CTTN, BMX, CFL2, CRYAB,
MAPK8, ADD1, RPS6KA5, MAP2K3, JUN, EIF2AK2, PAK1, GAP43,
TP53, SYN1, RPS6KB1, PTEN,MYL12A,MAP3K5, EIF4EBP1, MAP3K11,
PRKACB, CFL1, SMAD1, EIF2S1, RB1, CHEK2, PXN, PRKAR2A,MTOR,
MARCKS, PGR, PRKD1, IRS1, IGF1R,MAPT, CAMK2A, ITGB1, LIMK1,
KDR, PKN1, MAP2K2, MAPK3, NPM1, RPS6, STAT1, BAD, RAD17,
HIST1H1A, PDGFRB, EGFR, PRKCG,MAP2K1, DOK2, PRKCI, HSPB1,
MAPK7, INSR, ERBB2, PRKCH, ACACA, PTK2, STAT2, CDK1, PRKCZ,
TH, BLNK, CAV2, RAC1, H3F3A, STAT3, RPS6KA1, STAT5A, CHUK,
ADRBK1, RAF1.
The nodes involved in the unhealthy subjects:
• CTTN, CRYAB,MAPK8, MAP2K3, JUN, EIF2AK2, PAK1, TP53, SYN1,
RPS6KB1, PLK1, EIF4EBP1, CFL1, PRKACB, EIF2S1, RB1, PXN, PRKD1,
PGR, GSK3A, KIT, AKT1, GRIN1, PRKCD, PRKCB, SRC, PDGFRA,
JAK1, MAPK14, LCK, PRKCA, FOS, ZAP70, AKT1S1, MAPKAPK2,
HIST1H1A, MAPK3, NPM1, RPS6, STAT1, HSPB1, EGFR, PRKCG,
MAP2K1, CDK1, PRKCH, ERBB2, PTK2, ACACA, STAT3, STAT5A,
RPS6KA1, BLNK,H3F3A, KDR,MAPT, IRS1, PRKAA1, PKN1, MAP2K2.
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Pancreatic endocrine tumours dataset
Pancreas is an endocrine gland lying behind the stomach and in front of the spine.
It produces several hormones that have very important functions in regulating
different biological processes. Some examples of hormones produced by the pan-
creas are insulin, glucagon, somatostatin, and a polypeptide that has various func-
tions. It is formed by two different kinds of cells: endocrine pancreas cells and
exocrine pancreas cells. Endocrine cells produce hormones and are grouped in
clusters that are called islets, i.e. the so called islet of Langherans. The exocrine
cells produce enzymes that are released into the intestine. The Pancreatic En-
docrine Tumours we are interested into affect these specific kind of cells. There
are two kinds of PET depending on the fact that there is an extra production of
hormones, i.e. functional tumours, or that there is not an extra production of
hormones where the symptoms are caused by the growth of the tumour itself,
i.e. non-functional tumours. Functional tumours can be benign or malignant,
non-functional are only malignant. Functional tumours, depending on the hor-
mones that are produced in an higher amount, can be divided in: Gastrinomas,
Insulinomas, Glucagonomas, VIPomas and Somatostatinomas. VIPomas and So-
matostatinomas are quite rare, the treatments are very similar hence they are
considered as a single group. The World Health Organization divides these kinds
of tumours in three different groups, depending on the histological classification.
These groups are i) Well Differentiated (Low Grade, G1), ii) Moderately Differ-
entiated (Intermediate Grade, G2), and iii) Poorly Differentiated (High Grade,
G3). In the dataset we are analysing we have only two classes that represent G1
and G2 samples.
The data comes from a gene expression microarray. This technology allows to
measure how much a gene is expressed in a specific cell at a certain time point. A
microarray is formed by a set of DNA spots, a very high number of spots, that are
attached to a solid surface. These spots contain specific nucleic sequences, called
oligos or probes, that are specifically designed to hybridise with their complemen-
tary sequence like, for instance, a specific series of nucleotides in a gene. Oligos
that are hybridised, under very stringent conditions, to their target sequence can
be detected through specific, labelled targets that emit luminescence, i.e. a dye,
if stimulated. These kind of arrays allow the detection of thousands of DNA se-
quences. Indeed the data we filtered and normalised allows the analysis of fifteen
thousands genes. A network composed by so many nodes is very hard to handle
and, also, it is important to note that that the multiplication step will generate
a bigger network since each node will be multiplied by its expression. To avoid
creating networks that could generate a very high amount of data, we decided to
reduced the number of genes under investigation by considering only those genes
that shown a differential expression between the G1 and the G2 samples. Namely,
genes showing a p-value lower than 0.0025 were selected. The p-value was com-
puted by using a T-test. For genes appearing more than once in the microarray,
the expression was averaged before computing the T-test. In this dataset, only one
average network was used to describe both classes, because no gene had a value of
zero in any of the subjects. The only differences, in this case reflect the different
biological states.
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Both networks, i.e. G1 and G2, are formed by these nodes:
• ABHD14A, ABLIM1, APEX1, APOE, ARHGAP6, ARHGEF7, ASAP1,
BAD, BBS7, BRMS1, BUB1, BZW2, CBR1, CCNB1, CCNB2, CCND3,
CCNO, CD99, CDC45, CDK1, CDKN3, CELSR3, CENPE, CEP72, CEP76,
CHCHD3, CKS2, CLDN1, CRYBA2, DAZAP2, DDX23, DLGAP3, DRG1,
DSN1, DST, DZIP3, ECT2, EIF2AK1, EIF2B2, EIF4E3, EIF5B, ELL,
EML2, EPB41L3, ERG, FADD, FAM46C, FBXO7, FGD1, FGF13, FKBP5,
GALK1, GBF1, GEMIN6, GLTSCR2, GRPEL1, GTF2A2, GTF2H1, H2AFZ,
HMGB2, HSF4, HSPA1L, ICT1, IDO1, IFIT3, IGF2BP1, IL6R, ING1,
KCNMA1, KLF5, KLHL20, KRT18, KRT8, LDLRAP1, LEF1, LIG4, LPIN2,
MAP2K1, MED19, MEIS2, MELK,MITF,MPP6, MS4A2, NCAPG,NCAPG2,
NDC80, NDUFAF3, NDUFB10, NDUFB8, NEK2, NEK6, NPDC1, NUP160,
NUP85, NUSAP1, NXT2, OTUB1, PAX6, PBK, PEA15, PIAS1, PIK3R3,
PIM2, PKMYT1, PLAG1, POLD3, POLD4, POLR2H, PPP1CA, PRC1,
PRDX1, PRKCD, PSEN1, PTK2, PTPN6, PTPRH, RHOBTB3, RHPN2,
RNF126, RPL10, RPL15, RPL26L1, RPL3, RPS20, SDC2, SESN1, SHMT2,
SLBP, SLC1A5, SRBD1, SRPK1, SSR1, SSX2IP, STAT4, STMN1, STMN2,
STRBP, SUPV3L1, TERF2IP, TFF1, THOP1, TMOD1, TOP2A, TRIP13,
UBE2C, UBE4B, USP46, WDHD1, ZNF143, ZNF462.
3.2 Constructing a network
The network construction phase is a very important step in a network-based
analysis. The construction depends from several parameters that are the biologi-
cal data that are available, the process we want to model, the goal of the study and
the results we want to obtain. The limitations, in these kinds of analysis usually
depend on the data. The lack of information, the high dimension of the datasets,
the fact that data combines numerical and biological information are different as-
pects that should be considered while building a network. As said, for instance,
in the PET dataset we were dealing with a gene expression dataset that contains
thousands of nodes. Constructing a network consisting of thousands nodes re-
sult in a complex model that is difficult to analyse by using our multiplicative
approach. On the other hand, a network which contains fifteen thousands nodes
could be easily analysed by using a classical topological analysis. Indeed, extract-
ing several centrality indexes, clustering coefficients and other parameters is very
easy. But, the simple addition of some biological information that imply to cross-
analyse numerical values together with the biological function of a specific node
become a complex task, since it should be done thousands times. In this sense
filtering and normalising the raw data becomes a necessary step in order to deal
with the biological complexity even though these operations may lead to a, mea-
sured, loss of information of the modelled biological process. Again, when we
were dealing with the PET dataset we eventually ended up analysing 151 of the
thousands of genes the dataset was composed of. This fact leads to an enormous
loss of information since we are not considering the vast majority of the data but
this was the most meaningful way to analyse the dataset.
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Figure 3.1: The construction of a network, consists of several steps. Starting
from an existing network by using a probe it is possible to map the proteins in
the starting network (nodes in yellow). Once the mapping is done, by extracting
the proteins and their interactions a network is obtained.
Two possible approaches are available and allow constructing a biological net-
work. The first methodology is based on the modelling of a specific process which
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may, or may not, depend on the raw data. Modelling a well known process like,
for instance, the MAPK pathway, requires a fixed and very specific set of nodes,
representing molecular actors, that were found to be interesting in that specific
biological context. On the other hand it is possible to model a more personalised
experimental dataset by using a probe. A probe is a set of nodes that are present in
the dataset and that are used to construct a network. This is done by extracting a
list of nodes, i.e. the probe, and then, by using a bigger network, e.g. usually an
interactome, it is possible to map these nodes of interest and extract the subnet-
works they form by exploiting the existing interactions in the bigger network. In
both cases it is possible to obtain a set of nodes and edges that describe a biological
process.
The next important step refers to the newly created subnetwork. In this sense
it is important to verify if the network is connected. This means verifying that
each node is able to interact, directly of through other nodes, with all the other
nodes in the network. Only connected networks give meaningful results when
analysed. Non connected nodes are useless and should not be included when
performing a topological analysis. When studying pathological processes, it may
happen that some nodes are disconnected. This lack of connections may be due
to the fact that a specific pathway is affected by some pathological mechanisms
and, through a loss-of-function event, some nodes result to be disconnected. It
is very important to consider this aspect but, from a topological point of view,
it is not possible to include such information in the analysis since centralities are
computed only for those nodes that belong, i.e. are connected, to a network.
A disconnected component, i.e. a subnetwork, that is the result of a missing
node that worked as a bridge between two parts of network is different. If we
have more than two nodes that communicate, then it is possible to extract their
topological properties.
Also, it is important to note that dealing with disconnected nodes is possi-
ble. In this sense, disconnected nodes should be connected to the other nodes
and this operation could be done in different ways. Again, in order to perform
this operation a bigger network is required, in order to look for interactions that
allow the actual connection. Connecting nodes can be done in different ways.
It is possible to look for paths, shortest in our case, between the node which is
disconnected and at least a node of the connected network. Once the connection
is found new nodes will be added to the network and become the bridge that per-
mits to obtain a single, connected network. Adding new nodes is trivial when we
are modelling an experimental context. It is possible that the newly added nodes
do not belong to the set of nodes that were analysed, e.g. by using a microrray,
hence they should not be included in the final network. On the other hand, if
we are modelling a process which is not representing a very specific context, e.g.
a well known pathway, the addition of new nodes is usually the starting point
for new, interesting results. The second possible approach consists in the analysis
of the neighbourhood of the network. Starting from a subnetwork, mapped in a
bigger network, and extracting the neighbours of the nodes of interest could be
enough in order to obtain a fully connected network.
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Data normalisation and multiplied networks construction
The multiplied network construction followed a standardised procedure consist-
ing of some, clear steps that we defined as part of the framework. Each multiplied
network starts with a plain network, as we said in the paragraph above. While
plain networks do not require further information, a multiplied network, as said,
requires numerical values that are associated to nodes. These numerical values,
belonging to different datasets, required distinct normalisation approaches, re-
flecting the different technologies that originated the data. A normalisation step
is necessary since each technology returns, as output, different quantifications
which we use to create the potentiated network. These numerical values have
different scales and they should be normalised in order to fit a network-based
modelling. The issues we addressed were two. The first problem arises when the
quantified data have very high values like, for instance, in a range like [0−50000].
Clearly, it is not possible to assign to a network of dozens nodes an attribute
whose values are, for instance, 35392 for the Node1, 12394 for the Node 2 and so
on. If we let this happen then the resulting network will have a number of nodes
and edges that makes the network impossible to analyse in reasonable time. In this
sense it is important to normalise the values in a range which remains significant,
but, and here it comes the second issue we addressed, considering the fact that the
lowest value should be one. It must be one since a protein, for being represented
in a network, must have at least a copy. Generally speaking we assumed that
the minimum value the multiplying attribute may have is 1 and the maximum
value should be in the order of one hundred, in the worst case. This decision is
strictly related to the number of nodes our networks have. On the other hand,
a dataset may contain very low values that are, for instance, very small fractions
of one like 1 ∗ 10−4 or similar values, depending on the technology and its final,
numerical output. In these cases the same criteria for the normalisation should
be considered in order to obtain a meaningful multiplication attribute since the
lowest value, again, should be one.
Cytoscape, CentiScaPe and PeSca
The networks we have analysed were created and managed by using a specific
software which is Cytoscape [92]. Cytoscape is an open source software platform
for visualizing molecular interaction networks and biological pathways and integrat-
ing these networks with annotations, gene expression profiles and other state data.2.
Its importance is rapidly growing and it is considered as a general platform for
complex network analysis in different fields. It exploit the possibilities offered by
a high number of standard file formats that are SIF, GML, XGMML, BioPAX,
PSI-MI, SBML, OBO, and Gene Association files. Importing and exporting data
from Excel, in CSV format, is necessary when loading attributes files and saving
the results from the network analysis. Cytoscape also works as a web service
client allowing to connect it to public databases like Pathway Commons, NCBI
Entrez Gene and a few others in order to download already compiled networks
2http://www.cytoscape.org/what_is_cytoscape.html
Chapter 3. Real data experiments 46
and annotation datasets. It is very useful when it comes to draw nice graphs in the
sense that it allows creating personalised views and exporting them in different,
common file formats. It is written in Java by using specific API, and is composed
by an internal set of applications which allow common network analysis tasks
but it also take a very great advantage of an app-based nature. This fact allows an
extensive development of very useful and different tools that can be downloaded
and shared. By using this software it was possible to construct the networks and
to take advantage of some, well known tools that allowed us in order to extract
fully connected network and then to compute the centralities for the multiplied
networks.
CentiScaPe [93] is a Cytoscape App that allows computing centralities in di-
rected and undirected networks. It implements a version of the all pair shortest
paths algorithm based on the Djikstra algorithm and permits to compute and
visualise meaningful plots about the centrality values the nodes score. The new
version, not yet released, allows computing centralities in multiplied networks.
PeSca [75] is a Cytoscape App that allows computing shortest paths between
set of specific nodes. There are several options that allow for searching different
combinations of set of nodes. For instance, it is possible to connect a single node
to a set of nodes, or to connect a set versus of nodes to another set of nodes. Also
it allows extracting the tree of paths that are originated from a specific source.
Its main application is related to connecting isolated nodes in order to obtain
connected networks and we used it extensively.
Both these apps were exploited for constructing and analysing the networks
we presented in this thesis. So we decided to implement the main and most useful
functions we used, for the R library IGraph. Our implementation allows R users
to perform the same operations we described, in a personalised way that do not
require to use Cytoscape. This, in our opinion is very important since perform-
ing several operations by using Cytoscape is very time consuming and creating
a pipeline in R is easier and results in faster and more reproducible experiments.
However not all the functions are yet implemented.
Topological centralities
Topological centralities are mathematical tools that were developed and are used
to compute nodes properties describing the role each node plays in a network.
These tools take advantage from the definition of paths and distances in order to
rank the nodes and highlight the more central and the more periferic. Distance-
based centralities comprise Eccentricity, Radiality, Closeness, Centroid and Eigen-
vector. Path-based centralities comprise Stress, Betweenness, Bridging. Also there
is another centrality, i.e. the Degree, that considers the number of neighbours a
node has.
Degree
According to the mathematical definition of Degree, this index measures the num-
ber of incident edges a node has. Loops counts as two edges. The sum of all this
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edges represents the Degree of the node. In the multiplied network model the
Degree considers, as neighbours, also the new copy a protein has. The other ap-
proach for computing the Degree in the multiplied network model consider only
the actual neighbours of a protein without taking into account the new copies. It
is not yet clear which approach is better and, in this sense, the use of this central-
ity may be misleading. We included the version that considers the copy of a node
as part of its neighbourhood, in order to add this information, i.e. the numbers
of copies a node has, available from a topological perspective.
Eccentricity
The Eccentricity centrality [94] is a distance-based metric that describes the neigh-
bourhood of a node considering all the nodes in the network. This means that,
by definition, the Eccentricity is represented by the reciprocal of the maximum
distance between the node of interest and its most distant neighbour.
The mathematical definition:
Cecc(v) :=
1
max{dist(v, w) : w ∈ V }
This topological index gives an idea of the maximum path length a node de-
velops and, consequentially, how close it is to its farthest neighbour. An Eccen-
tricity which is equal to one means that the node and its neighbours are separated
by only one edge and indicates a very central node. The smaller the Eccenticity
the more periferic the node is.
Figure 3.2: In this network we have the Node 1, 2, 7 and 8 that scored the lowest
value of Eccentricity since they are very periferal node and require five steps
to reach each other, in the worst case. Node 4 and 6 have the best Closeness,
Radiality and Centroid values. These results highlight the central role these nodes
play in the network. The same applies for the Eigenvector which is higher in
Node 4 and 6 and give to these node a leading role in controlling the network.
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Closeness
The Closeness centrality [95] is another distance-based index which aims at de-
termining how long are the paths between a node and all the other nodes in the
network. A high Closeness highlight a node that minimises all the distances be-
tween itself and all the other nodes in the network.
The mathematical definition:
Cclo(v) :=
1∑
w∈V dist(v, w)
This index sums up the distances between a node and all the other nodes in a
network and gives a more precise idea, if compared to the Eccentricity, about the
node and how it interacts with the other nodes. Ideally, the most central node has
a distance of one with respect to all the other nodes, making its Closeness equal
to the reciprocal of the number of nodes in the network. The lower the Closeness
the less central the node is.
Radiality
The Radiality [96] centrality, like Closeness, is distance-based and allows high-
lighting central and periferal nodes. This means that the closer the node is to
other nodes the better it is integrated into the graph. Like Closeness, high values
of Radiality suggest that the node can easily reach other nodes.
The mathematical definition:
Crad(v) :=
∑
(∆G + 1− dist(v, w))
n− 1
Where n is the number of nodes in the network and ∆G that is the diameter
of the graph that is the longest shortest path found in the network.
Centroid
Centroid centrality is distance-based and describes tha neighbourhood of a node
in terms of vicinity. This means that, the more a node has nearest neighbours, if
compared to the other nodes in the network, the higher its Centroid will be. This
centrality is computed for each couple of nodes in the network since it requires
to compare the neighbourhood of each node with the neighbourhood of each one
of the other nodes. The obtained index is somehow weighted with respect to all
the other nodes in the network.
The mathematical definition:
Ccen(v) := min{f(v, w) : w ∈ V {v}}
Where f(v, w) = γv(w) − γw(v) with γv(w) the number of neighbours that
are nearer to v rather than to w. The index is computed by calculating γv(w) and
γw(v) for each node v and then by extracting the minimum.
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Eigenvector
The Eigenvector centrality measures the influence a node has in a network. The
centrality assigns relative scores to each node in the network by assuming that
being connected to a high-scoring node has a major contribution to the node
centrality, if compared to a low-scoring node.
The mathematical definition takes advantage of the adjacency matrix Av,t.
The relative centrality value for the a node v is denoted by:
ev :=
1
λ
∑
t∈M(v)
et :=
1
λ
∑
t∈G
av,tet
whereM(v) is the set of the neighbours of v and λ is a constant.
Figure 3.3: In this network the Node 4 has the highest value of Betweenness and
Stress, if compared to the other nodes. In terms of Bridging the node that scored
higher is the Node 6 while the Node 4 has a very low Bridging score.
Stress
Stress centrality[97] is based on shortest paths. Eccentricity, Radiality and Close-
ness are based on distances between node hence they could be considered as par-
tially overlapping. Stress is very similar to the Betweenness centrality, that is
shortest path based too. The Stress centrality gives us information about the
number of shortest paths passing through a node and tells us how much work a
vertex has to do in a graph.
The mathematical definition:
Cstr(v) :=
∑
s 6=v∈V
∑
t6=v∈V
δst(v)
The value δst(v) is the number of paths that pass through a node starting from
node s and ending in node t. Shortest paths starting and ending in v are excluded
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because Stress measures the paths that pass through a node. This assumption is
also used for Betweenness centrality.
Betweenness
Betweenness[98] like Stress is based on the number of shortest paths. This cen-
trality is computed by counting the number of shortest paths starting from the
node v1 and ending in another node v2 that pass through a third node which is the
one we are interested into, i.e. n. The computation of the Betweenness is done
by couples of nodes since, for each node in the network, two of the remaining
nodes are chosen at each iteration and then the number of paths between them is
counted. Then the value is compared to the number of paths that pass through
a certain node, and then to another node for all the nodes in the network ob-
taining partial Betweenness. Then another couple is chosen and the computation
restarts. In the end we have to sum all the partial Betweenness for each node.
The mathematical definition:
Cbet(v) :=
∑
s 6=v∈V
∑
t6=v∈V
δst(v)
where:
δst(v) :=
σst(v)
σst
if s reaches t. Else δst(v) = 0.
Bridging
The Bridging centrality [99] is another path based centrality that aims at finding
those nodes that could be considered as bridges. A bridge is commonly intended
as a structure that connects two parts that alternatively are not in direct connec-
tion. In this sense we can say that a bridge node is a node that connects two region
of a network, i.e. modules, that are considered dense in terms of number of edges
and nodes. Hence a bridge node helps in enhancing the communication between
different parts of the network. This index is a sort of weighted Betweenness.
Indeed, the mathematical definition takes advantage from the Betweeness def-
inition. The Bridging is computed by:
Cbri(v) := BC(v)xCb(v)
where BC(v) is the Bridging coefficient that is computed by:
BC(v) :=
d(v)−1∑
i∈N(V )
1
d(i)
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Biological meanings of centrality indexes
Centrality indexes were initially defined in the context of the social networks
analysis. With the new applications that take advantage of graph theory in differ-
ent field like, for instance, biology, it has emerged the necessity to contextualise
these mathematical metrics to different fields. In Systems Biology we are dealing
with biological properties of the nodes so, for instance, a node with a high De-
gree could represent a protein that has different biological properties that interacts
with a very wide set of other molecules to carry out very different duties. Each
centrality should be interpreted in the proper context, taking into account all the
available information. Also, different metrics should be used together in order
to obtain a comprehensive view about the real role a node plays. In this sense
our work aims at obtaining the wider and comprehensive mixture of information
in order to exploit all the topological centralities and the biological information
together.
Centrality measures like Closeness, Radiality, Centroid and Eccentriticy are
based on the distance between nodes. These kind of centralities give us a snapshot
that allows to comprehend how a node is interacting with the other nodes in the
network. These measures are able to depict howmuch a node is central, i.e. which
distances separate a node from the other nodes in the network. The more central
a node, i.e. the lower the distances, the more central it is. Higher distances may
indicate that the node has, potentially, a marginal role since it reaches the other
nodes through longer short paths.
On the other hand, centralities like Stress, Betweenness and Bridging are based
on the number of short paths that passes through a node. These kind of measures
give us a different kind of information, with respect to the distance-based cen-
tralities. Nodes that have a high value of the cited centralities are nodes which
functions as passageways. This means that a lot of communications pass through
these nodes and their absence may result in the network disruption and a possible
loss of communication. In particular the Bridging, as the name suggests, indicate
nodes that function as bottlenecks while Stress and Betweenness indicate node
that are subject to a high number of short paths passing through them. In this
case, nodes with high values of these centralities are considered very important
nodes, in terms of topological functionalities, while nodes with low values of
centrality are considered marginal nodes.
Giving a biological meaning to a centrality is not straightforward, since they
are mathematical properites that describe specific topological characteristics of a
node. For instance, a node with a high Betweenness is considered as a central node
since the information flow that is processed by the network passes through it.
But, from a biological point of view, what does it means to be a high Betweeness
node is strongly related to the biology of the network. The same applies for
the Stress and the Bridging centralities. Both these centralities, when the score
is high, represent nodes that have a high ratio of shortest paths passing through
them. The fact that a node is traversed by a lot of paths may be important since
its absence may affect the whole network and may be the cause of a disease. These
consideration should be done through a proper analysis of the biological process
that the network aims at modelling. The same applies for Closeness, Radiality
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and Eccentricity. High Closeness nodes are nodes that minimises the distances
between all the other nodes in the network. From a biological point of view this
means that they could be regulators for the network since they are near to a lot of
other nodes. On the other hand, a node with a very low Closeness is considered
as a periferic node. What happens, from a topological point of view, when a
node represents a receptor that, once activated, causes a biochemical cascade of
events that are necessary to the correct functioning of a cell? It happens that the
Closeness of this node will be lower, or very low, if compared to a more central
but less interesting node. This example clarify how, giving a biological meaning to
a centrality is possible and should be done, but this meaning should be considered
very carefully. Knowing the process under investigation is fundamental to give
the meaning to a numerical value.
3.3 Finding patterns
The four dataset we analysed comprise dozens of subjects and each network con-
sists of dozens of nodes and hundreds of edges. The substantial complexity of
such datasets does not allow to analyse the data by using a manually curated ap-
proach. Moreover, our idea considered the analysis of several centralities which
define the role a node play in the network. To achieve this goal, computing nine
different centralities for each node and for each subject, globally we have 183
subjects, means obtaining some high dimensional tables of double values. Such
wealth of information become tractable only by using a computational-based ap-
proach. Moreover, we wanted to exploit the information contents of all the
centralities as an ensemble, aiming at uncover emergent patterns that could be
shared along the different classes of subjects. In practical terms this operation
aims at finding those similarities, if there are some, that define the class of the
BCLL patients and the class of the BCLL controls. Eventually, these intra-class
similarities also allow to discriminate the two classes since they become inter-class
differences. This operation, which concerns the retrieval of occurring patterns in
complex dataset, in computer science, belongs to a field which is defined as ma-
chine learning. Currently there are some powerful techniques that allow training
different algorithms in order to look for hidden patterns.
Machine learning aims at addressing the problem of teaching to an algorithm
which characteristics make an object belonging to that specific class and then try-
ing to classify some new samples by assigning them a label and verifying how
many times the algorithm assigned the correct class. This task is called classifi-
cation. Teaching to an algorithm to decide which is the class of a new sample
is very useful since a computer can exploit a very high amount of information
which may come from very different sources. In our case what we wanted to
teach to the algorithm is what does it means to be a healthy and an unhealthy
subject in different, pathological contexts. To address this problem we needed
to tell to the computer which characteristics, called features make a patient a pa-
tient. The features we decided to use for describing the subjects are the centralities
computed over the multiplied networks. Our idea was related to the fact that, if
centralities describe the role a node play in a network, then a set of centralities
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should describe specific characteristics of that network. Then, having a set of net-
work belonging to the same class would result in a set of features that describes
the characteristics of the whole class. Hence, by using a classification approach
we should be able to find similarities between healthy subjects and differences be-
tween healthy and unhealthy subjects. For instance, the Betweenness computed
over a network from the PET datasets belonging to the G1 class is clearly a char-
acteristics which may help in identifying such class.
Feature Selection
Learning algorithms require tables of data in order to learn which object belong
to which class. These data are called features and are used to describe peculiar
characteristics of the objects we are analysing. For instance glasses could be con-
sidered objects that have several features like diameter, height, material, presence
or absence of an handle, colour, thickness, and weight. By measuring these char-
acteristics we are describing the features of a common glass, a mug, a shot glass, a
cocktail glass etc. . . . By describing a glass in terms of its features we are assigning
a specific set of measures to a specific kind of glass. The idea here is that we are
able to say that a set of measures refers to a mug instead of a cocktail glass. The
same principle applies to a lot of different objects and, in this work, we are using
topological centralities as measures to describe a class of networks and to discrim-
inate this class from another, different class. Each object can have a lot of different
features and, in our experiments, each protein in each network, has nine different
centrality measures that describe its topological role. Moreover, a network has a
set of features, that are all the features of all its proteins that defines its nature, i.e.
the class. Nine features for each protein means, for instance, that in a network
with one hundred proteins, the total number of features describing that network
are nine hundred.
Features are modelled in a multidimensional space and, to reduce its dimen-
sionality and to avoid redundant features which may negatively affect the learn-
ing process, several feature selection algorithms [100] were developed. These
algorithms, by reducing the number of features that are used by the model al-
low reducing computational times and address the problem of the over fitting.
Over fitting happens when a model is not able to generalise since it has too many
parameters that describe the features and it loses its ability in classifying. To per-
form the feature selection we used the Infinite Feature Selection (Inf-FS) [101].
The Inf-FS is a graph-based method that exploits the convergence properties of
the power series of matrices to evaluate the importance of a feature with respect
to all the other ones taken together. Indeed, in the Inf-FS formulation, each fea-
ture is mapped on an affinity graph, where nodes represent features and weighted
edges relationships between them. In particular, the graph is weighted according
to a function which takes into account both correlations and standard deviations
between feature distributions. Each path of a certain length l over the graph is
seen as a possible selection of features. Therefore, varying these paths and letting
them tend to an infinite number permits the investigation of the importance of
each possible subset of features. The Inf-FS assigns a final score to each feature of
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the initial set; where the score is related to how much the given feature is a good
candidate regarding the classification task. Therefore, ranking in descendant or-
der the outcome of the Inf-FS allows us to perform the subset feature selection
throughout a model selection stage to determine the number of features to be
selected. In the experiments of this work, the Inf-FS has also the advantage of
providing insights about the features that drive the outcome of the classification
and, indirectly, about the features that may become relevant biomarker.
The features that were used for the classification tasks are topological indexes
commonly used in biological network analysis to highlight the role a node plays
in a network. All the indexes in the AM, MI and BCLL datasets were com-
puted by using Cytoscape 3.2.0, and a modified version of CentiScaPe 2.1 that
allows computing centralities over multiplied networks and that allows multiple
network analysis at a time. The multiplied networks in the PET dataset com-
prehend a high number of nodes and this fact required that a first multiplication
step was performed with the same softwares to obtain the potentiated networks.
Eventually, the topological analysis was performed by using the online version of
CentiScaPe which allows computing centralities in big networks.
Each centrality describes a different topological characteristic; by using its val-
ues it is possible to rank the nodes according to their topological relevance. In
this work, nonetheless, since the network is personalised for each subject, the
multiplication algorithm enables a very sharp focus on the real role of a node
in each specific network. The main drawback concerns the fact that, instead of
a single network, there is now a network for each subject and a wealth of data
are generated, which is not easily tractable. In this scenario, the extremely high
dimensions of the datasets limit data analysis and it is not possible to find pat-
terns, similarities, or general insights by using manually curated techniques. The
only methodology that allows the investigation of this amount of information is
related to computer science; in particular, we have chosen a pattern recognition
based approach in order to exploit the information obtained.
Inf-FS method
Given a set F = {f (1), . . . , f (n)} of features that represents distributions and a
sample of the generic distribution f , it is possible to construct an undirected
and fully-connected graph where the nodes represents each distribution and the
edge represent a pairwise relation between two distributions. The weight that are
associated to the edges are called energies and are represented as a linear combi-
nation of two measures depending on the correlation and the standard deviation
weighted by a parameter, i.e. α, aij = ασij + (1− α)cij . The correlation and the
standard deviation are thus used to compute the energy of each edge in order to
consider both the feature dispersion of each distribution and their correlation. In
order to expand this idea to set of more than two distribution it is necessary to
introduce the definition of path between two features. In this graph a path repre-
sents a subset of the available features, i.e. the nodes in the graph and is defined
as γ = {v0 = i, v1, . . . , vl−1, vl = j}. So now the energy can be considered as
the product of all the energies that forms the path, i.e. all its edges. It is now
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possible to compute the single feature energy score for a feature f(i), at a specific
path length.
Once all the energies for all the features are computed it is possible to rank
these values to obtain a subset of relevant features. But to compute all these ener-
gies the complexity is equal to O(n4) hence the computation results not feasible
for large set of features. To overcome this limitation, the Inf-FS approach assumes
that the length of the paths tends to infinite in order to compute a new feature
score for the features:
s(i) =
∞∑
l=1
sl(i) = [(
∞∑
l=1
Al)e]i = [Se]i
Then, by using the geometric series of the adjacency matrix is it possible to
compute these scores while ensuring that this sum converges. By using the con-
vergence property of the geometric power series of a matrix it is possible to obtain
the matrix that contains the information about the energy of the set of features.
By marginalising the energy scores it is now possible to obtain the score for each
feature and order these values in order to obtain a ranked set of features.
Support Vector Machines
There are several, different algorithms that allow to implement automated pat-
tern recognition methodologies. These algorithms belong to the class of machine
learning algorithms and are designed to find recurring patterns in data. To achieve
this goal it is necessary to train the algorithm in order to teach what does it means,
for instance, being a dog instead of being a cat. To do so a set of observations,
i.e. data describing a specific object, is required. This set is said training set. Pat-
tern recognition algorithms can be divided in two major classes depending on the
training set. Supervised learning in the case that the label of each object is known,
i.e. we have a set of object that are dogs and cats and each one has its label ”dog”
or ”cat” associated, and Non-Supervised when the label remains unknown. For
both classes there are a number of algorithms which allow finding recurring pat-
terns. Finding a pattern means to search the data and see if the algorithm is able
to classify a sample that does not belong to the training set. Testing sets are used
to verify the performances of the algorithm.
The data that such algorithms consider are numerical vectors, grouped in ta-
bles, that describe specific characteristics of the object we want to investigate.
Lets assume we want to separate male from female by using a supervised pattern
recognition approach. We need some characteristics that are shared along the two
classes. For instance we can investigate the height and the weight and see if males
share some recurring values that are different from the females group. Height
and weight are called features and are used to create the training test which is
composed, lets say, by 50 males and 50 females. We have a table which contains
three columns that are, respectively, the label, the height and the weight. The
label could be a zero for male and a one for female. Now the algorithm tries to
retrieve some recurring patterns related to the label zero and to the label one, that
hopefully will be useful to separate the two classes. Once the training is done we
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could submit to the algorithm a new pair of values (height, weight), whose label
is known to us, and see if it is able to give the correct class. This is a common
classification task, that consider a two classes problem.
Figure 3.4: The SVM approach. The solid black line represent the separating
plane which creates two subspaces describing the two different classes. The dashed
lines represent the distance between the plane and the nearest observation. This is
the distance that should be maximised by the algorithm while trying to separate
the classes.
We applied a classification algorithm to the classes Healthy and Unhealthy,
since we are investigating the properties of disease networks and our datasets
could be divided in unhealthy patients and healthy controls. In particular, we
used a supervised approach, since we know who is a patient and who is a healthy
control, based on the SVM algorithm. SVM, like other linear classifier, work into
a multidimensional space (see Fig. 3.43). The goal of the linear SVM is to find an
hyperplane which separates the two classes of data. Ideally the distance between
the hyperplane and the nearest point of each class should be maximised.
More formally we can define a dataset as a set of points {(~x1, y1), . . . , (~xn, yn)}
where x is a vector of features and y is the label that is associated to that obser-
vation. In our case each xn contains nine centralities and y could be healthy or
unhealthy, respectively 1 and −1. The SVM aims at finding the best hyperplane
which is represented by this function: ~w · ~x + b = 0. In the linear classification
we could search for soft and hard margins. An hard margin is used whenever the
classes are linearly separable, the soft margin is used in the case that the data are
3https://commons.wikimedia.org/wiki/File:Svm_max_sep_hyperplane_with_
margin.png
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not linearly separable. A soft margin could behave like the hard margin in case
that the data are linearly separable.
Support Vector Machines (SVMs) is a very well known and widely used clas-
sification model. Is is a theoretically well-motivated algorithm that allows em-
pirically good performance in many fields of application ranging from computer
vision to biology. For instance, the SVM algorithm has been applied in the bio-
logical field for several medical applications [102]. More formally, an SVM con-
structs a hyperplane in a high-dimensional features space that is used to separate
observations belonging to a category from the others [103]. In this work, the
hyperplane, created by using the topological features, is used to discriminate be-
tween healthy and unhealthy subjects.
We decided to use the linear SVM since all our datasets, which describes four
different pathological conditions, consist of two classes that represents healthy
and unhealthy subjects. Actually, the AM dataset comprehend two different kinds
of unhealthy subjects but we decided to consider them as belonging to the ”un-
healthy” class. The same happens in the MI dataset where there are three different
subclasses of unhealthy subjects. The PET dataset is composed by two classes and,
finally, the BCLL dataset is also composed by two classes.
3.4 Results
Node multiplication algorithm
One of the novelties of this work concerns the ability to weigh the networks by
multiplying the nodes, thus obtaining a set of potentiated networks that better
represent experimental conditions. By assigning a numerical value to each node
in a network, using the multiplication algorithm, it becomes possible to reshape
the whole network structure by augmenting the copies of each node. By doing
so, it is now possible to personalise a network fitting it to very specific and in-
dividual experimental conditions enabling the investigation of the properties of
such potentiated topologies. This algorithm allows the creation of experimental
networks and permits to define a new set of analysis that aim at investigating the
properties of this new model.
Our approach is based on the idea that, in the context of the PPI networks
analysis, different, concurrent components exist. The firts one is static and in-
variant and is represented by the network topological architecture which strictly
depends on the genetic background. The second component is variable and com-
prehends the biochemical status, i.e. the activated or inhibited state, of the pro-
teins that participate in the network topology. The level of biochemical activity,
which may represent the phosphorylation level of a protein, is currently consid-
ered a further layer of information and is not considered as part of a topological
analysis. But this is a great limitation since in biology, the more a protein is ac-
tivated the more it is involved, in terms of number of copies actually present, in
the regulation of a biological process. It is important to note that the more a
protein is present in a specific process the higher it is involved hence, represent-
ing these numbers in terms of topological characteristics aims at giving a more
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precise mathematical description of the actual role that molecule plays. Finally,
the number of a specific molecule is related to the genetic background, the en-
vironmental conditions and the biochemical status so, a topology that is able to
represent the individual molecular fingerprint becomes necessary in the context
of the personalised medicine. To reach the goal we developed a new model that is
the multiplied model that aims at creating the potentiated topologies representing
a single individual.
To obtain potentiated topologies it is necessary to add new nodes and edges
to an existing network. More specifically a new node is added depending on
the experimental values it has and is connected to its original source by an edge.
Moreover each copy is connected to all the neighbours of the original source and
to all its copies. The result will be a clique that comprehend a number of nodes
that are copies of an already existing node, that has the same neigbours of the
original node. This also means that each copy has the same Degree of the original
source.
After the multiplication step a potentiated network is obtained and it could be
investigated by using specific algorithms. In this work we focused on topological
centralities and it required to develop a specific method that allows computing
a centrality for a node when this node is represented by more copies. The idea
here is that each original node and its copies share the same value of centrality,
for each centrality, and the sum of all the contributions is used to define the
topological role of a specific node. By doing so it is now possible to compute all
the centralities for all the multiplied nodes by summing up the contributions of
each copy computing the role each node has in the potentiated network.
Computational analysis
The multiplication algorithmwas applied to all the biological datasets and permit-
ted to construct around 180 personalised networks, in order to create individual
personalised models. After the construction, by computing the topological cen-
tralities we were able to determine the topological role each node plays in each
specific network. Finally, by using these values, we were able to infer hidden pat-
terns along the different classes of networks by applying some machine learning
techniques. The centralities we computed are nine: Degree, Eccentricity, Close-
ness, Radiality, Centroid, Stress, Betweenness, Bridging and Eigenvector [104].
The last step in our workflow, concerns the classification of the network bymeans
of an algorithm that is commonly used to search for shared patterns. The first
part addressed the problem of finding the best set of features for the classification.
The second step refers to the actual classification of each network, i.e. finding the
common patterns.
After computing the graph centralities, a feature selection algorithm let us
rank the centralities in order of discriminative power. This step was performed
with the Inf-FS algorithm. Finally, a learning algorithm based on a linear Support
Vector Machines (SVM) approach was applied to each set of selected features in
order to investigate the presence of similarities and recurring patterns. Here we
used a leave-one-out approach in order to generate training and testing set.
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Figure 3.5: Statistical parameters made easy. This image allows an easy under-
standing of how Precision and Recall are computed. Precision is computed by
truepositive
truepositive+falsepositive
. Recall is computed by truepositive
truepositive+falsenegative
.
The results refer to the ability of the algorithm in giving the correct label to
a specific subject. They are computed with respect to the best Precision the algo-
rithm was able to achieve during the classification step. Precision (see Fig. 3.54)
describes the number of actual healthy subjects that were classified as healthy ver-
sus the total number of subjects that were classified as healthy even though they
belong to the unhealthy class, i.e. the ratio between true positive and all the posi-
tive. The higher the value, the more precise is the algorithm in finding which set
of features belongs to the healthy class. As pointed out, for each dataset the best
Precision was computed and used as a reference. For each best Precision some
other parameters, i.e. Accuracy, Recall, and the Area Under the Curve (AUC),
were computed as useful indexes for better describe the real performances of the
classifier. Accuracy refers to the fraction of subjects that are classified as healthy
over the actual number of healthy subjects. Recall, also known as Sensitivity,
refers to the number of healthy subjects that are classified as healthy, over the
number of healthy and unhealthy subjects that were correctly classified. Finally
we computed the Receiver Operating Characteristic or ROC curve comparing
the true positive rate to the false positive rate. Here we reported a widely used
measurement that summarises ROC curves which is the Area Under the ROC
Curve (AUC).
For each dataset, several feature selections were performed since the algorithm
requires the exact tuning of a specific parameter, i.e. the α parameter, which di-
rectly influences the underlying model for the selection and ranking of the fea-
4https://commons.wikimedia.org/wiki/File:PrecisionRecall.svg
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alpha performance AM MI BCLL PET
0.0
Accuracy 1 1 0.9512195 0.7464789
AUC 1 1 0.9290323 0.8147826
PrecisionF1 1 1 1 0.65625
RecallF1 1 1 0.9 0.84
0.2
Accuracy 0.7142857 1 0.9512195 0.8169014
AUC 0.7992424 1 0.9032258 0.8765217
PrecisionF1 0.5789474 1 1 0.76
RecallF1 1 1 0.9 0.76
0.4
Accuracy 0.7428571 1 0.9268293 0.7887324
AUC 0.7689394 1 0.8354839 0.8252174
PrecisionF1 0.6153846 1 1 0.7727273
RecallF1 0.7272727 1 0.7 0.68
0.6
Accuracy 0.7714286 0.9722222 0.9268293 0.7746479
AUC 0.8219697 1 0.7870968 0.7930435
PrecisionF1 0.6428571 1 1 0.75
RecallF1 0.8181818 1 0.7 0.72
0.8
Accuracy 0.8 1 0.9512195 0.6901408
AUC 0.8333333 1 0.9 0.7591304
PrecisionF1 0.6666667 1 1 0.6296296
RecallF1 0.9090909 1 0.8 0.68
1.0
Accuracy 0.8285714 1 0.9268293 0.7605634
AUC 0.9015152 1 0.8935484 0.8095652
PrecisionF1 0.75 0 1 0.8
RecallF1 0.8181818 1 0.8 0.64
Table 3.1: The classification results for all the alphas
tures. This parameter was tested in between 0 and 1 with a step of 0.2 in order
to obtain six different experiments for each dataset. For each α a classification
was performed in order to uncover potential patterns (see Appendix A for all the
results) as mentioned above, i.e. SVM with leave-one-out. In the results it is pos-
sible to appreciate how the Precision remains above 0.57, which means that the
algorithm, even in the worst case, is able to find, at least, few recurring patterns
3.2. In particular, for the MI dataset, the classifier was able to label each subject
with its actual class, i.e. it scored 100%, while for the other dataset the Accuracy
remains generally high, i.e. some patterns appeared. Notably, it must be pointed
out that the dimension of the datasets and the kind of data that are used are two
very important parameters that could affect this kind of tasks. Balanced datasets,
i.e. with a similar number of subjects in both classes, are more reliable but, due to
the intrinsic complexity of experimental and clinical analysis they are difficult to
obtain. Hence, in order to assess whether the features are good at generalising the
classification task to new subjects, a leave-one-out cross validation was performed
before computing the parameters that were used for classifying.
Also, we performed several other comparisons using topological features ver-
sus raw data features. Five different algorithms were exploited to perform several
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Dataset Accuracy AUC Precision Recall
AM potentiated 0.714 0.799 0.579 1
AM raw data 0.629 0.284 0.324 1
MI potentiated 1 1 1 1
MI raw data 0.50 0.759 0.70 0.778
BCLL potentiated 0.951 0.903 1 0.90
BCLL raw data 0.805 0.932 0.667 1
PET potentiated 0.817 0.877 0.76 0.76
PET raw data 0.873 0.93 0.793 0.92
Table 3.2: Numerical results that allow the interpretation of the learning step
Here, the numerical results represent the values for each parameter computed
during the pattern recognition phase. The values we computed are Accuracy,
Area Under Curve (AUC), Precision and Recall. They are common statistical
measures that are associated to the classification task and allow interpreting the
output of the learning algorithm and to verify if it is capable of classifying the
samples. All values in the table were computed for α = 0.2 and refer to the best
Precision the algorithm scored in all the iterations.
Accuracy comparisons. These algorithms are Minimum least square linear clas-
sifier (fisher), Support Vector Machines (SVM), Logistic linear classifier (loglc),
Breiman’s Random Forest (randomforest) and K-nearest-neighbours (KNN). The
results are listed in Appendix A. Furthermore, we computed the statistical signifi-
cance of the differences between the performances of these classifiers (see Table 3.3
and Appendix A).
Feature Selection
As said, the feature selection is a crucial step since a poor set of features could
result in a failure while classifying. Hence, some automated algorithms that are
able to rank the most informative features and to discard redundant, not useful,
information are needed. As said, the feature selection ranked the features for each
dataset and the best one were used for the classification. In this work we refer to
α = 0.2. The results shows how some centralities occur more frequently than
others while some others are under represented in all the different experiments.
The histograms in Fig. 3.6 and Fig. 3.7 show how many times a centrality occurs.
Eigenvector, for instance, is a feature that is very often selected in AM, MI and
BCLL datasets. Also Eccentricity has, usually, an high rank for these datasets. On
the contrary, the PET data shows a different behaviour and the best centralities
used for classifying are Stress, Bridging and Betweenness. In numerical terms
we have that in the BCLL dataset Eigenvector and Eccentricity dominate the
scene with two very prominent peaks, and the other centralities are used very
rarely if compared to this two. The situation is smoother in both AM and MI
datasets. In the AM dataset we have a small number of features, 18 in total, and
Stress, Radiality and Eigenvector play the leading role but some other centralities
follow. Here there are not very interesting peaks. In the MI dataset we have,
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dataset result loglc randomforest SVM KNN fisher
AM H0p-value
1
1.69e-12
1
1.62e-19
1
1.01e-09
0
8.98e-02
1
6.62e-15
BCLL H0p-value
1
2.96e-26
1
6.17e-21
1
3.57e-26
0
1.58e-01
1
1.05e-16
MI H0p-value
1
6.33e-29
1
8.35e-12
1
3.49e-16
1
6.01e-27
1
2.86e-18
PET H0p-value
1
3.02e-02
1
1.94e-14
1
4.49e-22
1
7.17e-19
1
7.13e-20
Table 3.3: Statistical significance of the classification results are presented. In
this table it is possible to appreciate the statistical significance of the difference
between the errors the classified scored, while classifying the different features.
We performed 50 repetitions over a 2-fold cross-validation for each set of features
and for each classifier. Then we compared the 50 errors of each dataset for both
the kinds of features, i.e. topological versus raw data, using a T-test. This was
done in order to validate that the differences we note are statistically significant.
Here we reported, for each dataset the result of the t-test in terms of [1, 0] is the
H0 is rejected or not, and its p-value. 1 means that the two samples are different,
0 means that they may come from the same distribution.
again, a smooth trend but Closeness and Centroid are under-represented.
When performing a classification task by using a set of features it becomes
important to consider the actual nature of the features. This means that com-
plex features, such as centralities, could be useless if compared to other features
that are easier to compute like, for instance, the raw values coming from a pro-
teomic analysis. Constructing a network and extracting the centralities values for
each protein is computationally expensive. It becomes meaningful if the indexes
contain more information than the raw data. Therefore, in order to verify the
benefit of topological indexes as features, a comparison with the raw data features
was performed. By using these data, i.e. -omics data, some recurring patterns also
appeared, since the algorithm showed a good ability in separating the classes, but
it also emerged that better results are obtained by analysing the features extracted
using the networks as starting models. Only in one case, i.e. the PET dataset, the
raw data scored better.
The fact that centrality-based scores remain, in general, higher is probably
due to the fact that the models, from which such features are extracted, represent
complex sets of interacting objects. Indeed, such models are able to consider not
only the quantitative information but also the properties that arise from the in-
teractions, thus enhancing the ability of the model at describing a specific process.
On the contrary, raw data can only represent the numerical amount of a set of
proteins, measured with a specific technique. The results demonstrated that the
network analysis allows investigating complex behaviours and uncover hidden
properties that emerge because of the complex interactions modelled as graphs.
The last step of the feature selection analysis aimed at testing some differ-
ent feature selection algorithms on the same datasets, in order to support the
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results obtained through the Inf-fs approach we used. A specific Matlab library al-
lowed us in order to test the Infinite Feature Selection (InfFs), Relief-F [105], Mu-
tual Information (MutInf) [106], Concave minimisation (FSV) [107], Laplacian
Score [108], Recursive Feature Elimination (RFE) [109], L0-based method [109],
and Fisher method [110]. The features were ranked according to these algo-
rithms and then a classification step, based on the SVM algorithm, allowed to
test each ranking and to compute the classification Accuracy and error rate, i.e.
(1− Accuracy). The results (see Fig. 3.8 and Fig. 3.9) show how, in general, the
features we are using, i.e. the centralities, are good descriptors and allow sepa-
rating the two classes, i.e. healthy versus unhealthy subjects, by using different
approaches. It is important to note that we imposed to all the feature selection
methods to extract a fixed number of features. This is the same number that was
used to classify the results we presented (see Table 3.2). The same number of
features let these results being comparable. It is also important to highlight the
fact that we took advantage of the inf-FS algorithm present in the library. Again,
we did it, in order to let the result being comparable with the results we already
obtained, and with the other results coming from the same library, i.e. the other
feature selection algorithms.
Some interesting biological insights
In order to obtain biological information about the classification result, it is nec-
essary to retrieve information about the proteins that are linked to a specific topo-
logical feature. To do so, we decided to merge all the sets of selected features, e.g.
we merged the 18 best features for all the feature selection algorithms in the AM
dataset. We obtained a list of potential molecular targets that are always chosen
as most informative, i.e. as best features, for all the datasets.
Amyloidosis The results that come from the feature selection algorithms we
run over the Amyloidosis dataset (see Figs. A.13, A.14, A.15, A.16) shows few
discrepancies and some similarities. It is possible to notice how the histograms
obtained by using the algorithms Laplacian, InfFs, Rfe, Relieff and Fsv, show
similar trends, since there is not a specific feature that emerges as most chosen
centrality. In the other histograms, i.e. Fisher, L0 and Mutinffs, there is a ten-
dency in preferring certain centralites over some others but, it is possible to say
that, generally speaking the algorithms take advantage from a very complex set of
features that somehow involves most of the centrality indexes we computed with-
out a specifc preference. This fact suggests how all the topological indexes have a
comparable informational content even though, in some cases, some features are
preferred. It may be caused by the fact that this dataset has a limited number of
features due to the very low amount of shared proteins, i.e. 3 proteins and 27
features, and, since 18 of them were chosen as best features, the range of choice
is very limited. Finally it is possible to affirm that these results are similar to the
results we presented above, even though some differences are present. It happens
because the InfFS algorithm is not deterministic, thus the same input generates
different features ranks.
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B-Cell Lympocytic Leukemia The results that come from the feature selection
algorithms we run over the B-Cell Leukemia dataset (see Figs. A.17, A.18, A.19,
A.20), are very different in terms of selected features. Some of them took advan-
tage from all the available features, few others only exploited the information of
a smaller set of features. Globally it is possible to state that the four features, i.e.
Stress, Betweenness, Centroid, and Degree, that are found to be useful with the
Laplacian Score algorithm, appear to be selected as best features by all the feature
selection algorithms.
Moreover, merging all the results permitted to obtain only a shared protein
between all the best features selected. This fact suggests how different algorithms
allowed selecting a very wide range of different features suggesting that the infor-
mation that allow separating healthy and unhealthy subjects come from different
sources. It is worth noting that it is possible to perform several merging oper-
ations, using a subset of the algorithms, in order to see if more shared proteins
emerge. In this sense, the fact that the Laplacian algorithm only considered four
features over nine available may be a limitation factor.
Myocardial Infarction The results that come from the feature selection algo-
rithms we run over the Myocardial Infarction dataset (see Figs. A.21, A.22, A.23,
A.24) show how all the features are selected as best features. The only difference
that emerge from the comparison of the histograms refers to the RFE algorithm
that show how the Closeness was not considered as a best feature.
By observing the proteins we extracted from the merging step it is possible to
say that, apparently, the features are really robust and that these proteins, above
the others, seem to be strongly related to the ability the classifier has, in separat-
ing the two classes of subjects. It is worth noting that, even thoug 155 couples
(centrality, protein) were found shared between all the algorithms, only 44 pro-
teins are unique, in this set. These unique proteins are: ACO2, ACTA1, ACTB,
ACTC1, ACTG1, ACTG2, ACTN1, ACTN2, ANXA2, APOA1, ATP5A1, ATP5B,
C3, CFL2, CRYAB, DES, DPYSL2, ETFA, GAPDH, HADH, HADHA, HBD,
HIST1H2BC,HIST1H4A,HSP90AA1, HSPB1, LDHB, LMNA,MDH2, MYH2,
MYH7, SOD2, SPTAN1, SPTBN1, TGM2, TPI1, TPM1, TPM2, TPM4, TUBA1C,
UBA52, VCL, VIM, YWHAZ.
Pancreatic Endocrine Tumours The results that come from the feature selec-
tion algorithms we run over the Pancreatinc Endocrine Tumours dataset (see
Figs. A.25, A.26, A.27, A.28) show a high rate of variation. It is interesting
to note that, like in the BCLL set of histograms, the Laplacian algorithm selected
only three features as best features for classifying. It is also worth noting that
there is not a specific feature that is always selected as best features. The varia-
tions occur also in the number of times a centrality appear. Here, we were able
to retrieve a single protein, and this is probably due, as we pointed out for the
BCLL, the high variations that occur between the histograms.
Finally it is important to note that a centrality describes a topological char-
acteristic of a protein that plays a determined role in the network. Hence the
Chapter 3. Real data experiments 65
feature comprises some biological implications that directly depend on the molec-
ular composition of the network and that are used to retrieve recurring patterns.
Here we reported the tables for all the datasets.
Centrality Protein
Stress PRKACB
Table 3.4: Centralities and proteins retrieved in the BCLL dataset. In this ta-
ble it is possible to appreciate the pairs (centrality, protein) that resulted as most
selected features by all the feature selection algorithms, for the B-Cell Lympho-
cytic Leukemia dataset.
Centrality Protein
Stress RPL3
Table 3.5: Centralities and proteins retrieved in the PET dataset. In this table
it is possible to appreciate the pairs (centrality, protein) that resulted as most se-
lected features by all the feature selection algorithms, for the Pancreatic Endocrine
Tumours dataset.
Centrality Protein
Stress ANXA2
Centroid ACTB
Betweenness ANXA2
Degree VIM
Degree ACTB
Table 3.6: Centralities and proteins retrieved in the AM dataset. In this table
it is possible to appreciate the pairs (centrality, protein) that resulted as most se-
lected features by all the feature selection algorithms, for the Amyloidosis dataset.
Softwares
The results of the feature selection comparisons were computed using the Infinite
FS, Relieff, Mutinf FS, FSV, Laplacian, RFE, L0, and Fisher. The accuracies are
obtained using an SVM classifier. To compute all these values we took advantage
of an existing Matlab library, i.e. Feature Selection Library, version 2.1.1 [111].
The version of Matlab used for all the computations is the R2016A, the R version
we used to depict the histograms and plots is 3.3.2 (2016-10-31), ”Sincere Pumpkin
Patch”. To load the .mat files in R, we used the R.matlab v3.6.0 library.
The classification algorithms comparsions were obtained using PRTOOLS [112].
We reported all the plots obtained by comparing five different classifiers. We com-
pared topological versus raw data, i.e. proteomics, phosphorilation and gene ex-
pression raw data, using five different algorithms that are Minimum least square
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Centrality Protein Centrality Protein Centrality Protein
Stress HIST1H2BC Degree HSPB1 Betweenness TUBA1C
Stress VIM Centroid HSPB1 Eccentricity ATP5A1
Stress ACTB Centroid TPI1 Bridging TGM2
Radiality HBD Betweenness MYH2 Eccentricity UBA52
Bridging TPM4 Stress TPI1 Radiality SOD2
Stress ANXA2 Centroid HADH EigenVector DES
Stress ACTN1 Bridging MYH2 EigenVector CRYAB
Betweenness TPM4 Betweenness DES Eccentricity MYH7
Stress APOA1 Eccentricity HADH Radiality DES
Stress ACTA1 Degree C3 Betweenness TGM2
Stress LDHB Degree TPI1 Degree ACTG1
Stress CRYAB Radiality HSPB1 Betweenness YWHAZ
Betweenness ETFA Degree LDHB Degree CFL2
Betweenness ANXA2 Centroid UBA52 Radiality ACTG1
Stress SPTBN1 Degree MDH2 Degree TGM2
Betweenness SPTBN1 Centroid MDH2 EigenVector ACTG1
Stress TPM4 EigenVector ACTA1 Eccentricity DES
Stress ETFA Bridging MDH2 Radiality CRYAB
Bridging SPTBN1 Eccentricity LDHB Degree TPM1
Stress ATP5A1 EigenVector MDH2 Centroid TPM1
Stress DPYSL2 Bridging DES Eccentricity ACTG1
Bridging ACO2 Eccentricity ACTA1 Degree ATP5A1
Betweenness CRYAB Centroid LDHB Degree TPM2
Bridging DPYSL2 Bridging UBA52 Eccentricity APOA1
Table 3.7: Centralities and proteins retrieved in the MI dataset, part 1 of 2. In
this table it is possible to appreciate the pairs (centrality, protein) that resulted as
most selected features by all the feature selection algorithms, for the Myocardial
Infarction dataset.
linear classifier (fisher), Support Vector Machines (SVM), Logistic linear classi-
fier (loglc), Breiman’s Random Forest (randomforest) and K-nearest-neighbours
(KNN).
The results of the feature selection methods comparison were computed us-
ing the Infinite FS, Relieff, Mutinf FS, FSV, Laplacian, RFE, L0, and Fisher. The
accuracies are obtained using an SVM classifier. To compute all these values we
took advantage of an existing Matlab library, i.e. Feature Selection Library, ver-
sion 2.1.1.
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Figure 3.6: The number of features chosen for each dataset in order to clas-
sify the subjects. The histograms show how often a centrality was chosen by
the feature selection as the best feature for the classification task. Each dataset
has its own set of best features that depends from the parameter alpha, which was
set at level 0.2. The bins represent, from the top to the bottom, Betweenness,
Bridging, Centroid, Degree, Eccentricity, Eigenvector, Radiality and Stress cen-
tralities. The values represented in the X axis define the total number of times a
feature is chosen in the set of the best features. This number varies accordingly
with the dataset. It is a median value extracted from the set of trials the algorithm
automatically performs.
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Figure 3.7: The number of features chosen for each dataset in order to classify
the subjects. the histograms show how often a centrality was chosen by the
feature selection as the best feature for the classification task. Each dataset has its
own set of best features that depends from the parameter alpha, which was set at
level 0.2. The bins represent, from the top to the bottom, Betweenness, Bridging,
Centroid, Degree, Eccentricity, Eigenvector, Radiality and Stress centralities. The
values represented in the X axis define the total number of times a feature is
chosen in the set of the best features. This number varies with the dataset. It
is a median value extracted from the set of trials the algorithm automatically
performs.
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Figure 3.8: Showing the percentages of Accuracy of the SVM algorithm. On
the X axis the algorithms that were used are listed, on the y-axis it is possible
to appreciate the percentage of Accuracy each algorithm scored. The error rate
results from this subtraction: 100− Accuracy, since the values that are show are
considered in a range of [0− 100].
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Figure 3.9: Showing the percentages of Accuracy of the SVM algorithm. On
the X axis the algorithms that were used are listed, on the y-axis it is possible
to appreciate the percentage of Accuracy each algorithm scored. The error rate
results from this subtraction: 100− Accuracy, since the values that are show are
considered in a range of [0− 100].
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Centrality Protein Centrality Protein Centrality Protein
Betweenness DPYSL2 Betweenness ACTC1 Bridging ACTB
Stress HADHA Eccentricity MDH2 EigenVector TPM1
Stress TUBA1C Radiality ACTA1 Centroid ATP5A1
Stress MDH2 Eccentricity ANXA2 Bridging TUBA1C
Bridging CRYAB Eccentricity CRYAB EigenVector ATP5A1
Betweenness UBA52 Degree DPYSL2 Eccentricity HSP9AA1
Degree APOA1 Bridging ACTN2 Bridging TPI1
Bridging HIST1H4A Betweenness ACTB Degree SPTAN1
Betweenness HIST1H4A Betweenness VCL Eccentricity HADHA
Stress HIST1H4A Bridging ATP5A1 Eccentricity ACTG2
Betweenness ATP5A1 EigenVector LDHB Radiality ACTN2
Stress UBA52 Bridging HSP9AA1 Eccentricity CFL2
Betweenness HSPB1 Radiality MDH2 Eccentricity TPM2
Stress DES Betweenness MDH2 Eccentricity DPYSL2
Bridging LMNA Radiality APOA1 Radiality ACTB
Stress VCL Degree ACTG2 Centroid APOA1
Betweenness C3 Radiality LDHB Centroid LMNA
Stress TGM2 Centroid ACTN2 Radiality SPTAN1
Betweenness TPM2 Degree HADHA Eccentricity TPM1
Stress TPM2 Centroid GAPDH Bridging TPM1
Degree HADH EigenVector MYH7 Radiality ETFA
Stress MYH2 Degree MYH7 Radiality DPYSL2
Betweenness HSP9AA1 Degree DES Radiality C3
Betweenness APOA1 Centroid MYH7 Radiality ATP5A1
Eccentricity HSPB1 Betweenness TPI1 Radiality TPM2
Degree UBA52 Eccentricity ACTB EigenVector MYH2
Bridging TPM2 Centroid DES Degree HSP9AA1
Centroid ANXA2 Centroid ATP5B
Table 3.8: Centralities and proteins retrieved in the MI dataset, part 2 of 2. In
the table it is possible to appreciate the pairs (centrality, protein) that resulted as
most selected features by all the feature selection algorithms, for the Myocardial
Infarction dataset.
Part II
Validating experimental findings
using random networks
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Chapter 4
Network Randomizer
4.1 Introduction
In network analysis a lot of tools have been developed to address different prob-
lems related to the extraction of useful information from systems modelled as
graphs. Cytoscape [113] is a very well known platform that supports hundreds
of apps that simplify the information mining of complex networks, with a spe-
cific focus on different kinds of biological applications. By using Cytoscape it is
possible to perform topological analysis, cluster and motifs retrieval, biological
enrichment, draw nice graphs, search for ontologies, etc. As the number of apps
increases, the possibilities of performing more and more complex analysis grow
together with the amount of information that could be retrieved. The problem
is that these analyses remain preliminary to further experimental validation and,
in this sense, a sort of benchmark for an in-silico validation is required [114]. A
possible solution to this issue may come from the literature or experimental data
about the process under investigation [115]. But this is not always possible since
the network may represent some complex processes whose biology is not well
understood, or that take advantage of some novel insights that require a different
validation. In these cases, a possible solution refers to the generation of random
experiments and the comparison of the results that come from the real networks
with the results that come from the random networks analysis. This is basically
a statistical validation which allows researchers to state that the results are not
randomly distributed.
Indeed, Cytoscape has some apps that allow comparing networks. These apps
have different features and goals. The most similar app, with respect to the one
we developed, is Randomnetworks1 that works for Cytoscape 2.x. Currently,
it is not available for the new version of the Cytoscape platform, hence older
versions are required in order to exploit the app. Another app that takes advan-
tage from random network models is NetMatch*2. It allows retrieving all the
occurences of a subgraph in a bigger network. Other apps that allow comparing
1http://apps.cytoscape.org/apps/randomnetworks
2http://apps.cytoscape.org/apps/netmatchstar
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networks agains each other are GASOLINE3 and DyNet4. GASOLINE allows
retrieving subnetworks that are shared along a set of networks for obtaining a
similarity value. DyNet has several functionalities that allow comparing nodes
and edges between networks. Considering that the RandomNetwork app is no
longer maintained, Cytoscape lacks of an app that allows randomising, creating
and comparing networks in order to validate the results. This is another, im-
portant, reason that guided the develoment of NetworkRandomizer. Allowing
Cytoscape users to perform the same pipeline we are describing here is essential
in order to spread this methodology, hence generating random network becomes
a fundamental step.
In this sense, our app was created to address the problem of creating a vali-
dation layer which allows simulating random experiments. By using randomly
created networks it becomes possible to compare, through specific statistical tests,
the numerical results that come from a common network analysis. To do so,
our NetworkRandomizer [76] allows randomising existing networks by using a
simple shuﬄing algorithm and a Degree preserving algorithm, since these are the
most used shuﬄing algorithms. A Degree preserving algorithm is useful when the
Degree represents an important feature of a network like, for instance, in scale-
free networks where some nodes are hubs and some others are not. By keeping
the Degree fixed we are sure that the scale-freeness of the shuﬄed network will be
guaranteed. A scale-free network could be achieved by using the Barabási-Albert
model but the Degree of the nodes, as it is in the original network, will be lost.
Moreover, it is possible to create Erdős-Rényi, Barabási-Albert, Watts-Strogatz,
Lattice, and Community Affiliation models. We also implemented a new model,
called Multiplication model, which is designed to generate weighted networks
where nodes are multiplied, i.e. represented in different copies which have the
same topological characteristics, to fit experimental quantitative data. The mod-
els we implemented are not all actually random network models. This means
that, generating a Watts-Strogatz network does not mean that we are generating a
totally random network. What we are doing, while genererating a Watts-Strogatz
network, is creating a network with specific characteristics that fits some param-
eters. If we generate a network 100 times, using the Watts-Strogatz algorithm,
it will not be the same network repeated 100 times. Instead, we will obtain 100
different networks, depending on how we set the parameters. The app aims at
generating networks that follow the most known models of complex networks
in oder to let the users comparing their biological, real networks with a set of
synthetic, randomly generated networks.
Finally a statistical module, based on the two-sample Kolmogorov Smirnov
test, compares network attributes in order to see if their values come from the
same distribution or if they should be considered different. The original idea
behind the app was to compare topological attributes computed by using CentiS-
caPe or the Cytoscape’s built-in NetworkAnalyzer. But, our app, also supports
the comparison of all kinds of numerical attributes in order to be useful to any
user performing any analysis.
3http://apps.cytoscape.org/apps/gasoline
4http://apps.cytoscape.org/apps/dynet
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The application is released with an Apache License 2.0. Its code is freely
available as Git repository and downloadable from the Cytoscape app store5.
4.2 Implementation
NetworkRandomizer is a Cytoscape app, developed in Java, which is designed
for the Cytoscape 3.x environment. Its source code is available from the GitHub
website where it is kept updated. Each new version of the app is released through
the Cystoscape app store and the latest version is always available, as Java source
code, from the Git repository. Our application has a very simple and modular
structure that makes it easy to add additional network models and features in
future releases.
Each random model we implemented is represented by its specific class which
extends an abstract class that defines the common behaviour all the models share
(see Section 4.3). Each model is initialised by using some specified parameters
that are passed as input to the algorithm through the main GUI. Once the gener-
ation, or the randomisation, of the network(s) is done, the app deploys the newly
created network(s) into the Cytoscape’s Network Control Panel making them
instantly available to the user for the further analysis. Since the users may want
to generate a number of random networks, the network views are not created
automatically by the app. This feature was developed to avoid a high number
of pop-up networks in the main Cytoscape window while the algorithm is still
working. Moreover, visualising huge network results in a memory consumption
that slow down the entire computation. Eventually the user could create the view
for a single, or more, network.
As we already said, the app is divided in several classes which allow a very
flexible and modular structure. The CyActivator class runs the application and
communicates with Cytoscape. The RandomizerCore class is used as a model of
the current Cytoscape state like, for instance, the network handling. The Menu-
Action class allows the app initiation. The OptionsMenu class refers to the main
GUI that is used to interact with the app. The ThreadEngine class allows creating
and handling single and multithreads tasks even though the multithread is not yet
implemented. Finally, the AbstractModel is the abstract class that defines the ba-
sic randommodel and offers several methods that could be useful when defining a
new model. This is the starting point for each randommodels we developed. The
other classes in the app refer to the models we actually implemented. In order to
add a new model a new class should be instantiated by following the Abstract-
Model implementation and then it is necessary to modify the GUI in order to let
the new model become part of the app.
The statistical module we implemented exploits the two-sample Kolmogorov
Smirnov test [116]. This statistical test considers each pair of real and random
network(s) and, for each attribute, computes the difference between the two dis-
tribution. The K−S definition of the distribution difference is obtained by com-
puting the maximum gap between the cumulative probability functions of those
5http://apps.cytoscape.org/apps/networkrandomizer
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probabilities. We decided to use this method since it relies on the cumulative
probability functions withouth having the need to explicitly calculate them. In-
deed, the algorithm sorts the two series of values and then, after normalising
by the highest value, it sums up these values while performing the comparison.
Finally, only the largest difference is considered.
4.3 AbstractModel class
The AbstractModel class is the basic class that describes the behaviour of all the
random network models we implemented. Indeed, it is extended by all the other
random network models of the NetworkRandomizer app. The code we present
here is not the full code. It lacks of the algorithms that defines the behaviour of
the methods of the class, i.e. we just reported the names of the methods. Some
comments are also available in order to let the code be more readable.
A more comprehensive view of the code of the entire app, and the source
code, is freely available online. We store it in a GitHub repository at https:
//github.com/gabrielet/Network-Randomizer.
In this class we implemented several methods that has many different func-
tions. Some of them allow initialising and executing a random model. Some
other methods allow creating a network with a specific number of nodes and
edges. Finally, there are few other methods that allow handling and managing the
networks.
1 pub l i c a b s t r a c t c l a s s Abstrac tMode l {
2
3 p ro t e c t e d c l a s s Edge {
4 pub l i c Edge ( i n t a , i n t b ) {}
5 }
6
7 pub l i c Abstrac tMode l ( RandomizerCore core ) {\ do t s }
8
9 pub l i c vo id I n i t i a l i z eAndEx e c u t e ( ) throws Except ion {
10 I n i t i a l i z e ( ) ;
11 Execute ( ) ;
12 }
13
14 /**
15 * I n i t i a l i s a t i o n independent of the model .
16 */
17 pub l i c vo id I n i t i a l i z e ( ) {
18 i n i t i a l i z e S p e c i f i c s ( ) ;
19 }
20
21 /**
22 * I n i t i a l i s a t i o n s p e c i f i c o f each model , c a l l e d from
I n i t i a l i z e . I f unused ,
23 * l e a v e empty .
24 */
25 a b s t r a c t p r o t e c t e d void i n i t i a l i z e S p e c i f i c s ( ) ;
26
27 /**
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28 * Main ex e cu t i on po in t . This method i s c a l l e d by the
ThreadEngine a f t e r
29 * I n i t i a l i s a t i o n .
30 */
31
32 pub l i c a b s t r a c t vo id Execute ( ) throws Except ion ;
33
34 /**
35 * Genera te a network with a g i v en number of nodes and no
edg e s . For network
36 * naming convent ion , s e e <code>getStandardNetworkName</ code>
method . Nodes
37 * would be named by i n t e g e r s from 0 to <code>(numbderOfNodes
− 1 )</ code>.
38 *
39 * @param numberOfNodes
40 * @return CyNetwork g en e r a t e d
41 */
42 p ro t e c t e d CyNetwork generateEmptyNetwork ( i n t numberOfNodes ) {
43 // r e t u r n s a network ;
44 }
45
46 p ro t e c t e d CyNetwork generateNetworkFromNodeList ( ArrayL i s t<
S t r i n g> nodesNames ) {
47 // r e t u r n s a network ;
48 }
49
50 p ro t e c t e d CyNetwork copyOfCurrentNetwork ( boolean d i r e c t e d ) {
51 // r e t u r n s a copy of the E x i s t i n g Network ;
52 }
53
54 p ro t e c t e d CyNetwork copyOfExist ingNetwork ( L i s t<CyNode>
nod e l i s t , L i s t<CyEdge> e d g e l i s t , boolean d i r e c t e d ) {
55 // r e t u r n s a network ;
56 }
57
58 /**
59 * Send network to Cytoscape .
60 *
61 * @param net network to be s e n t to Cytoscape .
62 */
63 p ro t e c t e d void pushNetwork ( CyNetwork ne t ) {\ do t s }
64
65 /**
66 * Model name to be used for network naming
67 *
68 * @return
69 */
70 p ro t e c t e d a b s t r a c t S t r i n g getModelName ( ) ;
71
72 /**
73 * Network naming convent ion i s "model_ t ime _ rand " where : model
i s the name
74 * r e t u rn ed by <code>getModelName</ code> method , time i s the
c u r r en t time in
75 * mi l l i s e c o n d s r e t u rn ed by the system and rand i s a random
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th r ee−d i g i t
76 * number .
77 *
78 * @return network name fo l l ow ing the naming convent ion .
79 */
80
81 p ro t e c t e d S t r i n g getStandardNetworkName ( ) {
82 // r e t u r n s a name ;
83 }
84
85 p ro t e c t e d boolean randomBoolean ( f l o a t p robab i l i t yOfTrue ) {
86 // r e t u r n s a boolean ;
87 }
88
89 p ro t e c t e d void enda l gor i thm ( ) {
90 s top = t ru e ;
91 }
92
93 p ro t e c t e d CyNetwork getCurrentNetwork ( ) {
94 // r e t u r n s the cu r r en t network ;
95 }
96
97 p ro t e c t e d S t r i n g getEdgeName ( CyNode source , CyNode t a r g e t ,
CyNetwork ne t ) {
98 // r e t u r n s a S t r i n g " Edge_ " + sourceName + "_ " + targetName
;
99 }
100 }
4.4 Workflow
The NetworkRandomizer app was initially designed to interact with the CentiS-
caPe centralities. Then, we decided to let the user decide which kind of attributes
to compare so, currently, our application works for all kinds of numerical at-
tributes. These information may come from a specific app or could be defined
by the user itself. The workflow we defined consists of a few distinct steps, in
order to make it very easy to follow. The first step requires to load one, or more,
networks that model any kind of process. After the loading phase, the user select
one, or more, randommodel in order to generate some random networks. Also it
is necessary to decide how many random networks will be generated. These ran-
dom networks could be created in two different ways. Either by randomising the
real network(s), using an algorithm between the Degree Preserving shuﬄe and
the Completely Random shuﬄe (see Fig. 4.1), or by generating one, or more,
new random network(s) by using one of implemented models (see Fig. 4.2 and
Fig. 4.3) by filling the text field representing the input parameters. As said, the
user could specify how many networks the app will generate, for each selected
model.
After the real networks are loaded and the random networks are generated,
the last step concerns the analysis of the shared attributes. In this sense the app
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provides a statistical module that allows the comparison of some, interesting at-
tributes. Since the app was initially designed to be used in conjunction with the
topological centralities parameters, we recommend the use of the CentiScaPe app
which is completely compatible with our app. It is very important to note that
the app allows comparing the attributes that have the same name in all the net-
works that were previously selected through the menu in the statistical module.
It is also case sensitive, so particular care should be used when the attributes are
manually curated.
Finally, when all the data are available, the statistical test (see Fig. 4.5) com-
pares the selected attributes, highlighting their differences and similarities. The
output is returned as a textual file which summarises the results. It is important
to note that, depending on whether one or multiple networks were loaded, the
final output file will be different. More specifically, if the user selected only one
real network then the output file will have an higher level of details about the
network. Otherwise, in the case that multiple real networks were selected, then
the output file will contain a brief summary of all the statistical tests that were
carried out.
Importantly, in order to make all the workflow completely accessible, each
model, plus the statistical module, has a question mark button which provides
some information to help to the users exploiting its full potential.
Data preparation
The idea behind Cytoscape is to allow the investigation of biological network
properties through the use of the implemented tools. In order to exploit the
functionalities offered by this software it is required to construct a network. The
data preparation starts by obtaining a network and once it is loaded, it is possible
to go through its analysis. In order to exploit the statistical module of our app
some numerical information about the network’s characteristics are required. As
we said, we focused on topological information but any kind of numerical value
works. There are multiple ways to obtain numerical information that mainly
depends on the aspects that the user is interested into. Also it is possible to
import a .csv file by using the Cytoscape loader, or to create a new attribute and
manually fill it or, finally, to use one of the built-in network analysing function
that generates numerical information.
The approach we recommend, to easily generate correct attributes, refers to
the use of an app like, for instance, CentiScaPe. This app provides a lot of numeri-
cal information about the network(s) topology, grouped in distinct and meaning-
ful attributes. Also it provides an interesting perspective about the characteristics
of a network. The advantage that comes from the use of an app is that the user
automatically obtains some standard names for the attributes and also some, very
meaningful information, that could be compared among different networks. This
makes the whole analysis easier and useful. Importantly, when using user defined
attributes, the same attribute names must be used for both the real and the ran-
dom networks. Indeed, no attribute will appear while performing the statistical
analysis, if the names don’t match.
Chapter 4. Network Randomizer 80
Generating random networks
The most trivial point while comparing a real dataset to a random generated set
of samples concerns the methodology that should be used to generate the random
samples. Generally speaking we suggest that, the more the random models mimic
the characteristics of the real experiments, the better it is. Creating a random
dataset that is comparable, in biological terms, gives very strong foundations to
all the differences that is possible to highlight and gives a solid support while
stating that the real data are consequence of the biology, and not due to chance. It
is not possible to define, a priori, which model better fits a biological experiment
and this is why we decided to implement more, different models.
Each user should select the best one to fits his/her own requirements and this
is not easy. Moreover there is not a specific way to follow, hence the selection of
the model is strongly related to what the researcher wants to show. To help in
performing random experiments, our app provides two main methodologies for
obtaining a set of random networks. The first method allows the randomisation
of the current, real networks. This is probably the most common method that
allows copying an experimental set-up. On the other hand, the second, available,
option refers to the creation, from the scratch, of some parameters-dependent
networks.
The randomisation of an existing network requires to select a network into
the control panel. It is not necessary that a view of the network is available to
Cytoscape, to perform the computation. So, if the view is not necessary, we
suggest to not create it, since the visualisation of huge network requires a lot of
memory and the computation will be slower. Once the network is selected, i.e.
it’s name is highlighted in the panel, there are two randomising methods that can
be used i) the simple edge shuﬄe, and ii) the Degree preserving edge shuﬄe. The
users should select one, or both, model(s) by checking the boxes (see Fig. 4.1).
Once the module is selected, the Start button runs the randomisation. Here it
is also possible to define the number of network that will be generated, as for
the other models. It must be considered that the simple edge shuﬄe and the
Degree preserving algorithm allow randomising existing networks but the two
methodology may result in networks that are not very well randomised. This
fact is more common when using the Degree preserving algorithm which has
fewer degrees of freedom available, when it randomises the network. It may
happen that the resulting randomised network is the same as the original since it
was not possible to shuﬄe the nodes in order to keep the Degree fixed. This is
more likely to happen with very small networks that have a few nodes and edges
or by selecting the generation of a high number of networks. With few nodes and
edges there are a few numbero of networks that can be created, while keeping the
Degree, and if the number of the requested networks is higher than the number
of possible permutation of nodes and edges, then some networks will be present
in more than one copy.
The simple edge shuﬄe, from the version 1.1.2, allows randomising the ex-
isting network while keeping the names of the nodes as they were defined in
the original network. This is particularly important for those networks which
node names are important, like for instance biological networks where a node
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represent not only an abstract object but also some, very important biological
information, e.g. a protein. Importantly, the earlier versions of the apps have a
simple shuﬄe that creates a network where the nodes names are represented by
sequential numbers and do not keep memory of their real names.
Figure 4.1: The randomisation interface, from where the users can choose be-
tween a simple edge shuﬄe and the Degree preserving algorithm. Obviously it is
possible to choose both. These two algorithms are used only for the randomisa-
tion of an existing network.
Random network models
The main part of the NetworkRandomizer consists of the most known, and
widely used, random network models. The currently implemented models are:
• Erdős-Rényi [117];
• Watts-Strogatz [118];
• Barabási-Albert [119];
• Lattice graphs;
• Community Affiliation Graph [120];
• Multiplication model.
Erdős-Rényi
The Erdős-Rényi model (see Fig. 4.2) generates random networks by either uni-
formly choosing M pairs of nodes to connect or by connecting each pair with
a specific probability p. It is very similar to the Gilbert model for creating ran-
dom networks. These two models were introduced independently and generates
a random graph. The difference rely on the fact that for the ER model, all the
graphs generated with a fixed set of edges and nodes are equally likely to be cho-
sen, while for the Gilbert model an edge has a fixed probability of being present
of absent, independently from the other edges. The model we implemented is
available in two versions. The G(n,m) model allows selecting a random graph in
the set of all the graphs that has n nodes andM edges. TheG(n, P ) model assigns
edges at random with probability p, independently from the other edges. These
kind of graphs have a very low clustering coefficient and the Degree distribution
converges to a Poisson distribution.
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Watts-Strogatz
Watts-Strogatz model (see Fig. 4.2) generates networks which have some specific
properties like, for instance, the generation of the small-world phenomenon. This
model depends on three parameters that are n, κ, and β. The parameter n specifies
the number of nodes the new network will have. The parameter κ is the mean
Degree the network will have, and is expressed as an even integer. Finally, β is a
parameter that ranges between [0 − 1]. If it is equal to zero then the algorithm
generates a regular lattice, if it is equal to 1 the algorithm generates a random
graph that is comparable to an Erdős-Rényi G(n,M) model where n is equal to
N, andM = NK/2. The model was proposed to overcome the limitation of the
ER model and WS models are able to generate small world properties. On the
other hand, the Degree distribution varies as the β parameter varies. With β = 0
the Degree distribution follows a Dirac Delta Function. With β = 1, as for the
ER model, the distribution is a Poisson.
Barabási-Albert
The Barabási-Albert model (see Fig. 4.2) generates scale-free networks that are
extensively proven to be real world networks. In this sense it allows modelling
networks that are found to be close to many natural and human-based systems.
Scale-free networks means that the Degree distribution follows a power law distri-
bution of the form P (k) ∼ κ−γ and are built by using the preferential attachment
growth. Preferential attachment means that i) the network grow over time and
ii) each new node is connected to m other nodes, choosing them with a proba-
bility which is proportional to their Degree. The parameters that the algorithm
requires, in order to generate a network, are m the number of the nodes at the
time zero andN the final number of nodes the network has. At the first step, our
algorithm construct a connected graph with m nodes and m∗m0
2
edges. If m0 > 3
then m0 = m ∗ 2 else m0 = 6. Then the algorithm iteratively adds one node at a
time until the threshold N is reached. Each new node has an initial Degree equal
to m.
Lattices
Lattice graphs model (see Fig. 4.3) generates regular, multidimensional lattices.
Multidimensional lattices are grids of nodes, each of which is connected only to
its first neighbours. For example, the one-dimensional lattice is a path graph,
while the two-dimensional lattice is a square grid. Additionally, the users have
the option of generating torus-shaped lattices, where there are no end-nodes. For
instance, the generation of a one-dimensional torus lattice will result in a cycle
graph.
Communities
The Community Affiliation model (see Fig. 4.3) generates random networks by
using the community information that are passed as input by the user. Given
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Figure 4.2: Some random network models, like the Erdős Rényi, Watts Strogatz,
and Barabási Albert models. These models require some parameters as input in
order to generate a network. These parameters are chosen by the user. In the
figure it is possible to note that some labels, in red, appears once the check box
of a model is selected. These labels help the user in order to correctly fill all the
required fields.
a list of communities, their members in terms of nodes, and the probability, in
terms of p-value, of having an edge between two members of each community,
the algorithm randomly generates realistic social networks.
Multiplicative
Finally, the Multiplication model (see Fig. 4.3) generates randomly weighted net-
work starting from the existing network. This method does not generate a new
network from the scratch but, by using an existing network, it creates a new, or
more, multiplied network(s). The idea here, relies on the fact that integrating
quantitative, experimental information is becoming a fundamental step in bio-
logical data analysis. The model generates a random array which defines a weight
for each node belonging to an existing, user-defined network, starting from an
attribute file which contains quantitative information about the nodes. Then
the algorithm creates a new network which contains a number of copies that
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Figure 4.3: Some random network models, like the Multiplication model net-
work generator, lattice generator and the Community Affiliation Graph model.
Both the Multiplication and the Community Affiliation requires a file as input, in
order to generate random networks. Some red labels, as for the other models, ap-
pear in order to guide the user. Also the question mark boxes were implemented
to give some further information.
depend on the random weights that were assigned to each node. This random
weighted network represents a possible experimental set-up which derives from
the attribute file. In this sense it is possible to generate a number of randomly
weighted networks, in order to simulate a set of experiments.
App input
Through the main GUI whenever the user click on the check mark of a model,
some info will appear to help and guide the users while filling the text boxes re-
garding the input parameters constraints (see Fig. 4.2). These labels change and
update their values, in order to be more helpful, once they are correctly filled-
in and after pressing the Enter button. Also, few implemented models require
specific input files which define their behaviour. Currently only two of the im-
plemented models require an input file. They are the Multiplication and the
Community Affiliation model. The Multiplication file must contain numerical
values, one for each row. They can be integers or double. It is expected, but not
mandatory, that the number of rows is equal to the number of nodes and the
NetworkRandomizer will pop-up a dialog which asks the user if the number of
values found in the file is correct. The Community Affiliation model requires a
file which contains a set of rows where each line represents a community. The
rows starts with a p-value, i.e. the probability of an edge between two members
of the community, and is followed by the names of the nodes inside that commu-
nity, separated by spaces. There is a known bug, that affects the Multiplication
input file. This issue is probably due to the Java version. It, sometimes require
double that have a comma and sometimes double that have a dot as separator
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between the integer and decimal part of a number. It is quite easy to detect the
error since the multiplication range, suggested by the dialog tha appears when the
network generation starts, is wrong. In this case, the best solution is to substitute
the commas/dots with dots/commas in the text file.
Figure 4.4: Selecting the number of networks to be created, is done using
this text box. Once the check mark is selected, it allows to choose how many
networks will be created for each selected model. It is important to note that a
number of networks will be created and their dimension may affect the memory
consumption of the whole Cytoscape software.
It is worth noting that once a model is selected in the GUI, then each one of
the selected model will result in the desired number of random networks, every
time the Start Randomisation button is pressed. So, removing the check mark
from all the models that are selected, will prevent the generation of unwanted
networks that may slow down the analysis. This recommentadion becomes very
important if more networks are supposed to be created (see Fig: 4.4). Since it is
possible to select the number of networks to be created for each model then, for
instance, if the user inserted a value equal to 10 as a result, ten networks will be
created, for each selected model, every time NetworkRandomizer runs.
Comparing networks
The final step of the workflow we designed concerns the comparison of the net-
works. In order to perform this task a random network must be generated and at
least a numerical attribute should be present in all the networks that are supposed
to be compared. To run the statistical comparison module it is necessary to spec-
ify which networks the algorithm will use. To do so, the user needs to select the
real networks in the Networks Control Panel and press the Selected button in the
NetworkRandomizer GUI (see Fig. 4.5), to confirm the selection. Then, some
random networks must be selected in the same way. These random networks will
be used as benchmark to compute the difference. If all the selected networks do
not share at least one attribute, i.e. the names of the attributes do not match, then
it is impossible to perform the comparison. Note that the attributes names are
case sensitive. Also even if a network does not have the proper attribute name,
this attribute will not appear in the list, so the naming of the attributes is very
important. So, once the networks are selected, the shared attributes appear in
the module and it is now possible to select one, or more, attribute(s) for the final
analysis. If there are no attributes that are available, the user must check their
names in the Node Table panel of Cytoscape, making them suitable and then
he/she must re-select the real and the random networks to compare. If it is not
possible to find a shared attribute, then a dialog will appear suggesting to the user
to check again the attributes names or to select different networks. The attributes
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Figure 4.5: The statistical module implemented in the app. After the data
are generated, the statistical module allows comparing all the shared network
attributes in order to find important patterns. The attribute to be compared must
have the same name in all the networks that are selected. Importantly, the name
match is case-sensitive so some care should be taken while using upper or lower
case. In this example it is possible to note that both real and random networks
are already selected. The red label appears once the button Select is clicked. Also
it is possible to note that some attributes are present in the box and are waiting
to be selected.
could be selected by using the left-click and some, additional keys that are Ctrl
for one-by-one multiple selection, Shift for the range selection and Ctrl+A to se-
lect all the attributes. Once the attributes are selected, it is necessary to specify
an output file name and the directory where the file will be created and saved.
Finally the comparison can be executed by clicking the Start Statistics button.
Two-Sample Kolmogorov Smirnov
The two-sample Kolmogorov-Smirnov test is a non parametric hypothesis test
that permits to evaluate how different are the cumulative distribution functions
of the one-dimensional distributions that come from the two samples. TheH0, or
null hypothesis, for this test assumes that the two samples comes from the same
distribution.
The K-S does not give an idea about the distributions the two samples come
from. The statistics is computed by:
Dn,n′ = sup
x
|F1,n(x)− F2,n′(x)|
where F1,n(x) and F2,n′(x) are the empirical distribution functions of the two
samples. sup is the supremum function, i.e. the least upper bound. n and n′ are
the dimension of the two samples.
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H0 is rejected at level α if:
Dn,n′ > c(α)
√
n+ n′
nn′
c(α) is defined in a table, depending on the value of α.
Interpreting the results
The statistical module returns a textual file that consists of several, comma-separated-
values fields. Each field has a specific function, marked by the> symbol. The first
and the second fields give some information about the networks, real and random,
that were compared. The third field summarises the names of the attributes that
were used for the statistical analysis, and works as a remainder. From the fourth
field on, we listed the actual statistical results that come from the K-S test. These
fields are different depending on whether only one or multiple real networks were
selected for the comparison. In the case the user select a single real network the
output will comprehend these fields:
• Average difference across all centralities between real and random networks;
• Difference between real network and its most similar random network for
each centrality;
• Difference matrix between real and random networks for each centrality.
Here, the first field indicates how different is each random network from the
real one by using the average difference across all centralities. The second field
represents the difference between the real network and its most similar random
network, according to each centrality measure individually. The last field pro-
vides more in-depth information, by specifying the difference between the real
network and each random one, for each centrality measure.
On the other hand, if multiple real networks were selected the output file will
show these fields:
• Average difference across all centralities between real networks and their
most similar random network;
• Difference between real networks and its most similar random network for
each centrality;
• Average difference matrix between real and random networks across all cen-
tralities.
We decided to summarise the results since showing all of the generated data
to the user, in the case of multiple real networks, would result in a very unread-
able output. To avoid this possible outcome, only the most interesting points
were chosen and are shown. Either the pairs of real and random networks, or
the pairs of real networks and centrality measures which show the least statistical
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differences are put in the output file. In this way the user can check the networks
for important non-random processes. The first field specifies the average differ-
ence across all centralities between real networks and their most similar random
network. The second field shows the most similar random network with respect
to the real one, for each real network and each centrality, and specifies the level
of the difference. The last field refers to the real-random distance matrix. The
distances are defined as the average difference across all the centralities. A value of
0 indicates that the distributions are completely the same, up to a normalisation
factor that was used to let the value being comparable. The normalisation factor
here, refers to the number of elements in the series. So, for instance, the series
[1, 2, 3] and [1, 1, 2, 2, 3, 3] would be completely the same. On the other hand, a
value that is close to 1 indicates the existence of an important difference between
the distributions. This result is rarely achieved in real datasets. It may happen,
for instance, when the elements of one series are all greater than the elements of
the other.
4.5 The R implementation
The multiplication model allows the multiplication of the number of nodes de-
scribing a protein, by using a specific attribute. Then the resulting number of
copies is added to the original network, causing the generation of some new in-
teractions that better fits the actual biology of a process. We have implemented
this algorithm through two functions by using the R language. The idea here was
to allow more advanced users to exploit the existing IGraph library6. IGraphs is
a very powerful tool that can be used, in the R, Python and C environments, to
perform different kind of network analysis.
In particular, we implemented two main functions that allow the basic op-
erations to multiply and analyse a multiplied networks. The function addEges(),
allows to create and analyse weighted networks. Currently, three topological
metrics, over the whole set of centralities that are implemented by the R IGraph
library could be used to extract topological information. These centralities are
Closeness, Betweenness, and Alpha Centrality.
The second function we have implemented, i.e. rgSim(), allows to perform a
random simulation that generates a number of weighting arrays, depending on
how many simulations the user wants to perform, that can be seen as a set of ran-
dom experimental data. These arrays multiply the original network, substituting
the experimental data, to obtain a dataset of randomly personalised networks and
their average, selected centrality. The intent of the multiplication function is to
analyse personalised datasets, starting from a traditional static interactome, in or-
der to model a real experimental context. The random simulation is designed as
a validation benchmark for the experimental results, by using a set of randomly
generated networks as controls.
We decided to not implement a statistical module, like the one available in
our NetworkRandomizer app, since R is a statistical programming language and
6http://igraph.org/r/
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it is assumed that an R user is able to perform its own statistical tests. Also, R has
a wealth of already implemented statistical tests.
The library we developed, contains the two mentioned functions and some
other functionalities that are designed to help researches in order to interface R
with Cytoscape. Since Cytoscape uses some very specific file format that are not
standardised, we decided to develop a function that allows the users importing
their networks while keeping the nodes names, into the IGraph environment.
To this purpose we developed a function, called loadSif, which allows creating a
network from a sif file.
Also, we developed some functions that supply to the lack of very specific
functionalities, that are developed in our Cytoscape apps like the PeSca app.
These functions allow finding shortest paths and using them to build meaningful,
connected networks.
The two, main functions are:
• addEdges: allows creating a multiplied network by adding copies of node
according to a weighting array randomly generated. This function is called
by rgSim and takes, as inputs, the network, the array of weights and a
boolean value which is TRUE if the network is directed, FALSE otherwise.
By default it is set as FALSE;
• rgSim: allows simulating several multiplied network by creating some ran-
dom arrays that are used to weigh the networks. As input it takes several
parameters that are the network to multiply, the number of simulations the
algorithm will perform, the min and max values that determines a range in
which the weight will be randomly chosen, a string that describes which
centralities will be used for the comparison and a boolean value which is
TRUE if the network is directed, FALSE otherwise. By default it is set as
FALSE. The centrality is set to ”Closeness” by default but, currently it may
also include ”Betweenness” and ”Alpha.Centrality”
The functions that are implemented as part of the PeSca App project allow
performing specific short path search in the networks. The function we devel-
oped are:
• loadSif : allows loading sif files in order to create a very specific network
while keeping the nodes names. This is of basic importance in a biological
set-up where the nodes has some, very specific names;
• spCluster: allows finding the shortest path among a set of selected nodes, as
in the PeSca app, that are not connected. It requires, as input, a probe con-
taining the nodes of interest and returns, as output, the connected network
if the probe result in a disconnected network, the network formed by the
nodes in the probe otherwise;
• connectIsolated: allows finding the shortest paths along a set of selected
nodes that are not directly connected. It requires, as input, a probe con-
taining the nodes of interest and returns, as output, the connected network
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if the probe result in a disconnected network, the network formed by the
nodes in the probe otherwise;
• findNodesInPaths: allows showing the nodes that forms the shortest paths
that were used to connect isolated nodes;
• firstNeighbours: allows creating a subnetwork which comprehend the nodes
of interest and their first neighbours. It can be used as a preliminary analysis
while trying to connect isolated nodes;
• findNotConnectedNodes: allows finding the nodes that are not connected to
a network.
A future improvement will allow the function rgSim to exploit all the central-
ity indexes implemented in the IGraph library.
4.6 R code
The R code we developed requires that the IGraph library is installed in order to
work. The code we listed starts by loading such library, since it is necessary to
perform some of the operations that were used in our functions.
The term component indicates a subgraph that is formed by a set of nodes
that are present in a bigger network. Here, as giant component, we mean the
component with the higher number of connected nodes. In other words, all the
nodes in the subgraph share interactions between each others but no interactions
reach nodes outside this set. It is also possible to obtain more components. A
disconnected component is usually created when, by using a probe, we extract a
subnetwork from a bigger graph and we obtain more than one component. It is
possible that some of the nodes in the probe does not share interactions hence, the
subnetwork we created may contain different components that do not interact,
like in Fig. 4.6. To overcome this limitation, i.e. to connect isolated components
into subnetworks, it is possible to remap the subnetwork in the bigger graph
and locate the probe. Once the probe is located, by finding paths between the
disconnected component, new nodes will be integrated in the the subnetwork
allowing the creation of new interactions which keep the isolated components
communicating.
1 l i b r a r y ( " i g r aph " ) ; # l o a d t h e IGraph l i b r a r y
2
3 # t h i s f u n c t i o n a l l ow s f i n d i n g t h o s e nod e s t h a t f o rms t h e s h o r t e s t
p a t h s we a r e i n t e r e s t e d i n t o and t h a t c o nn e c t two componen t s .
4
5 f indNodes InPa th s <− funct ion ( e d g e l i s t ) {
6
7 # i n i t i l i s e an a r r a y
8 nodes<−array ( ) ;
9
10 #how many p a t h s have i found ?
11 n_ pa th s<−l ength ( e d g e l i s t ) ;
12
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Figure 4.6: An example of main component. On the left it is possible to ap-
preciate a network where all the nodes can communicate through, at least, a
shortest path. On the right, two networks that are a subnetwork of the original
graph. Suppose the probe contains the nodes in the two separated subnetworks,
i.e. Nodes 1, 2, 3, 4, 5, 7, 9, 10, 11 and 12 . Once the probe is mapped in the
left network and the resulting subnetworks are extracted the result will be two
disconnected networks. As main component we mean the bigger subnetwork, i.e.
the one on the right with the white nodes. The disconnected component, here,
is the smaller subnetwork, i.e. the one with the dark gray nodes. If we look for
connecting paths, using the bigger network, between the two components, i.e.
the giant and the disconnected, then the resulting network will include the Node
6 in addition to the nodes in the probe. The Node 6 is essential to keep the two
subnetwork togheter. This operation is done by using some of the functions we
developed or, in Cytoscape, by using the PeSca app.
13 # f o r e a c h p a t h
14 for ( i in 1 : n_ pa th s ) {
15 # i ne ed t o know which nod e s a r e i n v o l v e d
16 nodes<−c ( nodes ,V( network ) $name [ un l i s t ( e d g e l i s t [ [ i ] ] ) ] ) ;
17 }
18
19 # a s o u t p u t i r e t u r n t h e v a l u e s which o c c u r s on l y onc e . i f ound
them in t h e l i s t minus t h e f i r s t e l em en t t h a t i s a lway s n u l l !
20 return ( unique ( nodes [−1 ] ) ) ;
21 }
22
23 f i r s tNe i g hbou r s <− funct ion ( network , probe ) {
24 f i r s t<−induced . subgraph ( network , un l i s t ( neighbourhood ( network ,
order=1,probe ) ) ) ;
25 return ( f i r s t ) ;
26 }
27
28 # t h i s f u n c t i o n a l l ow s f i n d i n g t h e nod e s t h a t a r e d i s c o n n e c t e d .
29 # i t i s u s u a l l y u s e d a f t e r running t h e DECOMPOSE f u n c t i o n
30
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31 f indNotConnectedNodes <− funct ion ( decomposednet ) {
32
33 #how many d i s c o n n e c t e d componen t s a r e t h e r e ?
34 cmps<−l ength ( decomposednet ) ;
35
36 # i n i t i a l i s e an a r r a y
37 not_ connec ted<−array ( ) ;
38
39 # f o r e a c h component , s t a r t i n g from t h e s e c o n d one s i n c e i a s sume
t h e f i r s t one a s t h e main component t o which t h e o t h e r one
w i l l b e c o nn e c t e d
40 for ( i in 2 : cmps ) {
41 not_ connec ted<−c ( not_ connected ,V( decomposednet [ [ i ] ] ) $name ) ;
42 }
43
44 return ( unique ( not_ connec ted [−1 ] ) ) ;
45 }
46
47 # t h i s f u n c t i o n a l l ow impo r t i n g . s i f f i l e s
48
49 l o a d S i f <− funct ion ( f i l e n ame ) {
50 s i f _ f i l e<−read . t a b l e ( f i l e n ame ) ;
51
52 # c r e a t i n g t h e ne twork by u s i n g t h e column 1 and 3 from t h e . s i f
f i l e
53 tmp_ net<−graph . data . frame ( s i f _ f i l e [ , c ( 1 , 3 ) ] , d i r e c t e d=FALSE ) ;
54
55 # s e t t l i n g t h e c o nn e c t e d componen t s by removing d u p l i c a t e d nod e s
and l o o p s
56 network<−s imp l i f y ( tmp_net , remove . mu l t i p l e=TRUE, remove . l oop s=
TRUE) ;
57
58 i f ( l ength ( decompose ( network ) )>1){
59 pr int ( " v e r i f y t h a t t h i s network does not con t a i n any
d i s c onn e c t e d component . i f i t does t r y s pC l u s t e r or
c o nn e c t I s o l a t e d " ) ;
60 }
61
62 return ( network ) ;
63 }
The functions listed below are supposed to be used in order to find the paths
between the disconnected components. They are developed in order to simulate
the Cytoscape app, PeSca. It can be downloaded for Cytoscape 3.x and now it is
possible to exploit some of its functionalities in R. This fact allows saving a lot of
computational time, when dealing with very big networks, since R better deals
with big networks than the Cytoscape software. Also, loading huge networks in
Cytoscape requires machines that have an important amount of virtual memory
making it difficult to proceed with further analysis.
Here, the term component has the same meaning as above. But we add a
specification. Again, a component may be giant and disconnected. The giant com-
ponent is the bigger component we are able to find in a subnetwork, in terms of
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number of nodes. All the other components are said disconnected. The idea here
is that we want to connect the disconnected components to the giant component
in order to obtain a connected network.
1 # t h e v a r i a b l e p r o b e must c o n t a i n t h e l i s t o f t h o s e node i am
i n t e r e s t e d i n t o . a r e t h e y c o nn e c t e d ?
2
3 s pC l u s t e r <− funct ion ( probe ) {
4 # c r e a t i n g t h e subne twork and comput ing how many componen t s i t
h a s
5 subne t<−induced . subgraph ( network , probe ) ;
6 decomposednet<−decompose ( subne t ) ;
7
8 i f ( l ength ( decomposednet )>1){# i f t h e r e i s more than one component
i t means t h a t t h e y a r e d i s c o n n e c t e d
9 g i a n t<−V( decomposednet [ [ 1 ] ] ) $name ;
10 not_ cnc td<−f indNotConnectedNodes ( decomposednet ) ;
11
12 # sp− c l u s t e r
13 sp<−get . a l l . s h o r t e s t . p a th s ( network , g i an t , not_ cnc td ) ;
14
15 # c r e a t i n g t h e l i s t o f t h o s e nod e s t h a t b e l o n g t o t h e s h o r t e s t
p a t h s j u s t computed
16 n o d e s l i s t<−f indNodes InPa th s ( sp $ vpath ) ;
17
18 # add ing t h e two componen t s ( g i a n t and d i s c o n n e c t e d )
19 n o d e s l i s t<−unique ( c ( n o d e s l i s t , g i an t , not_ cnc td ) ) ;
20
21 #and t h en i c o n s t r u c t t h e ne twork
22 connec ted _ net<−induced . subgraph ( network , n o d e s l i s t ) ;
23 return ( connec ted _ net ) ;
24 }
25 e l s e {
26 return ( "no d i s c onn e c t e d component " ) ;
27 }
28 }
29
30 c o nn e c t I s o l a t e d <− funct ion ( probe ) {
31 # c r e a t i n g t h e subne twork and e x t r a c t i n g i t s c omponen t s
32 subne t<−induced . subgraph ( network , probe ) ;
33 decomposednet<−decompose ( subne t ) ;
34
35 i f ( l ength ( decomposednet )>1){# i f t h e r e i s more than one component
i t means t h a t t h e y a r e d i s c o n n e c t e d
36 g i a n t<−V( decomposednet [ [ 1 ] ] ) $name ;
37 not_ cnc td<−f indNotConnectedNodes ( decomposednet ) ;
38
39 # c o nn e c t d i s c o n n e c t e d component
40 connec t<−get . s h o r t e s t . p a th s ( network , g i an t , not_ cnc td ) ;
41
42 # c r e a t i n g t h e l i s t o f t h o s e nod e s t h a t b e l o n g t o t h e s h o r t e s t
p a t h s j u s t computed
43 n o d e s l i s t<−f indNodes InPa th s ( connec t $ vpath ) ;
44
45 # add ing t h e two componen t s ( g i a n t and d i s c o n n e c t e d )
46 n o d e s l i s t<−unique ( c ( n o d e s l i s t , g i an t , not_ cnc td ) ) ;
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47
48 #and t h en i c o n s t r u c t t h e ne twork
49 connec ted _ net<−induced . subgraph ( network , n o d e s l i s t ) ;
50 return ( connec ted _ net ) ;
51 }
52 e l s e {
53 return ( "no d i s c onn e c t e d component " ) ;
54 }
55 }
The following functions allow simulating multiplied networks and creating
experimental, biological data through a multiplied network approach. The addEdges
function allows creating multiplied networks, the rgSim function allow generat-
ing randomly weighted networks. In order to let the user computing the topolog-
ical centralities over multiplied networks we implemented some functions. These
functions allow summing up the centralities of the original node and its copies
and return a single value which reflects the weighted centrality.
The IGraph library implements several centralities, from the IGraph docs
page 7:
• alpha.centrality: find Bonacich alpha centrality scores of network positions;
• authority.score: Kleinberg’s authority centrality scores.;
• Betweenness.estimate: Vertex and edge Betweenness centrality;
• centralization.evcent: Centralise a graph according to the Eigenvector cen-
trality of vertices;
• centr_eigen: Centralise a graph according to the Eigenvector centrality of
vertices;
• Closeness.estimate: Closeness centrality of vertices;
• edge.Betweenness: Vertex and edge Betweenness centrality;
• edge.Betweenness.estimate: Vertex and edge Betweenness centrality;
• edge_Betweenness: Vertex and edge Betweenness centrality;
• eigen_centrality: Eigenvector Centrality Scores of Network Positions;
• hub.score: Kleinberg’s hub centrality scores;
• power_centrality: Find Bonacich Power Centrality Scores of Network Po-
sitions;
• subgraph.centrality: Find subgraph centrality scores of network positions.
7http://igraph.org/r/doc/
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The rgSim implements the computation for three specific centralities that are:
Closeness, AlphaCentrality and Betweenness. It is possible to extend the set of
available centralities by adding an if loop for each new centrality. The algorithm,
for each simulation, creates a numerical weights array in between a range, defined
by the user. The number of simulation and the input network are defined by the
user. The network can be directed and undirected.
The function addEdges algorithm works as follows. Starting from the net-
work and a random array, the edgelist is visited; for each node the algorithm
performs a loop for each copy the node has. The node 1 has 0 copies means 0
loops, the node 4 has 3 copies means 3 loops. For each loop a new node is added
and a new set of edges is created. First the algorithm finds the position of the orig-
inal node in the edge list. This step permits to get the neighbours of the original
node that will be neighbours of each copy (rows: 33-42). Then an edge is added
between the node and its copy (row: 43). Another edge is added if the network is
considered as directed: the edges between the original node and its copies are not
directed so a second edge A,B and B,A is added (rows: 44-46). Finally the new
edges are added to the edgelist and the loops begin again with a new copy, if it
exists.
1 # network i s t h e g r aph we want t o we igh in o r d e r t o p e r f o rm t h e
s imu l a t i o n
2 # s im u l a t i o n s i s t h e number o f n e two rk s t h e f u n c t i o n w i l l g e n e r a t e
3 # [ v a l _min−va l _max ] i s t h e r ang e in b e twe en t h e w e i g h t v e c t o r s w i l l
b e g e n e r a t e d
4 # c e n t r a l i t y c o u l d be a s i n g l e c e n t r a l i t y or a v e c t o r o f
c e n t r a l i t i e s ( i . e . a l p h a _ c e n t r a l i t y , a u t h o r i t y _ s c o r e , B e tw e enn e s s
, C l o s e n e s s , e d g e . B e tw e enn e s s , e i g e n _ c e n t r a l i t y )
5
6 addEdges <− funct ion ( network , weights , d i r e c t i o n=FALSE ) { # i n pu t :
network , t h e w e i g h t s and i f t h e ne twork i s d i r e c t e d . d e f a u l t :
u n d i r e c t e d ne twork
7
8 a l l _ the _ edg e s <− get . e d g e l i s t ( network ) ; # t h e e d g e l i s t o f t h e
ne twork
9 new_ edg e s <− c ( ) ;
10 l e n <− nrow ( a l l _ the _ edg e s ) ;
11 new_node <− l ength (V( network ) ) ; # t h e new node i s h o u l d add i s
n od e s + 1
12 c op i e s <− weights − 1 ; # t o t a l number o f c o p i e s e a c h node w i l l
add t o t h e ne twork
13
14 for ( n in V( network ) ) { # f o r t h e node n
15 i f ( c o p i e s [ n]>0){ # i f t h e r e i s a t l e a s t a c o p y
16 for ( cp in 1 : c o p i e s [ n ] ) { # f o r e a c h c op y
17 new_node <− new_node + 1 ; #a new node i s g o i n g t o be added
18 pos <− which ( a l l _ the _ edg e s==n ) ; # f i n d t h e node in t h e e d g e
_ l i s t
19 new_ edg e s <− c ( ) ;
20 for ( p in pos ) { # f o r e a c h p o s i t i o n c r e a t e a new c o u p l e o f
v a l u e s : ( n , o l d _ n e i g h b ou r _ o f _n_ f a t h e r )
21 i f ( p<=len ) {
22 new_ edg e s <− rbind ( new_ edges , c ( new_node , a l l _ the _ edg e s [
p+l en ] ) ) ;
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23 }
24 e l s e {
25 new_ edg e s <− rbind ( new_ edges , c ( a l l _ the _ edg e s [ p−l e n ] ,
new_node ) ) ;
26 }
27 }
28 new_ edg e s <− rbind ( new_ edges , c ( n ,new_node ) ) ; # add an e d g e
b e twe en t h e new node and i t s f a t h e r
29 i f ( d i r e c t i o n==TRUE) {
30 new_ edg e s <− rbind ( new_ edges , c ( new_node , n ) ) ;
31 }
32 a l l _ the _ edg e s <− rbind ( a l l _ the _ edges ,new_ edg e s ) ;
33 l e n <− nrow ( a l l _ the _ edg e s ) ; #how many e d g e s
34 }
35 }
36 }
37 #COMMENT THIS TWO LINES
38 new_network <− graph ( c ( t ( a l l _ the _ edg e s ) ) , d i r e c t e d=d i r e c t i o n ) ; #
t h e new network
39 return ( new_network ) ;
40 # IF THE USERS NEEDS AN EDGE LIST INSTEAD OF A NETWORK THEN
UNCOMMENT THE FOLLOWING AND COMMENT THE TWO LINES ABOVE
41 # r e t u r n ( a l l _ t h e _ e d g e s ) ;
42 }
43
44 # ###########################################################
45 # u s e t h i s method when t h e ne twork nod e s h a s s p e c i f i c names ! #
46 # ###########################################################
47
48 addEdgesWithNames <− funct ion ( network , weights , d i r e c t i o n=FALSE ) {
# i n pu t : network , t h e w e i g h t s and i f t h e ne twork i s d i r e c t e d .
d e f a u l t : u n d i r e c t e d ne twork
49
50 a l l _ the _ edg e s <− get . e d g e l i s t ( network ) ; # t h e e d g e l i s t o f t h e
ne twork
51 new_ edg e s <− c ( ) ;
52 l e n <− nrow ( a l l _ the _ edg e s ) ;
53 nnod<−l ength (V( network ) ) ;
54 new_node <− l ength (V( network ) ) ; # t h e new node i s h o u l d add i s
n od e s + 1
55 c op i e s <− weights − 1 ; # t o t a l number o f c o p i e s e a c h node w i l l
add t o t h e ne twork
56
57 for ( n in 1 : nnod ) { # f o r e a c h o r i g i n a l node
58 i f ( c o p i e s [ n]>0){ # i f t h e r e i s a t l e a s t a c o p y
59 for ( cp in 1 : c o p i e s [ n ] ) { # f o r e a c h c op y
60 new_node <− pa s t e (V( network ) $name [ n ] , cp , s ep="_ " ) ; #a new
node i s g o i n g t o be added
61 pos <− which ( a l l _ the _ edg e s==V( network ) $name [ n ] ) ; # f i n d t h e
node in t h e e d g e _ l i s t
62 new_ edg e s <− c ( ) ;
63 for ( p in pos ) { # f o r e a c h p o s i t i o n c r e a t e a new c o u p l e o f
v a l u e s : ( n , o l d _ n e i g h b ou r _ o f _n_ f a t h e r )
64 i f ( p<=len ) {
65 new_ edg e s <− rbind ( new_ edges , c ( new_node , a l l _ the _ edg e s [
p+l en ] ) ) ;
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66 }
67 e l s e {
68 new_ edg e s <− rbind ( new_ edges , c ( a l l _ the _ edg e s [ p−l e n ] ,
new_node ) ) ;
69 }
70 }
71 new_ edg e s <− rbind ( new_ edges , c (V( network ) $name [ n ] ,new_node
) ) ; # add an e d g e b e twe en t h e new node and i t s f a t h e r
72
73 i f ( d i r e c t i o n==TRUE) {
74 new_ edg e s <− rbind ( new_ edges , c ( new_node , n ) ) ;
75 }
76 a l l _ the _ edg e s <− rbind ( a l l _ the _ edges ,new_ edg e s ) ;
77 l e n <− nrow ( a l l _ the _ edg e s ) ; #how many e d g e s
78 }
79 }
80 }
81 #COMMENT THIS TWO LINES
82 new_network <− graph ( c ( t ( a l l _ the _ edg e s ) ) , d i r e c t e d=d i r e c t i o n ) ; #
t h e new network
83 return ( new_network ) ;
84 # IF THE USERS NEEDS AN EDGE LIST INSTEAD OF A NETWORK THEN
UNCOMMENT THE FOLLOWING AND COMMENT THE TWO LINES ABOVE
85 # r e t u r n ( a l l _ t h e _ e d g e s ) ;
86 }
87
88 rgSim <− funct ion ( network , s imu l a t i on s , v a l _min , v a l _max ,
c e n t r a l i t y=" C lo s en e s s " , d i r e c t i o n=FALSE ) {
89
90 weight <− array ( ) ;
91 c e n t r a l i t i e s <− array ( ) ;
92 c l o <− array ( ) ;
93 betw <− array ( ) ;
94 a lpha <− array ( ) ;
95 v e r t e x e s <− vcount ( network ) ;
96 means_ c l o <− array ( ) ;
97 means_ a lpha <− array ( ) ;
98 means_betw <− array ( ) ;
99 l a b e l <− c ( " C lo s en e s s " , " a l pha . c e n t r a l i t y " , " Betweennes s " ) ;
100 r e s u l t s <− data . frame ( ) ;
101
102 i f ( a l l ( c e n t r a l i t y %in% l a b e l , na . rm=FALSE ) ) {# i f a l l t h e
c e n t r a l i t i e s a r e c o r r e c t l y t y p e d t h en go on
103 for ( i in 1 : s imu l a t i o n s ) {# f o r e a c h s imu l a t i o n an a r r a y o f
random w e i g h t s i s g e n e r a t e d
104 weight <− round ( runi f ( v e r t e x e s , v a l _min , v a l _max ) ) ; # g e n e r a t e s
# v e r t e x e s w e i g h t s w i t h in va l _max and va l _min
105 # add t h e new e d g e s t o t h e ne twork and t h en compute t h e
c e n t r a l i t i e s
106
107 # IF THE ADDEDGES FUNCTION RETURNS AN EDGE LIST THEN
UNCOMMENT THIS TWO LINES \ d o t s
108 #new_ e d g e s _ l i s t <− addEdg e s ( network , w e i g h t ) ;
109 # improved _network <− g r aph ( c ( t ( new_ e d g e s _ l i s t ) ) ) ;
110 #AND COMMENT THE LINE BELOW
111 improved_network <− addEdges ( network , weight , d i r e c t i o n ) ;
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112 # p l o t ( improved _network ) ; dev . new ( ) ; # t o p r i n t t h e m u l t i p l i e d
ne twork s , uncomment t h e l i n e .
113
114 i f ( " C lo s en e s s " %in% c e n t r a l i t y ) {
115 c en t r _tmp <− Clo s en e s s ( improved_network ) ;
116 c e n t r a l i t i e s _ c l o <− c en t r a l i t y Sum ( c en t r _tmp , weight ) ;
117 c l o <− c ( c lo , c e n t r a l i t i e s _ c l o ) ;
118 #means_ c l o [ i ] <− mean ( c e n t r a l i t i e s _ c l o ) ; # compute t h e mean
C l o s e n e s s f o r t h e s imu l a t i o n # i
119 }
120 i f ( " a l pha . c e n t r a l i t y " %in% c e n t r a l i t y ) {
121 c en t r _tmp <− a lpha . c e n t r a l i t y ( improved_network )
122 c e n t r a l i t i e s _ a lpha <− c en t r a l i t y Sum ( c en t r _tmp , weight ) ;
123 a lpha <− c ( a lpha , c e n t r a l i t i e s _ a lpha ) ;
124 #means_ a l p h a [ i ] <− mean ( c e n t r a l i t i e s _ a l p h a ) ;
125 }
126 i f ( " Betweennes s " %in% c e n t r a l i t y ) {
127 c en t r _tmp <− Betweennes s ( improved_network ) ;
128 c e n t r a l i t i e s _betw <− c en t r a l i t y Sum ( c en t r _tmp , weight ) ;
129 betw <− c ( betw , c e n t r a l i t i e s _betw ) ;
130 #means_ betw [ i ] <− mean ( c e n t r a l i t i e s _ betw ) ;
131 }
132 }
133 }
134 e l s e {
135 s top ( "One of the c e n t r a l i t i e s you s e l e c t e d does not e x i s t " ) ;
136 }
137 # r e s u l t s <− c ( mean ( means_ c l o ) ,mean ( means_ betw ) ,mean ( means_ a l p h a )
) ;
138 row <− ( l ength (V( network ) ) * s imu l a t i o n s ) ;
139 r e s u l t s <− matrix ( nrow=row , ncol=3) ;
140 i f ( " C lo s en e s s " %in% c e n t r a l i t y ) { r e s u l t s [ , 1 ] <− t ( c l o [−1 ] ) ; } e l s e {
r e s u l t s [ , 1 ] <− t ( array ( 0 , row ) ) ; }
141 i f ( " a l pha . c e n t r a l i t y " %in% c e n t r a l i t y ) { r e s u l t s [ , 2 ] <− t ( a l pha
[−1 ] ) ; } e l s e { r e s u l t s [ , 2 ] <− t ( array ( 0 , row ) ) ; }
142 i f ( " Betweennes s " %in% c e n t r a l i t y ) { r e s u l t s [ , 3 ] <− t ( betw [−1 ] ) }
e l s e { r e s u l t s [ , 3 ] <− t ( array ( 0 , row ) ) ; }
143 colnames ( r e s u l t s ) <− l a b e l ;
144 return ( r e s u l t s ) ;
145 }
146
147 c r e a t eWe i gh t s <− funct ion ( howmany ,min ,max ) {
148
149 v a l _min<−round (min ) ;
150 v a l _max<−round (max ) ;
151 weight<−round ( runi f ( howmany , v a l _min , v a l _max ) ) ; # g e n e r a t e s
howmany w e i g h t s w i t h in va l _max and va l _min
152 return ( we ight ) ;
153 }
154
155 c e n t r a l i t y P o s <− funct ion ( n_nodes , weight ) { # f i n d i n g t h e p o s i t i o n
t h a t c o r r e s p o n d t o a node and i t s c o p i e s in t h e c e n t r a l i t y
a r r a y
156
157 c op i e s <− weight −1;
158 maxval <− max( we ight ) ; # f i n d t h e max m u l t i p l i c a t i o n f a c t o r ( t h e
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maximal number o f c o p i e s )
159 what_sum <− rep ( 0 , maxval ) ;
160 t o t a l _pos <− data . frame ( ) ;
161 pos <− 1 ;
162 for ( i in c op i e s ) { #how many c o p i e s a node h a s ?
163 what_sum <− rep ( 0 , maxval ) ;
164 i f ( i == 0 ) { # i f t h e node h a s 0 c o p i e s t h e c e n t r a l i t y i s j u s t
i t s e l f
165 what_sum [ 1 ] <− pos ; # in p o s [ 1 ] w i l l pu t t h e p o s i t i o n o f t h e
o r i g i n a l node in t h e c e n t r a l i t y a r r a y
166 pos <− pos + 1 ;
167 }
168 e l s e { # o t h e r w i s e i t s h o u l d sum t h e c e n t r a l i t i e s o f a l l t h e
c o p i e s and t h e o r i g i n a l
169 what_sum [ 1 ] <− pos ; # t h e p o s [ 1 ] i s a lway s f o r t h e r e a l
p o s i t i o n o f t h e o r i g i n a l node
170 for ( j in 1 : c o p i e s [ pos ] ) { # t h en f o r t h e o t h e r c o p i e s
171 n_nodes <− n_nodes + 1 ; # c opy j
172 what_sum [ j +1] <− n_nodes ; # add t h e p o s i t i o n o f t h e c o p y j
t o t h e a r r a y o f t h i s o r i g i n a l node
173 }
174 pos <− pos + 1 ; # go f o r t h e n e x t node
175 }
176 t o t a l _pos <− rbind ( t o t a l _pos , what_sum ) ; # add a row , one f o r
e a c h node
177 }
178 return ( t o t a l _pos ) ; # t h e f i n a l mat r i x h a s nrow a s t h e node in t h e
o r i g i n a l ne twork and n c o l h a s t h e maximum number o f c o p i e s a
node h a s in t h e ne twork
179 }
180
181 c en t r a l i t y Sum <− funct ion ( c e n t r a l i t y _tmp , weight ) { #sum up t h e
c e n t r a l i t i e s ( compute t h e c e n t r a l i t i e s o f t h e m u l t i p l i e d
ne twork in " c e n t r a l i t y _ tmp " ) o f e a c h o r i g i n a l node and i t s
c o p i e s
182
183 c e n t r a l i t y <− rep ( 0 , l ength ( we ight ) ) ; # t h e c e n t r a l i t y a r r a y h a s
t h e same l e n g t h o f t h e number o f o r i g i n a l nod e s
184 tmp <− c e n t r a l i t y P o s ( l ength ( we ight ) , we ight ) ; # comput ing t h e
p o s i t i o n o f t h e c e n t r a l i t i e s t o sum f o r e a c h o r i g i n a l node
185
186 for ( i in 1 :nrow ( tmp ) ) { # f o r e a c h row ( a node )
187 for ( j in 1 : ncol ( tmp [ 1 , ] ) ) { # f o r e a c h column ( t h e o r i g i n a l node
and i t s c o p i e s )
188 pos <− un l i s t ( tmp [ i , ] [ j ] ) ; # g e t t h e p o s i t i o n o f t h e
c e n t r a l i t y t o add t o t o t a l sum
189 i f ( l ength ( c e n t r a l i t y _tmp [ pos ] ) !=0 ) { # i f t h e r e a c t u a l l y i s a
c e n t r a l i t y t o add ( t h e r e i s a t l e a s t a c o p y )
190 c e n t r a l i t y [ i ] <− c e n t r a l i t y [ i ] + c e n t r a l i t y _tmp [ pos ] ; #sum
t h e c o r r e s p o n d e d v a l u e
191 }
192 }
193 }
194 return ( c e n t r a l i t y ) ;
195 }
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We also developed some utilities for those users that exploit our functions in
order to perform the network analysis. The function eccentricityMining allows
finding those nodes that have, in different networks, different values of eccentric-
ity. As we suggested in the Section 6.2 these nodes could be very interesting and
we made it simple to find them.
1 # ####################################################
2 #a_ c s v : must be a c s v t a b l e which c o n t a i n s i n f o rma t i o n abou t t h e
nod e s in t h e g r aph and t h e i r e c c e n t r i c i t y
3 # an o t h e r _ c s v : must be a c s v t a b l e which c o n t a i n s i n f o rma t i o n abou t
t h e nod e s in t h e g r aph and t h e i r e c c e n t r i c i t y
4 # c e n t r a l i t y : i s a s t r i n g which r e p r e s e n t s t h e name o f t h e
a t t r i b u t e r e l a t i v e t o e c c e n t r i c i t y
5 # f l a g : d o e s t h e c s v have an h e a d e r ?
6
7 # r e t u r n a l i s t o f node s , a s d e f i n e d by t h e IGraph l i b r a r y , which
shows a d i f f e r e n c e in t h e E c c e n t r i c i t y c e n t r a l i t y b e twe en t h e
two g r a p h s
8 # ####################################################
9
10 # t h i s f u n c t i o n a l l ow s t h e u s e r t o u s e a s i n pu t two l o a d e d c s v
f i l e s
11
12 eccen t r i c i tyMin ingFromCsv <− funct ion ( a_ graph , another _ graph ,
c e n t r a l i t y , f l a g=TRUE) {
13 i f ( c e n t r a l i t y %in% colnames ( a_ graph ) && c e n t r a l i t y %in% colnames
( another _ graph ) ) {
14 d i f f _nodes<−vec tor ( ) ;
15 for ( i in a_ graph $name ) {
16 a_pos<−which ( a_ graph $name==i ) ; # g e t t h e p o s i t i o n o f t h e node
i in a_ g r aph
17 another _pos<−which ( another _ graph $name==i ) ; # t h e same f o r
an o t h e r _ g r aph
18 a_tmp<−a_ graph [ , c e n t r a l i t y ] [ a_pos ] ; # g e t i t s e c c e n t r i c i t y
19 another _tmp<−another _ graph [ , c e n t r a l i t y ] [ another _pos ] ; # aga in ,
f o r a n o t h e r _ g r aph
20 i f ( l ength ( a_tmp ) ) {# i f a_ tmp c o n t a i n s s ome t h i n g
21 i f ( l ength ( another _tmp ) ) {#and an o t h e r _ tmp t o o
22 i f ( round ( a_tmp , 4 ) !=round ( another _tmp , 4 ) ) {# t h en s t o r e t h e
name o f t h e node
23 d i f f _nodes<−append ( i , d i f f _nodes ) ;
24 }
25 }
26 }
27 }
28 return ( d i f f _nodes ) ;
29 }
30 e l s e {
31 pr int ( " chosen c e n t r a l i t y i s not an e x i s t i n g column . Check
t h e s e l i s t s : " ) ;
32 pr int ( colnames ( a_ graph ) ) ;
33 pr int ( colnames ( another _ graph ) ) ;
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34 }
35 }
36
37 # t h i s f u n c t i o n a l l ow s t h e u s e r t o u s e a s i n pu t two s t r i n g s which
r e p r e s e n t s t h e f i l e n am e s
38
39 e c c en t r i c i t yMin ingFromFi l ename <− funct ion ( a_ csv , ano ther _ csv ,
c e n t r a l i t y , f l a g=TRUE) {
40
41 a_ graph<−read . csv ( a_ csv , header=f l a g ) ;
42 another _ graph<−read . csv ( another _ csv , heade r=f l a g ) ;
43 i f ( c e n t r a l i t y %in% colnames ( a_ graph ) && c e n t r a l i t y %in% colnames
( another _ graph ) ) {
44 d i f f _nodes<−vec tor ( ) ;
45 i f ( f i l e . e x i s t s ( a_ csv ) && f i l e . e x i s t s ( another _ csv ) ) {
46 for ( i in a_ graph $name ) {
47 a_pos<−which ( a_ graph $name==i ) ; # g e t t h e p o s i t i o n o f t h e
node i in a_ g r aph
48 another _pos<−which ( another _ graph $name==i ) ; # t h e same f o r
an o t h e r _ g r aph
49 a_tmp<−a_ graph [ , c e n t r a l i t y ] [ a_pos ] ; # g e t i t s e c c e n t r i c i t y
50 another _tmp<−another _ graph [ , c e n t r a l i t y ] [ another _pos ] ; #
aga in , f o r a n o t h e r _ g r aph
51 i f ( l ength ( a_tmp ) ) {# i f a_ tmp c o n t a i n s s ome t h i n g
52 i f ( l ength ( another _tmp ) ) {#and an o t h e r _ tmp t o o
53 i f ( round ( a_tmp , 4 ) !=round ( another _tmp , 4 ) ) {# t h en s t o r e
t h e name o f t h e node
54 d i f f _nodes<−append ( i , d i f f _nodes ) ;
55 }
56 }
57 }
58 }
59 return ( d i f f _nodes ) ;
60 }
61 e l s e pr in t ( " one of the f i l e s does not e x i s t " ) ;
62 }
63 e l s e {
64 pr int ( " chosen c e n t r a l i t y i s not an e x i s t i n g column . Check
t h e s e l i s t s : " ) ;
65 pr int ( colnames ( a_ graph ) ) ;
66 pr int ( colnames ( another _ graph ) ) ;
67 }
68 }
69
70
71 # ####################################################
72 #a_ g r aph i s a g r aph a s d e f i n e d by t h e IGraph l i b r a r y
73 #a_node i s a node a s d e f i n e d by t h e IGraph l i b r a r y
74
75 # r e t u r n a l i s t o f p a t h s
76 # ####################################################
77
78 f i ndLonge s tP a th <− funct ion ( a_ graph , a_node ) {
79
80 pa th s<−get . a l l . s h o r t e s t . p a th s ( a_ graph , from=a_node , to=V( a_ graph ) ,
mode=" a l l " ) ;
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81 tmp<−1 ;
82 i n t _ pa th s<− l i s t ( ) ;
83 # f i n d t h e l e n g t h o f t h e l o n g e s t s h o r t e s t p a t h g e n e r a t e d from a_
node
84 for ( i in 1 : l ength ( p a th s $ r e s ) ) {
85 l<−l ength ( p a th s $ r e s [ [ i ] ] ) ;
86 i f ( l>tmp ) {
87 tmp<−l ;
88 }
89 }
90 #now c h e c k i f t h e r e a r e more p a t h s which have t h a t l e n g t h
91 j<−1 ;
92 for ( i in 1 : l ength ( p a th s $ r e s ) ) {
93 i f ( l ength ( p a th s $ r e s [ [ i ] ] )==tmp ) {
94 i n t _ pa th s [ [ j ] ]<−pa th s $ r e s [ [ i ] ] ;
95 j<−j +1;
96 }
97 }
98 return ( i n t _ pa th s ) ;
99 }
100
101 # ####################################################
102 # t a r g e t s i s a f i l e which c o n t a i n s t h e p r o t e i n s t o s e a r c h
103 # p a t h s i s a l i s t o f p a t h s
104
105 # r e t u r n a l i s t o f p a t h s a s s o c i a t e d t o t h e t a r g e t s
106 # ####################################################
107
108 f i n dT a r g e t s <− funct ion ( t a r g e t s , p a th s ) {
109
110 l<−1 ;
111 t a r g e t e d _ pa th s<− l i s t ( ) ;
112 i f ( f i l e . e x i s t s ( t a r g e t s ) ) {
113 f i l e<−read . t a b l e ( t a r g e t s ) ;
114 for ( i in 1 : l ength ( a_ pa th s ) ) {#how many l i s t s a r e in p a t h s ?
115 for ( j in 1 : l ength ( a_ pa th s [ [ i ] ] ) ) {# f o r e a c h l i s t , how many
o b j e c t s a r e s t o r e d ?
116 for ( k in 1 : dim ( f i l e ) [ 1 ] ) {# s e a r c h a p r o t e i n in a l l t h e
o b j e c t s
117 i f ( f i l e [ k , ] %in% a_ pa th s [ [ i ] ] [ [ j ] ] $name ) {
118 t a r g e t e d _ pa th s [ [ l ] ]<−append ( t a r g e t e d _ paths , t o S t r i n g ( a_
pa th s [ [ i ] ] [ [ j ] ] $name ) ) ;
119 l<−l +1;
120 }
121 }
122 }
123 }
124 }
125 e l s e {
126 pr int ( " the chosen f i l e does not e x i s t " ) ;
127 }
128 return ( t a r g e t e d _ pa th s ) ;
129 }
130
131 # t h e same bu t wi th t h e s p e c i f i c a t i o n d o e s _ not _ c o n t a i n a s e t o f
p r o t e i n s
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132
133 f i ndTa r g e t sWi thou t S e t <− funct ion ( c on t a in s , not_ con t a in s , p a th s ) {
134
135 l<−1 ;
136 t a r g e t e d _ pa th s<− l i s t ( ) ;
137 i f ( f i l e . e x i s t s ( t a r g e t s ) ) {
138 c on t a i n s<−read . t a b l e ( t a r g e t s ) ;
139
140 for ( i in 1 : l ength ( a_ pa th s ) ) {#how many l i s t s a r e in p a t h s ?
141 for ( j in 1 : l ength ( a_ pa th s [ [ i ] ] ) ) {# f o r e a c h l i s t , how many
o b j e c t s a r e s t o r e d ?
142 for ( k in 1 : dim ( c on t a i n s ) [ 1 ] ) {# s e a r c h a p r o t e i n in a l l t h e
o b j e c t s
143 i f ( f i l e [ k , ] %in% a_ pa th s [ [ i ] ] [ [ j ] ] $name ) {
144 t a r g e t e d _ pa th s [ [ l ] ]<−append ( t a r g e t e d _ paths , t o S t r i n g ( a_
pa th s [ [ i ] ] [ [ j ] ] $name ) ) ;
145 l<−l +1;
146 }
147 }
148 }
149 }
150 }
151 e l s e {
152 pr int ( " the chosen f i l e does not e x i s t " ) ;
153 }
154 return ( t a r g e t e d _ pa th s ) ;
155 }

Chapter 5
Validating experimental findings
5.1 Introduction
The final step of our workflow refers to the validation of the findings that re-
sulted from the analysis of the real, biological networks. This last step allow us
giving a statistical foundation to the results. We decided to develop an approach
that is based on the comparison of real versus random data. This is a very well
known methodology which permits to affirm that the obtained results are not
due to chance. If they are statistically relevant they could really have a strong,
biological background and potential clinical implications. Using random tests
to validate experimental results is a common practice which is applied in several
field. The idea of creating such benchmark for the validation was born when
I had the opportunity to perform a work, as bioinformatician, that required to
validate some biological evidences in the context of the Alzheimer’s disease [77].
Here, I designed and developed a simple algorithm, by using R, which allowed
simulating a biological experiment using a number of randomly generate in-silico
experiments. After extracting the required information it was possible to validate
the biological results, to support the hypothesis presented in the paper, by com-
paring the real versus the random generated data. The final comparison was done
by using a statistical test for evaluating the different data distributions. What I
learnt was the importance of the experimental validation and how it can be ap-
plied in the biological field. So we decided that a tool that allows creating random
experiments was needed also in the field of biological network analysis and we
decided to fill the gap between random networks and Cytoscape.
5.2 Random network analysis
Validating biological networks is a process which is not straightforward in the
sense that there are several, different possible paths to follow and there are not
guidelines which define what is the best way to get the results. In this sense there
are several different random network models that were developed over time and
has different mathematical and topological properties. The first model refers to
the researches of Erdős & Rényi [117]. They defined a graph whose main char-
acteristic is a complete random topology where some nodes are linked by some
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randomly distributed edges. Then we have the Watts & Strogatz [118] model.
This is the first random graph model that shows the small-world property. A
more modern model refers to Barabási & Albert [119]. It allows the creation of
scale-free networks. These are networks with a hub-based structure, where an
hub is a node with a high number of neighbours. Finally there are also Com-
munity Affiliation Graphs [120] that are designed to describe social networks
between people and lattices that are grid of nodes. Currently, there is also the
new model we designed, called the Multiplication model that allows integrating
all the existing models by randomising the weight that are assigned to each node.
This amount of possibilities make it difficult to choose which model better
fits a specific biological experiment. Each model has its own characteristics and,
probably, the best way to create a random experiment is by trying to fit the
characteristics of our network and choose the model which recreates the most
similar behaviour. In this sense a very detailed analysis should be carried out
over a network aiming at describing its characteristics. Is our network scale-free?
Has it an high clustering coefficient? Is it showing small-world properties? These
questions should drive the decision for the best random model to use. Indeed, it
is not obvious which way one should choose and the multiplication model make
it more complex since there are no guidelines that may suggest how to proceed.
Also, the validation step is somehow not straightforward. It is possible to validate
different characteristics of the network. For instance, it is possible to compare the
Degree distribution of the real and the random networks or, generally speaking,
a specific centrality. Also, it is possible to compare the clustering coefficient,
the diameter and other networks parameters. But, since we are not interested in
comparing the topological characteristics one by one, we decided to compare the
classification results obtained from the real data with the same results from the
randomised data. The idea is to verify if the classifier is able to separate the healthy
and the unhealthy class even in a randomised set-up. What we expected is that the
algorithm should not be able to discriminate between two random classes since
the data come from the same, random distribution. In other words, the classifier
Accuracy should be around 50% since the algorithm should choose at random one
of the two classes, leading to a situation in which it is throwing a coin. To achieve
this goal, we decided to follow an experimental-based approach in order to model
the random networks. We performed several experiments in order to test which
is the best way to use randommodels. This means that we tried to mimic as much
as possible the real experiments using different, meaningful, approaches. Also we
exploited the same pipeline, i.e. the same algorithms, we used to perform the
computational analysis related to the multiplication model. We created different
sets of random experiments and we tested the pipeline for each one of them.
Following the experimental set-up allowed us creating a set of random datasets
that can be considered as plausible biological datasets.
Creating random networks
We designed three different experiments based on the random networks. We de-
cided to investigate the properties of only three, out of four, datasets that are
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respectively MI, BCLL and PET. AM dataset was left out since each network,
both for the healthy and the unhealthy subjects, has a variable number of nodes
making it very difficult to randomise the whole dataset. Hence, we created a set
of random networks for each of the outlined datasets obtaining a total number
of nine random datasets. The three experiments was designed in order to have an
increasing level of randomisation. In this sense, the first experiment has a very
low level of randomisation, the second one introduces another level of randomi-
sation and, finally, the third one shows the highest level of variations between the
original and the random data.
Figure 5.1: An example of network, that represents the interactions between a
set of proteins. Starting from this network we proceeded in creating some random
models, by applying different layer of randomisation. The first experiment used
this network and applied some random weights in order to multiply its topology.
The first experiment we designed required us to find the range of variation
in which the nodes experimental values vary. We found the minimum and max-
imum number of copies of node each class of network has. For instance, in the
MI dataset we found four ranges even though the classes are two, i.e. healthy and
unhealthy. We had to compute four ranges since the unhealthy class is divided
in different treatments, i.e. F, H, U and N. To better fit the experimental back-
ground, we found a range for each treatment. Once the ranges were found we
created an equal number of networks with randomly distributed nodes weights,
i.e. we generated a random array of weights for each network and we multiplied
it. The topology of the network in terms of nodes, edges and their connections
remained unchanged but the weights are now randomly distributed.
The second experiment we designed, aimed at adding an additional layer of
randomisation. The networks, each network for each class of each dataset, were
randomised by using a Degree preserving shuﬄing algorithm and then multi-
plied using some randomly computed weights. The Degree preserving algorithm
allowed randomising a network while keeping the Degree of the nodes fixed. In
this sense, if the Node 1 has five neighbours before the randomisation, it will
have five neighbours after the randomisation but these neighbours will, usually,
be different. It is important to note that the five neighbours before and after the
Chapter 5. Validating experimental findings 107
Figure 5.2: An example of random network. This is the same toy network that
has been randomised using the Degree Preserving shuﬄing algorithms. It allowed
obtaining a network with a fixed Degree but with randomly assigned neighbours.
This means that, for instance, the Node 3 have had a Degree equal to 3 in the
original network and it have a Degree equal to 3 in the randomised network. The
same happens for all the other nodes. Over this network an additional multipli-
cation, by using random weights, was done.
randomisation could be different, partially overlapping or the same depending on
the network. Clearly networks with a reduced number of nodes are more diffi-
cult to randomise using an edge shuﬄing algorithm. Finally, the random weights
were computed by using the same approach that takes advantage from the ranges.
This further randomisation step allowed to test the biological information that
arise from the actual biological interactions.
The third, and the last, experiment we designed and carried out, required the
creation of a set of random networks by using a randomising algorithm and then
by multiplying these networks by a set of random weighting array. What we
did was to randomise each network, for each dataset, we analysed by using the
Erdős–Rényi model randomisation. This model allows creating random network
which have the same number of nodes and edges as the starting network, but these
nodes and edges are randomly placed without considering any prior or posterior
information or design. Then, each node was multiplied by using the usual array
or random weights computed in the ranges for each class.
Results
The three different experiments allowed to generate different datasets of random
networks which aimed at modelling the same experimental set-up we were inves-
tigating. Then we applied the same pipeline that was used over the real, biological
data in order to extract the same topological features. Finally the same classifica-
tion step was performed, for each of the random sets, in order to compare the real
and the random classification performances. By applying the same methodology
we made the results from the biological and random networks comparable. The
results are showing very different classification outcomes that are very interesting
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Figure 5.3: An example of random network. This is the same toy network
that has been randomised using the Erdős–Rényi model. It allowed obtaining a
network with a fixed number of nodes and edges, randomly distributed. This
means that, starting from an original network with five nodes and six edges, the
algorithm created a new network with five nodes and six edges randomly assigned.
Over this network an additional multiplication, by using random weights, was
done.
and open new challenges. One of the results, i.e. the one from the PET analysis,
we obtained was expected. The two others give some interesting insights about
the nature of the networks and the features we used for describing them. Gen-
erally speaking, it is possible to affirm that for both the MI and BCLL random
datasets the classifier is able to find patterns and separate the classes with a very
high level of Accuracy. On the other hand the PET random dataset shows very
poor classification Accuracy.
Pancreatic Endocrine Tumours The results (see Fig. 5.4) obtained from the
PET random datasets show how the classification task resulted in a lower rate of
performance, in terms of classification ability, for all the three random datasets,
when compared to the biological dataset. This result is expected because of the
structure of the healthy and the unhealthy networks. Both these networks were
designed by using the same set of nodes and resulted in a network that is the same
for both classes, i.e. healthy and unhealthy. What happened while classifying was
that when multiplying and shuﬄing, using random information, we are making
the learning step more difficult. This means, in classification terms, that the clas-
sifier is not able to trace a clear threshold to decide to which class a sample belong.
Since the two networks are the same and since none of them, 71 in total, contain
a real, experimental and biological information, then the algorithm seems to be
not able to assign the sample to its class. Indeed, the Accuracy remains below
60% and, more generally, around 50% which is the same, as already mentioned,
as throwing a coin. This is even more clear when looking at the Accuracies.
The lowest score where obtained using the completely random network. This
means that, keeping the Degree fixed hence considering some original, topologi-
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cal characteristics, is fundamental to enhance the classifier performances. When
the information about the origina topology is completely lost, i.e. in the random
set-up, then the Accuracy decrease reaching the expected percentage, i.e. 50% or
so. From a network perspective, a topology that is randomly weighted lose the
information that is derived from the biochemical activity that allows potentiat-
ing it. Indeed, the algorithm is no more able to find recurring patterns since the
value we assigned are completely random. This result is a very good example that
support the hypothesis we wanted to validate.
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Figure 5.4: Showing the percentages of Accuracy of the original data versus
the random experiments, for the Pancreatic Endocrine Tumours dataset. On
the X axis the different alpha that were used to compute different accuracies, on
the y-axis it is possible to appreciate the percentage of Accuracy that each dataset
scored at different alpha level.
B-Cell Lymphocytic Leukemia The results obtained from the BCLL dataset
(see Fig. 5.5) shows a more linear behaviour. The results shows how the original
dataset scored the lowest values of Accuracy. This result is totally unexpected
since, in principle, random data should not be useful for separating two random
classes. But, a second possible explanation exists. Since the two average networks
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Figure 5.5: Showing the percentages of Accuracy of the original data versus
the random experiments, for the B-Cell Lymphocytic Leukemia dataset. On
the X axis the different alpha that were used to compute different accuracies, on
the y-axis it is possible to appreciate the percentage of Accuracy that each dataset
scored at different alpha level.
are different, it is possible that, by randomising the weights, the differences be-
tween these networks are, somehow, highlighted. Hence, a classifier will gain
in terms of classification performances since the task is easier, if compared to its
biological version where differences exist but are, somehow, more subtle. Obvi-
ously this is only an hypothesis but, surely, when classifying two networks whose
structure is different, but that share some common proteins, the algorithm takes
great advantage from the differences between the two networks.
Myocardial Infarction The results obtained with the MI dataset (see Fig. 5.6)
show another very interesting, altough unexpected, situation. As already said,
the original data allowed separating the two classes, i.e. healthy versus unhealthy,
with an Accuracy equal to one. What it is possible to appreciate from the re-
sults in the plot is that, when we randomise the weights and the whole topology,
we are losing some useful information and the learning algorithm is somehow
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Figure 5.6: Showing the percentages of Accuracy of the original data versus
the random experiments, for the Myocardial Infarction dataset. On the X axis
the different alpha that were used to compute different accuracies, on the y-axis
it is possible to appreciate the percentage of Accuracy that each dataset scored at
different alpha level.
mislead and its Accuracy has a limited drop. Surprisingly, the worst accuracies
were obtained with the dataset which was randomised by computing only ran-
dom weights. On the other hand, the other two randomised datasets, that should
contain a bigger amount of noise, show higher levels of Accuracy.
Both the MI and the BCLL random datasets are suggesting that the experi-
ments we designed may be not the proper way to address our question. In this
sense, randomising a network may require some different steps. What we did was,
by starting from the average networks for each class of subjects, to i) randomise
its weights or ii) randomise, at different level, its topology and weights. In both
cases, for the MI and the BCLL, it seems that these two directions do not repre-
sent the best approach for comparing real versus random data. The PET dataset
showed the expected results but, as already pointed out, this is probably due to
the fact that the two average networks, i.e. G1 and G2, are represented by the
same network.
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It is possible to define few new lines of research that aim at addressing this
question. The first, possible, experiment will generate a dataset that consider the
same network multiplied with two different sets of weights, one for the healthy
and one for the unhealthy class. The second possibility concerns the generation
of two distinct network, i.e. the same used in the original experiments, but a
single set of weights that is applied to both the networks. By doing so we are
investigating the properties of the weights, in the first case, and the properties
of the networks, in the second case. The last option refer to the fact that per-
forming only one experiment, i.e. we randomised only once and we classified
only a dataset for each random model, is not enough to evaluate a classifier over
a set of random networks. Probably, by generating more random datasets and
performing more classification will give us better results.

Chapter 6
Discussion and future works
6.1 Considerations about the topological and com-
putational analyses
We have defined a new approach to analyse complex biological systems, exploit-
ing experimental, quantitative datasets in the context of static topological analysis.
The two main goals were:
• the definition of a new modelling technique for integrating graphs and
quantitative data;
• the investigation of several topological indexes that could be used as poten-
tial biological markers;
• the definition of a computational pipeline that allows performing the same
analysis we carried out;
• the development of some tools that are required to perform the analysis;
• to give some biological directions in order to demonstrate how the model
could be useful.
Consistently, four biological datasets, obtained using high-throughput tech-
nologies, were modelled as potentiated networks. Then, all the proteins in the
networks were categorised by using nine different topological features, well known
in biological network analysis. The categorisation allowed the investigation of
these features and also the validation of their biological relevance in the context
of the new, multiplied models. In particular, the classification algorithm revealed
that topologies belonging to the same class share recurring patterns, which were
inferred by using specific topological descriptors. Healthy and unhealthy topolo-
gies were correctly classified, thus showing that the proposed multiplied model is
able to mimic the nature of a specific process. Moreover it appeared that some of
the features are more useful than others during the learning step.
A very interesting aspect, concerning the fact that the features that were used
are based on two different network characteristics, emerged. Indeed, a group
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of centralities focuses on the length of the shortest paths, while the second set
focuses on the number of shortest paths related to a specific node. The node
multiplication technique, as the theorem proved, only affects the second aspect,
i.e. the number of paths, since it involves the addition of some nodes and edges
leading to an increased number of shortest paths. Notably, in the PET dataset the
two more informative features are Betweenness, Bridging and Stress. To contex-
tualise this result it is important to note that these centralities are computed using
the number of shortest paths passing through a node. Also, the network used
for describing the two classes is the same, hence the distance between the nodes
remain the same. These two facts are two faces of the same coin and are strongly
dependent from each other. Indeed, the two networks differ only in terms of mul-
tiplication values. For this reason the classifier take great adavantage, in terms of
performances, from the augmented number of short paths. In other words, the
classifier takes great advantage from the information contained in the shortest
path based centralities to create its discriminative threshold. The other centali-
ties, in contrast, do not contain a comparable amount of information, since the
paths do no change, thus are not selected as best, i.e. most informative, features.
Figure 6.1: Showing a network which has a variable Eccentricity depending
on the presence of a node. The Node 1 allows the Node 5 to be connected to
the Node 4 in two steps, i.e. by the dotted lines. If the Node 1 is missing in a
subject, then it will not result in the network modelling that subject. In this case
the Node 5 should pass through the Node 3 and the Node 6, i.e. the dashed lines,
to reach the Node 4. The presence or absence of the Node 1, in this example
could be the difference between the two classes of subjects.
On the other hand, also shortest paths based centralities should be considered
very interesting indexes. In particular, we are referring to those proteins that are
present in a class of networks and not in the other class (see Fig. 6.1). Indeed,
centralities like Closeness, Radiality and Eccentricity are directly affected since
specific shortest paths become peculiar of a class. This is a very interesting aspect,
in the sense that a protein which is systematically missing in one class, becomes a
very interesting target. This fact allows the creation of novel shortest paths, mak-
ing this protein a marker for a class, in terms of topological characteristics of the
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network. In this sense, it becomes fundamental to understand, for each protein
which is present in a class and not present in the other class, why it is missing and,
more interestingly, which paths are affected. Indeed, different physio-pathological
conditions activate different molecules that are present in distinct amounts. By
using a topology that is able to emphasise such specificity, it becomes possible to
investigate particular experimental set-ups. It will be very interesting to develop a
computational methodology that allows the automated discovery of missing pro-
teins and, also, the paths that are influenced by such events. Missing proteins are
not informative because they are not present in a class. They become informative,
from a network perspective, in the sense that the new paths that are generated to
supply to the limitation of a missing protein, may suggest novel potential molec-
ular targets and pathways. These facts surely affect the learning step, since the
new centrality indexes that the nodes have, are surely affected by the new role the
node play when a protein is present or not.
Also, it resulted that specific features have an higher score, i.e. they have a
better ranking, in terms of best features, more frequently than others. For in-
stance the Eigenvector appears to be relevant in the AM, MI and BCLL datasets.
This centrality refers to nodes that have a relevant neighbourhood thus, the cen-
tral the neighbours the higher the Eigenvector of a specific node will be. In the
BCLL there are two peaks that correspond to Eccentricity and Eigenvector. The
presence of the Eccentricity could be explained by looking at the structural, i.e.
topological, differences between the two networks. Here, we have two average
networks, one for each class, that are different in terms of nodes interactions but
share some common proteins. These differences influence the distances between
the nodes. Also the shared proteins has a very high rate of variation in terms of
neighbourhood. Not only the nodes are different but also the number of copies
they have is different. These two facts greatly influence the Eccentricity that
becomes a very informative index. In other words, the same node, in the two net-
works, may have a very different neighbourhood depending on the multiplication
values. The range in which the multiplication values vary may be different, i.e.
it is possible to obtain a specific range for healthy and for unhealthy subjects. As
we said the Eccentricity for the multiplied topology sums up the contribution of
each copy of a node. So, the number of copies a node has strongly influence the
Eccentricity. Also the number of nodes a node reach, i.e. through short paths, is
an important factor that influences the Eccentricity. Hence, both these values, i.e.
the number of copies and the number or reached nodes, become a very impor-
tant information that is reflected, at the network level, by the Eccentricity. Also,
the Eigenvector is strongly influenced by the number of nodes and its variation,
i.e. high number or low number. The Eigenvector is a complex centrality and it
appeared as one of the best features in the BCLL, MI and AM datasets. Here, as
already highlighted, the two average networks are different. Also, they differ in
terms of relevance of the shared proteins, i.e. the number of copies they, and their
neighbours, have. Indeed, this happens because of the multiplication step, since
the Eigenvector is a sort of weighted Degree since it considers the Degree of the
neighbours too. The multiplication affects the number of nodes, hence the shared
proteins inherit very different roles depending on the class to which they belong.
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This means that their neighbourhood largely varies between the two classes, sug-
gesting a different level of involvement for the analysed proteins, in the global
topology of the networks. It is important to note that the Eigenvector is surely
influenced by the number of copies a node has since they are considered their
neighbours too. As we mentioned for the Degree (see Section 3.2), the number
of copies is considered as a contribution to the Degree a node has. Hence, nodes
with a high Eigenvector could be nodes that have:
• a high number of copies;
• neighbours with a high number of copies;
• a high number of neighbours.
Obviously the three possibilities may occur at the same time. Eigenvector is
able to take into consideration all these aspectes and nodes with a high Eigenvec-
tor centrality should be carefully considered.
In the future, the role of the centralities we are using should be clarified in
terms of biological meaning, see Section 3.2 since the current interpretation is
too general to be actually helpful. Using other metrics we didn’t exploited will be
surely interesting. Also contextualising the results is fundamental to understand
what a centrality is telling us. Finally, a deep knowledge of the model is basic
in order to consider all the information that come from this kind of analysis.
Another future improvement for our model and its investigation must focus on
the mathematical definition of the centralities we are currently using. We are
dealing with a new model and we defined some centralities that take into account
the existence of new nodes, i.e. the copies, but this may be good or not. A further
investigation should consider the fact that, for instance, the Degree should not
consider the copies of the nodes but only the actual neighbouts of a node. Also,
using other centralities could be meaningful, in order to obtain more information.
It is hard to define which centralities better describe the properties of a node or a
network. It is possible to investigate some characteristics rather than others but,
to obtain a comprehensive description of a process, different classes of centralities,
i.e. shortest path based and distance based, may be a good choice.
6.2 Considerations about the biological usefulness
of our approach
The datasets we analysed, that are very different in terms of biological context
and raw data, show some similarities when modelled as networks. It is important
to note that all the networks we built are, at some level, similar. This similarity
is due to the fact that they were constructed starting from the human proteome,
hence its underlying structure is found in all the subnetworks. But, even though,
the nodes multiplication, which is the crucial step allowing the personalisation
of a network, greatly affects the results. Indeed, multiplying the nodes allows
generating a great number of networks that become the tool that exploit the
personalised medicine approach.
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Obtaining a lot of networks describing a class of subjects permits a pattern
recognition approach whose predictive ability is directly influenced by the num-
ber of networks we are able to construct. Extracting a lot of topological infor-
mation from PPI networks allow the classifier, as we showed and discussed, to
take great advantage of these numbers in order to identify the specific class of a
network making the multiplication step fundamental for this task. The study we
carried out demonstrated that the proposed model is reliable and precise and, as
we mentioned, has very strong applications in the field of personalised medicine.
In this sense, it is easy to foresee that a multiplied model can easily be used to
model the whole proteome, once and if the data will be available, at the indi-
vidual level. The approach also helps us investigating -omics data from a system
perspective, enhancing the predictive ability of the raw data, e.g. proteomics or
genomics, by using specific features, i.e. the topological centralities, extracted
from the networks. It would be very interesting to create a healthy interactome
that could be used as a benchmark for validating different pathological interac-
tomes. Moreover, in a biomedical context, the investigation of those molecules
that potentially affect the length of the shortest paths along the different classes, as
already mentioned in Section6.1, could give interesting insights and suggest new
pharmacological targets. In these scenarios novel algorithms are required and,
from a computational perspective, there is the need for a benchmark which can
be used as a validation layer. In this sense the tool we developed, capable of creat-
ing random networks, which aims at simulating real data PPI networks, becomes
necessary to compare real data PPIs and randomised experiments to support this
kind of analysis.
From the biological point of view the investigation is not yet started and it
is very difficult to define the boundaries of our work in these terms. Indeed,
our contribution does not have a biogical focus and the results we obtained,
from a biological perspective, should be considered as suggestions for further,
in-depth investigation. On the other hand, the identification of the most interest-
ing molecules through the classification algorithms, is one of the results we were
expecting. There are a wealth of bioinformatical analysis that are designed to aid
the experimental side of the biomedical research. Our pipeline aims at enhancing
these practices in a personalised medicine context, presenting a novel model for
construcing precise networks. At this stage it is not possible to discuss the rele-
vance of the biological findings since we don’t have an experimental validation.
What we actually did was to show how the pipeline allow modelling -omics
data. We suggested some targets that we consider of sure interest since their bio-
logical role and relevance emerged from a complex analysis. Finally, we showed
how to obtain these molecular targets through our analysis. All these steps do not
concern the laboratory practice but, as already highlighted, become fundamental
in order to perform appropriate and very specific laboratory analysis. What fol-
lows is a targeted, experimental approach. It will be interesting to evaluate the
role of the proposed molecules through a preliminary experimental quantifica-
tion in order to assess whether they are present in the pathological cell lines or
not. These results should be compared with control cell lines in order to verify
if some differences exist and if they are statistically relevant. Then, investigating
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the behaviour of their first interactors could be meaningful in order to assess the
role these molecules are playing in regulating other proteins. Indeed, a question
that need to be addressed refers to the effect of the molecules we are suggesting
with respect to other proteins, e.g. their first neighbours, in a pathological setup.
What happens if the molecule is, somehow, silenced, i.e. not activated? What hap-
pens if it is overexpressed? As we know, proteins work togheter in order to carry
out complex biological tasks. Identifying these tasks in a complex network could
help reducing the complexity and the number of molecules under investigation,
while keeping an eye on the proteins that emerged from the computational anal-
ysis. Also, as we suggested, the Eccentricity centrality highlighted that missing
proteins, i.e. underexpressed or silenced proteins, could play a very interesting
role. In this sense, an experimental approach that consider not only a target but
also a pathway, will be surely of interest.
Another important aspect of the biological data we investigated, that should
be considered, refer to their temporal and spatial characteristics. Protein compo-
sition varies in time and in different families of cells. A protein may be present in
a pancreatic cell but not in a liver cell. These facts do not affect the analysis we
are proposing since, when dealing with a pathology, it is fundamental to compare
the same kind of cells. This means that, if we want to investigate breast cancer,
we will not use healthy glial cells as control cell lines. This is a basic consider-
ation but it is important to highlight the fact that it is not always possible, or
easy, to deal with specific cell lines because some can be difficult to isolate or to
grow in an artificial environment. Comparing meaningful samples is fundamen-
tal to obtain useful results. The same considerations apply to the temporal aspect.
Moreover, time requires a further consideration. When we build a network what
we are doing is basically to construct a steady model that represent a specific time
point. The exact time point is represented by the data, that comes from a biolog-
ical sample. Obtaining a biological sample in the morning may be different from
obtaining it at noon or in the evening. This fact becomes particularly relevant
when we are dealing with clinical samples that are obtained from real subjects.
The temporal aspect is very interesting and challenging since it can be used as
an advantage. It is possible to model different time points, generating a sort of
semi-dynamical network-based approach but it require a lot of data and it is not
the goal of this thesis. Summarising, the source of the data is fundamental, in
particular in a computational analysis like the one we are presenting that aims at
comparing different classes of the same objects.
In the future, enriching the networks by using a layer of biological infor-
mation giving insights about the role each protein plays, could be surely very
informative. Considering the experimental numerical values we used for the mul-
tiplication step in an enriched biological context will give a different perspective.
It may potentially helps in retrieving new, interesting evidences about the patho-
logical mechanisms. Also, the approach we are proposing become more and more
important if we consider that we have access to both healthy and unhealthy net-
works. In the future, it will surely be interesting to compare different set of
unhealthy subjects. As pointed out, we have two datasets, i.e. AM and MI, where
the unhealthy classes are composed by different kinds of unhealhy subjects. By ap-
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plying our workflow over these data it may be possible to find specific molecules
that directly depend on the kind of pathology and its, very specific, mechanisms.
It could be very interesting to investigate the properties of a specific pathology
since our approach points out the differences that occur in two, or more, different
samples.
These considerations are particularly interesting if we contextualise the work
in the field of personalised medicine. As we reported (see Section 1.2, the per-
sonalised approach requires very fine representations that allow depicting a single
individual and its molecular characteristics. This could be done by exploiting the
approach we proposed:
• it takes strong advantage from the increasing usage of high throughput anal-
ysis that allow obtaining personal data in a very short time and at decreasing
costs;
• it does not require expensive technologies and can be easily extended to a
lot of different biological data; also it theoretically works for any kind of
pathology;
• the data that are necessary to construct the network are constantly increas-
ing and are more and more reliable; so, it is possible to foresee that the
methodology will increase its predictive power.
On the other hand, our technique has some drawbacks. The pipeline requires
different softwares that should be used. We took advante of Cytoscape, Matlab
and R in order to perform the whole analysis and this may be not accessible
to a researcher that is not fluent in programming. Also, the workflow is quite
time consuming, since the steps that regarded the construction of the network
were manually curated. The higher the number of the networks, the longer the
workflow. Furthermore, our pipeline requires that the dataset consist of, al least,
two classes in order to perform the comparison and, ideally, they should have the
same number of samples.
Algorithmic drawbacks could be tackled, in the future, by developing specific
algorithms that are able to construct meaningful networks starting from a probe
and a well defined set of interactions. Ideally, these algorithms will be able to
cross the information from different databases in order to obtain a reliable model
in a very short time. Also, the pattern recognition step should be integrated into
both the Cytoscape side and our R library in order to make it availabe to the
broader audience, even to those researchers who don’t know what a classifier is.
Data drawbacks are, and probably will be, the most challenging issues since
the model we propose greatly depends from the numerical attributes that could be
obtained only through expensive -omics technologies. The advent of new, cheaper
technologies will surely enhance the quality and the amount of the available data
but this depends on multiple factors that it is not possible to foresee. We believe
that the whole pipeline could be automatised. The bottleneck is, as mentioned,
directly dependent from the availability of clinical data.
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6.3 Considerations about the random experiments
The app we developed, i.e. NetworkRandomizer, allows Cytoscape users in or-
der to create sets of random network which aim at validating real data networks.
This app offers some, different models that were proposed over time from dif-
ferent, expert researchers and that aimed at addressing some specific issues that
they were facing. For instance the Erdős-Rényi model was defined in 1959, which
means that the Systems Biology, as we intend it today, was very far from being
conceived [121]. This model aimed at creating networks by adding edges between
randomly chosen couples of nodes. Then some other properties of complex net-
work were uncovered, e.g. the small world property, and new models were devel-
oped like, for instance the Watts-Strogatz model. This fact is somehow confusing
when it is time to decide which model better fits our requirements.
To validate our findings we constructed different datasets of networks, by
using three different levels of randomisation. This was done by applying differ-
ent techniques but still it is possible that the methodologies we used could be
improved or proven to be not suitable. What we was aiming at, was to find rel-
evant differences between the biological data and the random data. We wanted
to achieve this result using a set of networks that strictly mimic the biological
experimental design. In other words, we wanted to introduce the lower level of
random noise that was enough to show, by using the same learning algorithm
we used for the analysis, an acceptable difference in terms of classification Accu-
racy. What we actually found out was that, no matter how much we randomise
a network, the random data seemed to be not suitable, for this task, in all the
experiments we carried out. Indeed, the random data show very different classifi-
cation results, which could be interpreted by saying that, probably, we are using
a wrong approach.
So, the approach we used for the creation of random dataset requires some
adjustments. The first problem that arose while designing the randomisation
step was related to the fact that the AM dataset, which have a very high level
of variations along the networks, does not have two average networks. In this
context it is not yet clear how we are supposed to proceed. Should we create a set
of random networks with random weights? Should we create a random network
that only considers the frame, i.e. the core structure, that is shared between all the
networks and lose the information that come from the first neighbours? We still
don’t have an answer to these questions, and this is a point that should be deeply
investigated, since biological datasets are very far from being homogeneous.
Also, the approach we used for randomising the other dataset could be cer-
tainly improved. Is that correct to use a random network for the healthy subjects
and one for the unhealthy subjects? Could it more meaningful to use a single
random network and weight it by using some random values? All these questions
arose when the results showed how in two datasets the classification task scored
very high accuracies. This is an unexpected result that poses some very interesting
questions but also that supports the results we obtained in the real, experimental
set-up. On the other hand, the PET random results demonstrated how, by using
the same network for both classes, the randomisation works and the classifier is
Chapter 6. Discussion and future works 121
no more able to separate the two classes. Indeed, the classification Accuracy is
around the 50% which means quite random. Also, these results highlight the fact
that managing random data in the context of biological network is not as easy
as it initially seemed. This means that it will be necessary to reconsider the ap-
proaches we proposed and evaluate the possibility to define some new, random
model which better fits the original experimental design.
Finally, and more interestingly, the multiplied model we propose, aiming at
modelling experimental values, is not studied and it may hide some interesting
properties that may be peculiar. The use of the cliques to model over-represented
proteins may result in some emergent properties we have not yet uncovered. So,
maybe, a new algorithm for generating this kind of networks may be defined,
giving rise to new possibilities for what it concern the randomisation of real,
experimental networks.
6.4 Conclusion and further considerations
The work we carried out has a multi-disciplinary nature and includes very differ-
ent fields ranging from the information technologies to the applied clinical prac-
tice. The model and the computational analysis we presented, aim at providing
some ideas and guidelines that may potentially improve the investigation of com-
plex biological process. We designed the whole work in order to aid researchers
in the field of personalised medicine. Indeed, we showed four different patho-
logical contexts in which our analysis gave interesting results and little biological
insights. Managing mathematics, computer science, biology and pathology is
surely challenging. We provide some tools that allow to interface these different
worlds. Also, our approach will hopefully open new perspectives and aims at
giving a new point of view, i.e. a system-based point of view, that is not yet fully
investigated and understood.
One of the main issues with Systems Biology reflect the difficulty of explain-
ing to those people who are not working in the field why and how it is a very
powerful tool and how it could potentially affect the way they usually manage a
laboratory and the way they carry out their everyday research. In-silico predic-
tions allow reducing time and cost for a very wide range of wet-lab experiments
that are currently carried out. Moreover, it can significantly enhance our predic-
tive power through the development of very detailed models for the diseases and,
generally speaking, for all the complex processes that take place in every organ-
ism and, also, between different organisms. The approach we proposed has very
interesting applications in the field of personalised medicine but, since it involves
complex subjects like machine learning, the motivations that induced us at using a
pattern recognition algorithm to investigate a set of topological centralities could
be misunderstood.
A very important future development, in this sense, must aim at overcoming
the communication limitations. How to present these kinds of works to medical
doctors, biologists, biotechnologist, laboratory technicians is very challenging
but also explaining what a molecular mechanism is to programmers and software
developers requires big efforts. Ideally, these two worlds should work together in
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order to face the new challenges that are arising from a complexity that cannot
be tamed in a wet-lab, by using a Petri dish. Finding a common language will be
more and more necessary since the collaborations between each other, considered
as a big, interacting system should be exploited.
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Figure A.1: Comparison between topological and raw data features, AM dataset.
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Figure A.2: Comparison between topological and raw data features, AM dataset.
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Figure A.3: Comparison between topological and raw data features, AM dataset.
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Figure A.4: Comparison between topological and raw data features, BCLL
dataset.
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Figure A.5: Comparison between topological and raw data features, BCLL
dataset.
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Figure A.6: Comparison between topological and raw data features, BCLL
dataset.
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Figure A.7: Comparison between topological and raw data features, MI dataset.
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Figure A.8: Comparison between topological and raw data features, MI dataset.
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Figure A.9: Comparison between topological and raw data features, MI dataset.
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Figure A.10: Comparison between topological and raw data features, PET
dataset.
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Figure A.11: Comparison between topological and raw data features, PET
dataset.
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Figure A.12: Comparison between topological and raw data features, PET
dataset.
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Figure A.13: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.14: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.15: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.16: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.17: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.18: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.19: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.20: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.21: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.22: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.23: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.24: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.25: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.26: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.27: Histograms that shows all the feature selections algorithms that were
run.
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Figure A.28: Histograms that shows all the feature selections algorithms that were
run.
